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ABSTRACT 
DISTRESS, CIRCADIAN RHYTHMS, IMMUNITY, AND SURVIVAL 
IN PRESURGICAL BREAST CANCER PATIENTS 
 
Whitney Nicole Rebholz 
 
October 10, 2016 	  
 Women with breast cancer experience significant stress related to diagnosis and 
treatment, which may negatively affect physiology (e.g., circadian, endocrine, and 
immune) and contribute to cancer progression. Demographic (e.g., ethnic minority) and 
neighborhood factors can contribute to cancer-related stress. African American women 
with breast cancer experience more adverse disease pathology and earlier mortality; 
however, factors that explain these disparities rarely have been explored. It is 
hypothesized that psychosocial stressors (i.e., ethnicity, neighborhood stress, and cancer-
related stress) will be related to one another. Associations of psychosocial stress with 
physiological disruption are posited with regard to circadian, endocrine, and immune 
function. It is also hypothesized that psychosocial stress and physiological disruption will 
predict earlier cancer recurrence/mortality. 
Presurgical breast cancer patients (N=57) reported on demographics and cancer-
related stress and provided three-day home-based collection of rest/activity rhythms and 
salivary cortisol. Neighborhood stress data were obtained via the 2010 Census. Immune 
parameters were assessed in serum samples. Progression-free survival status was 
obtained at a median of seven years post-enrollment. 
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Bivariate correlations examined relationships between psychosocial stressors. 
Hierarchical linear regressions adjusted for age, cancer stage, and income in tests of 
associations between psychosocial stress and physiological disruption. Cox proportional 
hazards analyses tested the prognostic value of psychosocial stress and physiological 
disruption on progression-free survival from initial diagnosis and study entry. 
African Americans had higher neighborhood stress compared to non-Hispanic 
White patients. Patients with greater neighborhood stress had greater overall cortisol 
secretion (ΔR2 = .246, p = .001). Patients reporting greater cancer-related stress had 
accentuated diurnal cortisol rhythms (ΔR2 = .084, p = .047). Exploratory post hoc 
analyses revealed this finding was likely driven by avoidance of cancer-related thoughts. 
Psychosocial stress was not significantly related to circadian or immune disruption, nor 
was psychosocial stress or physiological disruption predictive of progression-free 
survival.  
Improved resources within disadvantaged neighborhoods may help counter the 
effects of neighborhood stress on cortisol disruption by reducing stress and improving 
health outcomes. Interestingly, during the acutely stressful presurgical period, avoidance 
appears to serve as an adaptive coping strategy. Therefore, the presurgical period may be 
the opportune time to introduce psychosocial interventions to combat challenges 
throughout one’s cancer journey.
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INTRODUCTION 
 
Breast Cancer 
Incidence, risk, and mortality. Breast cancer is the most common cancer 
diagnosed in women and accounts for approximately 29% of new female cancer 
diagnoses (Siegel, Ma, Zou, & Jemal, 2014). In the 1980s, rates of breast cancer 
increased dramatically, primarily due to better detection through utilization of 
mammography (DeSantis, Ma, Bryan, & Jemal, 2014). Increases in rates of obesity and 
use of menopausal hormones, both of which are breast cancer risk factors, partly explain 
a small increase in incidence rates in the late 1990s (DeSantis et al., 2014). In the early 
2000s, the rates of breast cancer incidence dropped drastically, most likely due to a 
decrease in the use of hormone replacement therapy following a Women’s Health 
Initiative publication (DeSantis et al., 2014). The current risk of being diagnosed with 
breast cancer is 1 in 8 for women living in the United States (DeSantis et al., 2014). 
Incidence rates of breast cancer have remained stable over the past decade (Siegel et al., 
2014). 
Breast cancer is the second most common cause of death from cancer among 
women, accounting for 15% of cancer deaths in women (Siegel et al., 2014). Among 
women aged 20 to 59, breast cancer is the leading cause of cancer death (Siegel et al., 
2014). However, rates of mortality from breast cancer have been declining, particularly 
due to improvements in detection and treatment (DeSantis et al., 2014). 	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Breast cancer types. There are different types of breast cancer, which are 
classified based on the origin and spread of cancer. Ductal carcinoma in situ (DCIS) is 
noninvasive carcinoma, meaning cancer occurs within the breast ducts and has not spread 
beyond the duct of origin (Van Goethem et al., 2006). Invasive breast carcinoma 
indicates that cancer has spread beyond the site of origin (e.g., duct or lobule) and into 
the surrounding breast tissue (Andersson, 2005). Invasive carcinomas often develop from 
DCIS. When cancer has spread to distant tissue and organs, it is considered metastatic 
disease.   
Breast tumors can be classified as a carcinoma or sarcoma. Carcinoma is the most 
common type of breast cancer, which indicates that the cancer originated in the epithelial 
cell lining of breast tissue (Andersson, 2005). Sarcomas, which arise from the 
mesenchymal tissue of the breast (Adem, Reynolds, Ingle, & Nascimento, 2004), account 
for less than one percent of breast cancer diagnoses (Pandey, Mathew, Abraham, & 
Rajan, 2004). 
Disease staging. Breast cancer is staged in order to measure the extent of the 
disease. The tumor-node-metastasis (TNM) staging system is widely used and is based on 
the size of the tumor, the presence of metastasis to lymph nodes, and the presence of 
distant metastases (Singletary et al., 2002). Stages of breast cancer range from 0 to IV. 
Stage 0 is a mass that has not yet spread beyond the lobule or duct where it originated, 
which is referred to as carcinoma in situ. Stage IV is cancer that has spread to distant 
organs of the body.  
Hormone status. Determining the hormone receptor status of breast cancer cells 
has become a common practice, as there are implications for treatment options and 
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predictions of subsequent survival time based on the presence or absence of certain 
hormone receptors. The status of three receptor types is determined using tumor tissue 
samples, taken during diagnosis of breast cancer. These are estrogen receptor (ER), 
progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). The 
most common combination is ER/PR positive (+) and Her2 negative (-) (68.9%; Onitilo, 
Engel, Greenlee, & Mukesh, 2009). The absence of all three hormone receptors is known 
as “triple negative” breast cancer. For an individual diagnosed with triple negative 
cancer, there are fewer treatment options, as receptor-targeted hormone therapy is not 
effective with these cases (Bauer, Brown, Cress, Parise, & Caggiano, 2007). Triple 
negative status is associated with the shortest survival rate (Onitilo et al., 2009). The 
prevalence of various hormone receptor types varies across racial/ethnic groups. Triple 
negative breast cancer is highest among African American women (Bauer et al., 2007). 
Treatment options. Multiple standard treatments are used to treat the different 
stages and types of breast cancer (Carlson et al., 2011).  Localized disease is treated with 
surgery, radiation therapy, or both, whereas widely invasive or metastatic disease is 
treated with chemotherapy, endocrine therapy, biologic therapy, or combination therapy 
(Carlson et al., 2011). Surgery is performed in order to remove cancer from the breast. 
One type of surgery is breast-conserving, (e.g., lumpectomy or partial mastectomy), 
indicating that tumor is removed but the entire breast is not (Parajuli, 2015). 
Alternatively, patients may opt for total mastectomy, which is the surgical removal of the 
entire breast (Parajuli, 2015). Chemotherapy, the use of systemic drug treatment to either 
kill cancer cells or inhibit their division, may be used prior to surgery, a strategy known 
as neoadjuvant treatment (Parajuli, 2015). Chemotherapy is used to reduce the tumor size 
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and therefore the amount of tissue to be removed at the time of surgery (Parajuli, 2015) 
Chemotherapy and/or radiation therapy, the use of radiation to kill or shrink cancer cells, 
may be used after surgical treatment (Jacobs & Finlayson, 2010). Endocrine therapy is a 
treatment that blocks the effects of naturally occurring hormones that stimulate the 
growth of breast tissue (e.g., estrogen; Miller & Ingle, 2002). Biologic therapy is drug 
treatment that activates the immune system to inhibit tumor growth and spread (Vachani 
& Millar, 2015) and includes HER2-targeted therapy (Carlson et al., 2011). 
Psychological symptoms. Breast cancer can be thought of as a series of stressors 
that relate to diagnosis, treatment, reduction in functional ability, changes in social and 
vocational roles, and concerns related to morbidity and mortality (Spiegel & Sephton, 
2001). Psychological distress can manifest as depressive symptoms, anxiety, insomnia, 
and increasing social isolation; all of which are common following a cancer diagnosis 
(Mertz et al., 2012). In a study of women with breast cancer, clinically significant levels 
of either anxiety or depression were observed in 34% of patients two months following 
diagnosis (Gallagher, Parle, & Cairns, 2002). These symptoms decreased by six months 
post-diagnosis; however, rates of psychological illness remain higher among cancer 
patients in comparison with those of the general population (Gallagher et al., 2002). 
Additionally, women newly diagnosed with breast cancer experience greater role 
limitations related to emotional difficulties than those with stable disease (i.e., women 
who have completed adjuvant treatment and are at least six-month post-diagnosis, and 
women who have not experienced a recurrence; Hanson Frost et al., 2000). 
Tumor progression.	  The spread of cancer from the primary site to lymph nodes 
and distant organs constitutes metastatic disease. Cancer cells and associated tissue 
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develop “Hallmark” capabilities that promote tumor growth and spread (i.e., movement 
out of the site of origin into other tissues; Hanahan & Weinberg, 2011). Many steps are 
essential for cancer to metastasize, including proliferation (i.e., growth or production of 
cancer cells; Guo & Hay, 1999), angiogenesis (i.e., development of a blood supply; 
Lutgendorf, Sood, & Antoni, 2010), detachment, and invasion (i.e., cancer cells must 
separate from their site and move through the body in order to invade other organs; 
Armaiz-Pena, Cole, Lutgendorf, & Sood, 2013). Embolism, circulation, stopping in an 
organ and adhering to vessel walls, extravasation (i.e., the movement of cells from blood 
vessel to tissue; Miles, Pruitt, Golen, & Cooper, 2007), and the establishment of a tumor 
microenvironment, and blood supply (Fidler, 2003; Hanahan & Weinberg, 2011) are also 
steps needed for metastasis. Additionally, cancer cells must evade growth suppression, 
immune destruction, and apoptosis and stimulate inflammation that helps to promote the 
tumor (Hanahan & Weinberg, 2011). Metastatic tumors are responsible for 90% of cancer 
deaths, as compared with primary tumors (Sporn, 1996).	  
Stress and Health 
Psychological stress is defined as the appraisal of an event or circumstance as 
demanding or overwhelming to the point that coping resources will be taxed or exceeded 
(Lazarus & Folkman, 1984). Neuroendocrine and immune stress responses that function 
in a normal manner (i.e., activated in response to threats to survival) are essential to 
leading a healthy life. Under acute stress conditions, these systems serve protective 
functions for the human body. However, when stress responses are frequently and 
repeatedly activated over an extended period (i.e., chronically activated), elevations in 
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exposure to stress hormones occur and may have detrimental effects on other body 
systems causing a loss of flexibility of biologic responses to stress (McEwen, 1998).  
When stress responses are chronically activated, a buildup of physiological 
damage can occur (McEwen, 2006), leading to stress-related diseases (Sapolsky, 2004). 
Specifically, chronic stress can affect biological processes (i.e., neuroendocrine and 
immune responses) that influence cancer progression (i.e., metastasis; Moreno-Smith, 
Lutgendorf, & Sood, 2010). A biobehavioral model (Andersen, Kiecolt-Glaser, & Glaser, 
1994) indicates that cancer diagnosis and treatment can serve as a stressor sufficient to 
impact tumor growth and immune defenses through overactivation and dysregulation of 
neuro-endocrine-immune pathways, promoting the progression of cancer (Andersen et 
al., 1994).  
Stress Related to Ethnicity 
A person’s ethnicity, and their identification with their ethnicity, can contribute to 
psychological stress. Racial or ethnic identification is defined as the “cognitive-affective 
representation of ethnic group membership within a person” (Contrada et al., 2001, p. 
1779). Ethnicity-related stress can be defined as the appraisal of the environment with 
regard to one’s ethnicity, which may lead to the anticipation of harm, either physical or 
psychological, or to the belief that harm has already occurred (Contrada et al., 2001).  
A review article described three contributing factors to ethnicity-related stress: 
ethnic discrimination (i.e., unfair treatment of an individual based on their race/ethnicity), 
stereotype threat (i.e., the risk of conforming to a negative stereotype for the group that 
one belongs to), and own-group conformity pressure (i.e., being pressured to comply with 
expectations from the group that one identifies with; Contrada et al., 2000). Ethnicity-
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related stress may develop in response to a number of events, such as believing that there 
are threats to one’s self-esteem, recognizing a lack of normalization by the group to 
which one belongs, and experiencing hopelessness related to one’s ethnic identification 
(Clark, Anderson, Clark, & Williams, 1999). Additionally, maintaining one’s ethnic or 
cultural identity may contribute to stress due to pressure to conform to the group to which 
one belongs or to conform to the perceptions of norms and expectations of the in-group 
(Contrada et al., 2000). However, ethnic identity has also been shown to be positively 
related to quality of life (QOL) and overall well-being (Utsey, Chae, Brown, & Kelly, 
2002). Therefore, it is important to delineate what aspects related to ethnicity (e.g., racial 
discrimination) contribute to ethnicity-related stress and what facets may enhance well-
being. 
Certain life stressors are more often experienced in ethnic minority groups, which 
may promote stress in these individuals. These stressors are largely based on 
socioeconomic disadvantages (Lillie-Blanton & Laveist, 1996; Harrell, 2000). As is well 
known, socioeconomic status (SES) covaries with ethnicity. Generally, SES can be 
characterized as a measure of opportunities, both educational and economic, that are 
available in an individual’s environment (Lillie-Blanton & Laveist, 1996). In a large 
longitudinal study that followed Baltimore schoolchildren for years, in adulthood the 
African American men earned less and had lower employment than the non-Hispanic 
(NH) White men with equal educational attainment (Alexander, Entwisle, & Olson, 
2014). Additionally, African Americans were more likely to be single parents, and while 
African American women earned similar income to NH White women, because of the 
larger number of African American single-mother households, the family income was 
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substantially lower compared to NH Whites (Alexander et al., 2014). Although all 
participants in the study were socioeconomically disadvantaged, it was determined that 
NH White participants had access to greater resources, especially with respect to 
obtaining employment, and these resources may be beneficial in creating a pathway 
toward better SES over time (Alexander et al., 2014). In a study of NH White and 
Hispanic lesbian, gay, and bisexual individuals an association between ethnicity and 
perceived stress was observed, and this relationship was mediated by SES, as well as 
lifetime discrimination (Kim & Fredriksen-Goldsen, 2016). Furthermore, ethnic 
minorities experience greater perceptions of stress related to employment, financial 
strain, life discrimination, job discrimination, relationships, and early life (Sternthal, 
Slopen, & Williams, 2011). 
A biopsychosocial model of perceived racism can further illuminate the effects of 
ethnicity-related stress. Sociodemographic, psychological, and behavioral factors, as well 
as coping resources, interact in response to the perception of racial discrimination, 
playing a vital role in the impact of ethnicity-related stress on health outcomes (Clark et 
al., 1999). Both negative physical and psychological health outcomes have been observed 
in those who experience perceived racism (Clark et al., 1999) and ethnicity-related 
stressors (Contrada et al., 2000). Additionally, effects of both intergroup and intragroup 
racism may culminate in adverse health outcomes (Clark et al., 1999). Perceived racial 
discrimination has been shown to be associated with psychological distress (Sellers, 
Caldwell, Schmeelk-Cone, & Zimmerman, 2003; Kessler, Mickelson, & Williams, 1999), 
as well as depressed mood and anxiety (Kessler et al., 1999). The accumulation of 
ethnicity-related stress along with other general stressors may deem ethnic minorities at 
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greater risk for mentally and physically detrimental effects than those who are within the 
ethnic majority, for example, NH Whites in the United States. In a sample of first year 
African American medical students, those with lower racial identification were less likely 
to endorse depressive and anxiety symptoms (Hardeman et al., 2016).  
Disparities exist among ethnic minority groups in health status, morbidity, and 
mortality (Myers, 2009). It has been shown that ethnic differences in disease relate more 
to underlying social conditions (i.e., childhood poverty, inadequate education, low 
income, minimal employment, and separated living conditions), rather than to behavioral 
differences (e.g., coping style; Harrell, 2000). Socioeconomic factors also contribute 
substantially to ethnic health disparities (Lillie-Blanton & Laveist, 1996). Also, ethnic 
health disparities may be due to one’s surroundings (i.e., neighborhood and work 
conditions), social relations, and power arrangements (i.e., individual and community 
control and influence; Lillie-Blanton & Laveist, 1996). 
Ethnic minorities differ from the majority in the trajectory of chronic disease and 
in response to treatment (Myers, 2009). Ethnicity-related stress has been shown to 
accelerate the progression of a number of diseases, one of which is cancer (Myers, 2009). 
Specifically, adverse disease outcomes occur at higher rates in ethnic minorities, with 
African Americans experiencing the greatest burden (Myers, 2009). Breast cancer 
incidence is highest among NH Whites, but African Americans suffer the highest 
mortality (DeSantis et al., 2014). Additionally, in comparison with NH Whites, African 
American breast cancer patients are more likely to be diagnosed at an earlier age, and are 
diagnosed with more advanced stage disease or more aggressive cancer types (Middleton 
et al., 2003).  
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Access to health care and receipt of treatment do play a role in the association 
between ethnicity and cancer. Ethnic minorities experience disparities in receipt of 
definitive primary (i.e., surgery and radiation) therapy, conservative surgery, and 
adjuvant treatments (i.e., chemotherapy and hormonal therapy; Shavers & Brown, 2002). 
Additionally, NH Whites are more likely to receive aggressive cancer treatments 
(Shavers & Brown, 2002). Evidence suggests there are relatively fewer ethnic differences 
in health care access in systems with universal accessibility (i.e., Department of Defense), 
supporting the notion that poor access may be a major determinant of ethnic differences 
in health outcomes (Mayberry, Mili, & Ofili, 2000). Concerning cancer outcomes, the 
literature is less clear due to a lack of treatment data and limited quality of previous 
research (Mayberry et al., 2000). Therefore, further research should more broadly explore 
factors that contribute to the relationships observed between ethnicity and cancer to better 
understand ethnic differences in clinical characteristics (e.g., age and stage at diagnosis), 
as well as differences in treatment modalities and outcomes (e.g., morbidity and 
mortality). 
Some data suggests that ethnic differences in health behaviors also explain a 
portion of the differences in cancer progression. A telephone survey of 42,044 
households revealed that, in general, African Americans are more likely to smoke, report 
a lack of physical exercise, and be overweight compared to NH Whites (Shariff-Marco, 
Klassen, & Bowie, 2010), all of which enhance the risk of breast cancer. Compared to 
NH Whites, Latino participants were more likely to binge drink and be overweight, Asian 
American participants were more likely to be less physically active, and American 
Indian/Alaskan Native participants were more likely to smoke, binge drink, report a lack 
	  	   11 
of physical exercise, and be overweight (Shariff-Marco et al., 2010). These health 
behaviors may contribute to cancer progression (Calle, Rodriguez, Walker-Thurmond, & 
Thun, 2003; Tammemagi, Neslund-Dudas, Simoff, & Kvale, 2004; Vucenik & Stains, 
2012). The possible effect of health behavior differences on cancer outcomes is a nascent 
research area. 
It is also possible that genetic differences related to ethnicity may explain some 
disease outcome variance. Indeed, genetic factors can interact with environmental ones to 
produce discrepancies in health outcomes (Caspi et al., 2003).Thus, gene-environment 
interactions related to alleles more prevalent in ethnic minorities may potentially explain 
some ethnic differences in cancer outcomes (Braun, 2002). 
Research has primarily focused on perceived racism/racial discrimination as 
determinants of ethnicity-related stress. While this research aids in understanding 
interactions of ethnicity and stress, there are additional areas that warrant attention. 
Perceived stress in relation to minority ethnic identification should be investigated, as 
understanding these associations may help in identifying ethnic differences in the 
perception of stress. Additionally, exploring ethnicity-related stress and health outcomes 
may help to elucidate potential mechanisms that drive ethnicity-related health disparities. 
Neighborhood Stress 
Research has shown that neighborhood disadvantages may impact health more 
than individual socioeconomic and demographic factors (Ross & Mirowsky, 2001). 
Neighborhood-level variables may include the built environment (e.g., the presence of 
toxic waste facilities, traffic exposure, and medical infrastructure; Matthews & Yang, 
2010). Additionally, neighborhood safety, residential stability, and measures of social 
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disadvantage, including poverty, unemployment, and receipt of public assistance are 
considered social characteristics of neighborhoods (Matthews & Yang, 2010).   
Neighborhood factors can be viewed as a source of chronic stress that may have 
an adverse impact on health (Steptoe & Feldman, 2001). Neighborhood factors that may 
influence the health of residents include the percentage of people that are poor, lack of 
education, are unemployed, and the percent of single mother households (Hill, Ross, & 
Angel, 2005).  In low socioeconomic neighborhoods, there are greater rates of cancer 
(Adler, Boyce, Chesney, Folkman, & Syme, 1993). Furthermore, research has shown that 
even though the relationship between neighborhood-level stress and health of the 
residents has been established, the mechanisms of this relationship remain underexplored 
(Ellen, Mijanovich, & Dillman, 2001; Ross & Mirowsky, 2001).  
Environmental stressors may “get under the skin” by way of psychological, 
physiological, and behavioral pathways. Indeed, unstable neighborhoods (i.e., high 
turnover and low homeownership), appear to negatively influence the health of the 
residents (Boardman, 2004). Given the importance of stress in the progression of cancer, 
it will be very informative to consider the role neighborhood factors in stress-cancer 
associations.   
Cancer-Related Stress 
Acute stress disorder (ASD) and post-traumatic stress disorder (PTSD) are 
classified as trauma- and stressor-related disorders in the fifth edition of the Diagnostic 
and Statistical Manual of Mental Disorders (DSM 5; American Psychiatric Association, 
2013). ASD and PTSD are diagnosed after the development of a constellation of 
symptoms (i.e., intrusions, avoidance, negative alterations in mood or cognition, and 
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changes in arousal or reactivity) following a traumatic event (American Psychiatric 
Association, 2013).  In ASD the symptoms are present from three days to one month after 
the traumatic event, whereas PTSD is diagnosed when the symptoms endure longer than 
one month (American Psychiatric Association, 2013). It is important to note that DSM-IV 
allows for a life-threatening illness as a traumatic stressor; however, with changes to 
DSM-5, life-threatening illnesses are no longer considered a traumatic stress event 
(Swartzman, Booth, Munro, & Sani, 2016). Therefore, it is possible that individuals with 
cancer may experience symptoms of PTSD (e.g., intrusions or avoidance) and no longer 
meet diagnostic criteria for PTSD.  
Cancer-related stress differs from ASD and PTSD, as both are mental disorders 
recognized in DSM-5, whereas cancer-related stress is not a diagnosable mental disorder. 
Cancer-related stress includes two symptoms of PTSD, intrusions and avoidance. 
Intrusions include intrusive thoughts, nightmares, intrusive imagery, and dissociative-like 
re-experiencing, whereas avoidance includes numbing of responsiveness and avoiding 
feelings, situations, and ideas (Horowitz, Wilner, & Alvarez, 1979). The presence of both 
symptoms indicates elevated cancer-related stress and more severe impact of illness 
(Mcbride, Clipp, Peterson, Lipkus, & Demark-Wahnefried, 2000). Cancer-related ASD, 
cancer-related PTSD, and cancer-related stress have been observed throughout the breast 
cancer trajectory. 
In a sample of 85 newly diagnosed (i.e., average of 11.65 days after diagnosis) 
breast cancer patients, those who experience high levels of intrusions or both intrusions 
and avoidance had the poorest psychological adjustment to diagnosis (Primo et al., 2000). 
In contrast, those who reported low levels of both symptoms had the lowest level of 
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depressive and anxiety symptoms at six-month follow-up (Primo et al., 2000). In a study 
of 166 breast cancer patients, four met criteria for cancer-related ASD and two met 
criteria for cancer-related PTSD after diagnosis and prior to surgery (i.e., lumpectomy or 
mastectomy; Voigt et al., 2016). After chemotherapy (i.e., seven and one-half months 
after baseline assessment) and one year after baseline assessment, three of the patients in 
the study met criteria for either cancer-related ASD or cancer-related PTSD (Voigt et al., 
2016). Of note, while not meeting criteria for ASD or PTSD, 82.5% of patients endorsed 
cancer-related PTSD symptoms at baseline, and 57.3% endorsed symptoms at one-year 
follow-up (Voigt et al., 2016). In a sample of 437 women with breast cancer, three 
percent (n=13) met criteria for PTSD, diagnosed with a Structured Clinical Interview for 
DSM-IV, at baseline (i.e., average of 65.4 days after diagnosis; Kwakkenbos, Coyne, & 
Thombs, 2014). At three month follow-up, nine patients met criteria for PTSD 
(Kwakkenbos et al., 2014). One-hundred seventeen patients with primary breast cancer 
within six months of a diagnosis experienced cancer-related stress at a level that is 
moderately high (Koopman et al., 2002). In a sample of 150 women with breast cancer, 
high levels of intrusions and avoidance following diagnosis and prior to surgery remained 
two years later (Arnaboldi et al., 2014).  
Women with metastatic breast cancer also report high rates of intrusions and 
avoidance, rates that are comparable to those who have had experienced other traumatic 
stressors such as survivors of multiple shootings and motor vehicle accidents (Butler, 
Koopman, Classen, & Spiegel, 1999). However, it appears that levels of cancer-related 
stress are lower among women with primary breast cancer (Koopman et al., 2002a) as 
compared with metastatic patients (Butler et al., 1999). In a sample of women who had 
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completed treatments for breast cancer, five to ten percent met criteria for the diagnosis 
of cancer-related PTSD (Cordova et al., 1995). A recent meta-analysis revealed that 
survivors of cancer are 1.66 times more likely to have PTSD than controls without cancer 
(Swartzman et al., 2016).  
Possible factors that may increase the likelihood of cancer-related PTSD include 
younger age at diagnosis, receiving chemotherapy, and time since diagnosis (i.e., PTSD 
rates appear to decrease over time; Swartzman et al., 2016). Cancer-related stress has 
been shown not to be associated with time since diagnosis (Mcbride et al., 2000). It 
appears that cancer-related stress is present from the time of a breast cancer diagnosis and 
remains throughout the treatment trajectory. Therefore, the stress associated with a breast 
cancer diagnosis may be psychologically impactful and salient in the long-term for the 
patient, rather than only present initially following the diagnosis (Mcbride et al., 2000). 
Circadian Rhythms 
Healthy circadian regulation. Human physiology is synchronized with the 
rotation of the earth by the hypothalamic suprachiasmatic nuclei (SCN). The central 
circadian clock, located in the SCN, synchronizes the peripheral clocks of most 
mammalian cells through an array of circadian physiological rhythms that include 
rest/activity rhythms, hormonal secretions, body temperature, and feeding (Mohawk, 
Green, & Takahashi, 2012; Schibler et al., 2015). Light-dark cycles are the strongest 
zeitgebers of central control over peripheral rhythms (Schibler et al., 2015). The 
traditional view of the relationship between the SCN and the peripheral cellular clocks is 
believed to be hierarchal in nature, with the central clock of the SCN regulating the 
timing of peripheral clocks; however, recent research is beginning to show that the 
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relationship may be more “federated,” such that various oscillators are equal to one 
another (Husse, Eichele, & Oster, 2015, p. 1120). Therefore, it is likely that peripheral 
clocks are influenced by independent zeitgebers (e.g., light-dark cycles, hormones, blood-
borne signals, body temperature; Husse et al., 2015).  
Circadian rhythms and cancer. Research has shown that dysregulated circadian 
rhythms, specifically shift work that involves the disruption of circadian rhythms, is 
probably carcinogenic to humans, which makes it a Class 2A carcinogen (Straif et al., 
2007). Shift work is associated with changes in rest/activity rhythms, such that patterns of 
activity become deregulated and circadian synchronization is lost, which can lead to 
dysregulation of the endocrine and immune system (Herichova, 2013). Research 
regarding the prognostic value of circadian disruption and cancer risk has confirmed 
higher incidence of breast cancer in nurses who worked night shift for many years 
(Davis, Mirick, & Stevens, 2001; Schernhammer et al., 2001; Schernhammer, Kroenke, 
Laden, & Hankinson, 2006).  
Changes to circadian rhythms occur in tumor tissues, animal models with tumors, 
and human cancer patients. As a tumor progresses, circadian alterations worsen 
(Mormont & Levi, 1997). Research on effects of lesions to the SCN in murine models 
has revealed changes to implanted tumors that result in accelerated growth and shorter 
survival (Filipski et al., 2002; Filipski, Li, & Levi, 2006). When a tumor is present, it is 
possible that disruption of circadian rhythms may be a response to biological effects of 
the tumor, or may be the consequence of the physiological and psychological demands of 
disease (Eismann, Lush, & Sephton, 2010).	  
Circadian disruption. 
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Rest/activity rhythms. Rest/activity rhythms, patterns of activity levels over 
multiple days, are strong indicators of central clock activity and have been shown to be 
related to cancer outcomes (e.g., QOL and survival; Mormont & Waterhouse, 2002). 
Circadian rhythms can be measured noninvasively in humans through the use of wrist-
worn accelerometers, known as actigraphs. While polysomnography is widely considered 
the “gold standard” in measuring sleep and related variables, actigraphy is a valid and 
reliable approach to measuring rest/activity rhythms (Ancoli-Israel et al., 2003). Given its 
portability, this method is often preferred in research.  
Rest/activity rhythms have been shown to be disturbed prior to and during 
chemotherapy treatment in women with breast cancer (Ancoli-Israel et al., 2006; Savard 
et al., 2009). Additionally, women with metastatic breast cancer have dysregulated 
rest/activity rhythms (Koopman et al., 2002). While relationships have been observed 
between rest/activity rhythms, QOL, and cancer survival in colorectal samples 
(Innominato et al., 2009; Lévi et al., 2014; Mormont et al., 2000; Mormont & 
Waterhouse, 2002), limited research has been conducted in breast cancer samples. In a 
sample of 57 presurgical breast cancer patients, no relationship was observed between 
rest/activity rhythms and QOL (Rebholz et al., 2016). Continued research exploring the 
relationship between rest/activity rhythms and cancer outcomes (i.e., QOL and survival) 
within breast cancer patients may be beneficial in understanding relationships between 
rest/activity rhythms and cancer outcomes and mechanisms that may contribute to the 
associations. Additionally, research with this focus may help in identifying whether 
changes occur throughout the cancer trajectory (e.g., presurgical, between surgery and 
adjuvant treatment, during adjuvant treatment, and after the completion of treatment). 
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Hypothalamic pituitary adrenal (HPA) axis. The HPA axis is one of the two 
major physiological stress responses systems. It is likely a zeitgeber by which the SCN 
coordinates peripheral oscillators, and loss of its circadian rhythmicity is prognostic for 
mortality among several cancer types (Innominato et al., 2009; Lévi et al., 2014; 
Mormont, Bogdan, Cormont, Touitou, Levi, 2002; Sephton, Sapolsky, Kraemer, & 
Spiegel, 2000; Sephton et al., 2013). The HPA axis is activated by perceived stress 
(McEwen, 1998; Miller, Chen, & Zhou, 2007). Specifically, to maintain physiological 
stability when presented with a challenge, whether real or perceived, the HPA axis is 
activated. Frequent and repeated (i.e., chronic) activation of the HPA axis can lead to the 
development and progression of disease, including cancer, heart disease, obesity, and 
diabetes (McEwen & Stellar, 1993; Smith & Vale, 2006). 
The primary glucocorticoid produced by the human body is cortisol, which rises 
in the blood within a few minutes of experiencing a stressor (Jameson, 2003), and peaks 
about 20 minutes after the onset of a continued stressor. The cortisol awakening response 
(CAR) is a measure of HPA axis activity following awakening (Kudielka & Wüst, 2010). 
A positive relationship between response to awakening and perception of chronic stress 
has been observed among 100 individuals (Schulz, Kirschbaum, Prüßner, & Hellhammer, 
1998), among 212 individuals chronically stressed from work overload (Schlotz, 2004), 
and among 66 public school teachers (Pruessner, Hellhammer, & Kirschbaum, 1999). 
CAR is only weakly associated with the response of the HPA axis to acute stress 
(Kudielka & Wüst, 2010). Cortisol levels are generally low during the late evening hours, 
increase rapidly in the morning prior to waking, and peak just after waking. Levels then 
gradually decline throughout the day (Chan & Debono, 2010). Examining the rhythmic 
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pattern of cortisol levels throughout the day yields the diurnal cortisol slope, which 
reflects the rate of change of cortisol secretion. Unhealthy slopes are those that appear 
consistently flat with little variance, regardless of the whether there is a high or low 
intercept for the slope. In cancer patients, cortisol slopes often appear to be idiosyncratic 
with erratic peaks and troughs, as well as phase changes (Touitou et al., 1995). Although 
the HPA axis is under circadian control, it can also be influenced by stress and other 
factors.  
Immune Function 
Healthy immune defenses. The immune system is the human body’s natural 
defense against illness and disease, which includes a complex array of cellular responses 
that are coordinated in order to protect the body. Cell-mediated inflammatory processes 
are brought about by TH-1 cells (Mosmann & Sad, 1996). TH-1 cytokines may initiate 
both cytotoxic and inflammatory functions, while antibody production is linked to TH-2 
cytokines (Mosmann & Sad, 1996). Type 1 cytokines are classified as pro-inflammatory 
and type 2 as anti-inflammatory (Elenkov & Chrousos, 1999). 
Immune function and cancer. Psychoneuroimmune pathways may mediate 
observed relationships between stress and cancer outcomes (Andersen et al., 1994; 
Antoni et al., 2006; Eismann et al., 2010; Lutgendorf et al., 2010). The first evidence of a 
link between inflammation and cancer came in the 1800s when the presence of 
leukocytes was discovered in tumors (Grivennikov, Greten, & Karin, 2010). Immune 
cells may impact cancer cells by producing cytokines, chemokines, growth factors, 
prostaglandins, and reactive oxygen and nitrogen species (Grivennikov et al., 2010).  
	  	   20 
Several specific immune parameters have been implicated in the relationship 
between immune function and tumor progression. Vascular endothelial growth factor 
(VEGF) is released by cells that are not receiving sufficient oxygen. It promotes 
angiogenesis—the growth of new blood vessels— and is released by some tumors. In 
ovarian cancer cells, stress-related hormones (i.e., epinephrine and norepinephrine) have 
been shown to increase the production of VEGF (Lutgendorf et al., 2003). VEGF 
overproduction is linked to both growth and metastasis of solid tumors (Veikkola & 
Alitalo, 1999).  Matrix metalloproteinase (MMP)-9 helps to facilitate tumor invasion and 
metastasis, particularly in response to signals from stress hormones (Sood et al., 2006). In 
the early stages of cancer, transforming growth factor (TGF)-β suppresses development; 
however, the invasiveness and potential of metastasis are enhanced by TGF-β in the later 
stages (Zheng, Safina, & Bakin, 2008). Large quantities of TGF-β are produced in the 
tumor microenvironment, and it is generally immunosuppressive; however, the exact 
means by which this cytokine interacts with the tumor is dependent upon the tumor 
microenvironment and the other immune parameters that are present (Zamarron & Chen, 
2011). Additionally, TGF-β serves to inhibit macrophage activation, which may decrease 
production of proinflammatory immune parameters (Zamarron & Chen, 2011). 
Downstream effectors of tumor growth are triggered by interleukin-6 receptor (IL-6R; 
Grivennikov & Karin, 2008). Monocyte chemoattractant protein (MCP)-1 also 
contributes to inflammation and the progression of tumors (Fujimoto et al., 2009). 
Myeloid-derived suppressive cells and the cytokines that are secreted, including 
interleukin (IL)-6, tumor necrosis factor (TNF)-α, and IL-1β, are vital in the development 
of tumors (Zamarron & Chen, 2011). Additionally, immune parameters that are 
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proinflammatory in nature, including IL-1β, TNF-α, IL-6, IL-12, and interferon (IFN)-γ, 
promote tumors by stimulating proliferation, angiogenesis, and metastasis (Mantovani, 
Allavena, Sica, & Balkwill, 2008).   
Theoretical Models 
It has been proposed that psychoenuroendocrine pathways, including activation of 
the HPA axis, may directly or indirectly influence cancer progression (Eismann et al., 
2010). It is suggested that a relationship between the HPA axis and psychosocial factors 
exist and that this relationship may influence cancer progression (Eismann et al., 2010). 
Stressors, and an individual’s psychological response to stressors, can trigger 
neuroendocrine activity (Antoni et al., 2006). In turn, endocrine stress responses can 
impact the tumor microenvironment and promote migration and/or invasion of cancer 
cells, as well as stimulate angiogenesis, and alter immune disease-resistance capability 
(Antoni et al., 2006).  
In a related theoretical model, it has been proposed that biobehavioral factors 
influence cancer-related processes through biological, neuroendocrine, and immune 
factors (Antoni et al., 2006). Such biobehavioral factors may include life stress, 
psychological processes, and health behaviors (Antoni et al., 2006). A similar model 
explores the relationships between psychosocial processes, biological factors, health 
behaviors, life stress, and psychological interventions and posits neuroendocrine and 
immune pathways leading to cancer progression and mortality (Lutgendorf & Costanzo, 
2003).  
These models illustrate the complexity of factors relevant to the progression of 
cancer. While cancer-related stress has been explored in the context of some of these 
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models, no studies have examined whether stress related to ethnicity, neighborhood 
factors, and cancer-related stress may impact cancer progression via the hypothesized 
pathways. Therefore, exploring the relationships of psychosocial stress and physiological 
disruption with each other and in relation to cancer progression-free survival contributes 
to a missing area of the literature. By better understanding these relationships within the 
cancer context, there is potential to begin to elucidate factors that contribute to cancer 
disparities and identify interventions that may improve quantity and/or quality of life in 
patients with cancer. 
Proposed Model 
The proposed model (Figure 1) builds upon our lab’s prior of model of circadian 
effects on tumor progression (Eismann et al., 2010). This study proposes 
interrelationships of psychosocial stress related to ethnicity, neighborhood stressors, and 
the cancer diagnosis and suggests specific associations between psychosocial stress, 
physiological disruption, and medical outcomes of cancer (progression-free survival 
time). A significant contribution of this model is the focus on multiple domains of 
psychosocial and physiological distress. The measures of psychosocial stress take into 
account an individual’s ethnicity; their environment, by exploring stress associated with 
their neighborhood; and their individual response to a cancer diagnosis. Additionally, the 
measures of physiological disruption take into account circadian rhythms measured by 
rest/activity rhythms and endocrine hormone secretion, as well as functioning of the 
immune system. By exploring multiple domains of stress, one can begin to investigate 
what areas are most salient in cancer patients that have not yet received treatment. Given 
that treatment for cancer affects biological parameters, studying presurgical patients who 
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have yet to begin treatment allows for exploration of associations while the tumor is still 
present and prior to biological changes brought about by treatment. This can help us to 
understand the relationship between stress and physiological disruption, which can 
provide strong implications for medical and psychological clinical interventions.  
 
 
 
 
 
 
 
 
 
 
 
Ethnicity and Physiological Disruption (Figure 1 Arrow A) 
Associations with circadian disruption. 
Rest/activity rhythms. No research could be found exploring ethnic differences in 
rest/activity rhythms. Research has focused on sleep-related ethnic differences, which is 
likely correlated with rest/activity rhythms. Research has shown no differences between 
ethnicities in sleep architecture (Rao et al., 1999). Other studies have demonstrated that 
Figure 1. Study aims. 
	  	   24 
African Americans had longer rapid eye movement sleep, greater total sleep time, a lower 
percentage of deep sleep (Profant, Ancoli-Israel, & Dimsdale, 2002), and less slow wave 
sleep (Stepnowsky, Moore, & Dimsdale, 2003). Among older adults, sleep disturbances 
were associated with ethnicity, specifically with European Americans having worse sleep 
disturbance (Jean-Louis et al., 2001). This is in contrast to research showing African 
American older adults having more sleep difficulties, including daytime sleepiness and 
problems falling asleep (Ancoli-Israel et al., 1995), difficulties initiating and maintaining 
sleep, as well as early morning awakening (Jean-Louis, Kripke, Ancoli-Israel, Klauber, & 
Sepulveda, 2000), short or long sleep duration (Hale & Do, 2007), greater variation in 
day-to-day sleep duration, lower sleep efficiency, greater wake after sleep onset, lower 
total sleep time (Lemola et al., 2013), and greater odds of daytime sleepiness (Chen et al., 
2015).  
Mixed results have been observed with regard to ethnic differences in sleep. 
Research has shown ethnic differences in sleep architecture and sleep, while other 
research has not observed these differences. It is possible that the differences in results 
are due to differences in methodology and study populations. Therefore, much research 
remains in order to better elucidate the relationships between ethnicity and rest/activity 
rhythms and potential factors that help to explain these relationships. Factors could 
include psychosocial variables, such as racial/ethnic discrimination, or genetic factors. It 
is also possible that rest/activity rhythms help to explain ethnic health disparities. 
Hypothalamic pituitary adrenal (HPA) axis. Ethnic differences have been 
observed in cortisol, such that, after controlling for both education and managerial status, 
greater overall salivary cortisol secretion was observed for European Americans than 
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African Americans (Bennett, Merritt, & Wolin, 2004). An interaction of ethnicity and 
education was observed, with lower educated African American participants having 
lower levels of cortisol upon awakening (Bennett et al., 2004). It is suggested that low 
waking cortisol could be an indication of chronic stress which, in turn, may influence 
systemic HPA axis dysregulation (Bennett et al., 2004).   
Lower waking salivary cortisol and higher levels at bedtime were observed in 
African Americans compared to White young adults, which is indicative of a flattened 
cortisol slope (Cohen et al., 2006). Similarly, among adolescents, both African 
Americans and Hispanics had flatter salivary cortisol slopes than Caucasians (DeSantis et 
al., 2007). Flattened slopes were observed in African American and Hispanic middle to 
older age participants, indicating the possibility that a below normal salivary cortisol 
response occurs due to chronic stress (Hajat et al., 2010). Additionally, among middle to 
older adults, African Americans had lower waking salivary cortisol and a slower decline 
in the afternoon (Samuel, Roth, Schwartz, Thorpe, & Glass, 2016), which is indicative of 
a less healthy diurnal cortisol pattern. However, no ethnic differences have been observed 
in urinary cortisol levels among middle-aged adults (Masi, Rickett, Hawkley, & 
Cacioppo, 2004).  
Among women who were pregnant, African Americans had lower levels of 
plasma cortisol, specifically with a decrease in levels from 24-26 weeks gestation to 30-
32 weeks gestation (Glynn, Schetter, Chicz-DeMet, Hobel, & Sandman, 2007).  
Additionally, an association between cumulative stress and flat salivary cortisol rhythms 
was seen in African American women who were pregnant; however, this association was 
not observed in Hispanic women (Suglia et al., 2010). A possible explanation for this 
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association could be due to the African American women having higher levels of stress, 
or Hispanic women having greater social support coping strategies (Suglia et al., 2010).  
Furthermore, salivary cortisol levels have been explored among those whom are 
caregivers of individuals with dementia. Ethnicity was associated with cortisol slope with 
African American caregivers having flatter slopes (McCallum, Sorocco, & Fritsch, 2006) 
and in a sample of caregivers and non-caregivers, Hispanic women had flatter diurnal 
cortisol slopes than NH Whites (Gallagher-Thompson et al., 2006).  
Cortisol, when measured in saliva, has been shown to differ in NH Whites and ethnic 
minorities, with less cortisol secretion and flattened slopes observed in ethnic minorities. 
Differences in plasma cortisol levels have also been observed. However, in a study 
exploring urinary cortisol, no ethnic differences were observed. This lack of a difference 
in only urinary cortisol, and neither salivary nor plasma cortisol could be due to the 
difference in the collection of bodily fluids in which cortisol was measured.  
Associations with immune function. Ethnic differences with regard to immune 
function have been explored to a limited degree. Genetic differences for cytokines have 
been observed, such that African Americans have significant differences compared to NH 
Whites in the distribution of polymorphic alleles for some cytokines; therefore, inheriting 
certain cytokine genes may be determined in part by ethnicity and have implications for 
the optimization of immunosuppressive regimes in those receiving transplants (Hoffmann 
et al., 2002) and those with Hepatitis C (Zein, Germer, El-Zayadi, & Vidigal, 2004). 
Genotypes that upregulate inflammation are more common in African American women 
than Whites (Ness, Haggerty, Harger, & Ferrell, 2004). Additionally, among newborns, 
African Americans have higher frequencies of some alleles that have been implicated in 
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cancer risk; which may help to explain disparities in the incidence of certain cancers 
(Zabaleta et al., 2008).    
In addition to cytokine allelic distribution differences, limited research has 
explored ethnic differences in circulating immune parameters. IL-8 and granulocyte 
colony-stimulating factor (G-CSF) levels were higher and neutrophil count was lower in 
African participants compared to Caucasians, (Mayr et al., 2007) and greater levels of IL-
6 and C-reactive protein (CRP) have been observed in African Americans compared to 
NH Whites (Stowe, Peek, Cutchin, & Goodwin, 2010). However, NH Whites have been 
shown to have higher levels of IL-4, IL-5, IL-8, TNF-α, and IFN-γ compared to African 
Americans (Pine et al., 2016). Furthermore, elevated levels of IL-1β, IL-10, TNF-α were 
associated with lung cancer among African Americans and elevated levels of IL-6 and 
IL-8 were associated with lung cancer in both NH Whites and African Americans (Pine et 
al., 2016).  
There is a dearth of literature regarding ethnic differences in immune function, 
particularly circulating immune parameters. However, given the limited research, this 
appears to be an area that may help to explain ethnic disparities in the development and 
progression of disease. Additional research with regard to immune function and the 
relationships between ethnicity and disease may help to illuminate mechanisms by which 
ethnic disparities are observed, particularly in patients with cancer. 
Neighborhood Stress and Physiological Disruption (Figure 1 Arrow A) 
Associations with circadian disruption. 
Rest/activity rhythms. Research regarding neighborhood stress and rest/activity 
rhythms has not been conducted; however, is an important area to study given the 
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relationships observed between chronic stress and disruption of sleep. In neighborhoods 
characterized as high stress due to crime, there are more self-reported sleep difficulties 
among its residents (Steptoe, O’Donnell, Marmot, & Wardle, 2008). Residents in 
neighborhoods with high levels of stress based on safety, cleanliness, and noise report 
worse sleep quality (Hill, Burdette, & Hale, 2009). Furthermore, sleep quality has been 
shown to moderate the relationship between neighborhood stress and psychological 
distress (Hill et al., 2009) and mediate the relationship between neighborhood stress and 
physical health (Hale, Hill, & Burdette, 2010), as well as the relationship between 
neighborhood stress and psychological distress (Hill et al., 2009).  
The limited research has shown relationships between variables of neighborhood 
stress and self-reported sleep. Research regarding neighborhood stress and rest/activity 
rhythms may be beneficial in further understanding possible relationships. It is likely that 
a variety of factors related to neighborhood stress, perceived and observed, may be 
related to rest/activity rhythms, in addition to sleep. Further, there may be different types 
of neighborhood stress (e.g., socioeconomic or violence) that may be more predictive of 
rest/activity rhythms than others.  
Hypothalamic pituitary adrenal (HPA) axis. It is possible that neighborhood 
stress can influence disease through neuroendocrine pathways (Steptoe & Feldman, 
2001). Flattened salivary cortisol rhythms have been observed in individuals who live in 
neighborhoods with high levels of both perceived (e.g., perceived violence) and observed 
(e.g., homicide rates) stressors (Karb, Elliott, Dowd, & Morenoff, 2012). Flattened 
diurnal slopes and flatter decline from 30 minutes post-awakening to about two hours 
post-awakening were associated with neighborhood poverty (Hajat et al., 2015). African 
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Americans with high glucocorticoid genetic sensitivity living in neighborhoods with low 
SES had lower waking cortisol (Coulon, Wilson, Horn, Hand, & Kresovich, 2015). 
Neighborhood violence was associated with low waking cortisol; however, neighborhood 
poverty associations with salivary cortisol in this sample were weaker and less consistent 
(Do et al., 2011). Additionally, African American children with greater exposure to 
neighborhood stress had higher levels of serum cortisol; however, this association was 
not observed in European American children (Dulin-Keita, Casazza, Fernandez, Goran, 
& Gower, 2012).  
Previous research has shown relationships between neighborhood stress and 
endocrine disruption. These associations have been seen for both perceived and observed 
stressors. Given the relationships between chronic stress and dysregulation of the HPA 
axis, and knowing that neighborhood stress is chronic in nature, exploring the 
associations of neighborhood stress and dysregulation of the HPA axis is imperative in 
understanding potential mechanisms by which neighborhood stress impacts health (Ross 
& Mirowsky, 2001). Further research could help to elucidate the relationships between 
neighborhood stress and cortisol, which could have strong implications for progression of 
disease, including cancer.  
Associations with immune function. Limited research has been conducted with 
regard to neighborhood stress and immune function. In a study of African American 
women, an association was seen between neighborhood SES and CRP, such that those 
living in the poorest neighborhoods had worse biomarker levels compared to those living 
in neighborhoods with better SES (Cozier et al., 2016). Additionally, elevated levels of 
CRP were observed in children living in areas with high poverty or crime (Broyles et al., 
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2012). The relationship between elevated CRP and low neighborhood SES was also 
detected in a sample of Mexican-American women (Gallo et al., 2012).  
It has been suggested that immune function may be a mediating factor in the 
relationship between neighborhood stress and disease (Steptoe & Feldman, 2001). By 
focusing on the possibility of an association between neighborhood stress and immune 
function, it may be possible to begin to better understand the role of these variables in 
various disease processes, including cancer. It appears that CRP, a protein component 
that elevates in concentration in the acute phase of inflammation (Koj, 1974), and 
possibly other pro-inflammatory cytokines may be immune markers of interest in relation 
to neighborhood stress.  
Cancer-Related Stress and Physiological Disruption (Figure 1 Arrow A) 
Associations with circadian disruption. 
Rest/activity rhythms. Daily intrusions have been shown to be associated with 
consistency of rest/activity rhythms over several days, as well as sedentary behaviors 
during the day (Dedert et al., 2012). Additionally, daily avoidant coping was also 
associated with consistency of rest/activity rhythms over several days, sedentary 
behaviors during the day, and restlessness at night (Dedert et al., 2012). Differences in 
sleep have also been observed in a sample of presurgical breast cancer patients, the night 
prior to surgery intrusive thoughts were associated with less sleep duration and lower 
sleep efficiency (Wright, Schnur, Montgomery, & Bovbjerg, 2010). In breast cancer 
survivors, intrusive thoughts were shown to be related to self-reported symptoms of 
insomnia (Taylor et al., 2012).  
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Within samples of women with breast cancer and breast cancer survivors, 
research has shown relationships between components of cancer-related stress (i.e., 
intrusions and avoidance) and rest/activity rhythms, sleep, and symptoms of insomnia. 
More research has focused on associations with intrusions, rather than avoidance. This is 
expected given the established relationship between intrusive thoughts and sleep 
disturbance (Harvey, 2002; Harvey, Tang, & Browning, 2005; Wicklow & Espie, 2000). 
While focusing on intrusions seems intuitive, avoidance may also be associated with 
rest/activity rhythms, particularly daytime sedentariness. 
Hypothalamic pituitary adrenal (HPA) axis. Cancer-related stress and its 
associations with endocrine activation have also been explored. Relationships between 
intrusions and alterations in endocrine activation have been observed in individuals who 
have suffered a psychological trauma (Yehuda, 2002). Among healthy women, breast 
cancer-specific intrusions were related to greater levels of cortisol during a work period, 
which was considered a life stressor in this study (Dettenborn, James, Valdimarsdottir, 
Montgomery, & Bovbjerg, 2006). In this same sample of women, daily intrusions and 
daily avoidant coping was not related with measures of salivary cortisol (Dedert et al., 
2012). Exploring the relationship between cancer-related stress and endocrine disruption 
allows for a better understanding of the role a cancer diagnosis and the associated 
symptoms of stress plays in changes to cortisol. In turn, this may be beneficial in 
elucidating effects on chronic disease. 
Associations with immune function. Generally, the immune system is adaptive 
and responds to various signals from the body, including distress. How the immune 
system reacts is dependent upon whether the stressor is acute or chronic in nature. Acute 
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stressors, which are time-limited, upregulate natural immunity (e.g., inflammation) and 
suppress specific immunity (e.g., proliferation), whereas chronic stressors trigger global 
immunosuppression (Segerstrom, 2004). Specifically, psychosocial stressors and 
depression are associated with decreased cytotoxic T-cell and natural killer cell activities, 
which influence immune processes of tumors (Reiche, Morimoto, & Nunes, 2005; 
Reiche, Nunes, & Morimoto, 2004). Among breast cancer patients that have completed 
surgery, cancer-related stress has been shown to be related to inhibition of cellular 
immune response (Andersen et al., 1998), declines in natural kill cell activity and IFN-γ 
(Von Ah, Kang, & Carpenter, 2007), and elevations of IL-1Rα (Mundy-Bosse, Thornton, 
Yang, Andersen, & Carson, 2011). More research regarding the effects of cancer-related 
stress, including intrusions and avoidance, and their influence on immune function may 
be advantageous in understanding mechanisms of cancer progression. 
Psychosocial Stress and Medical Outcomes of Cancer (Figure 1 Arrow B) 
Associations with ethnicity. Much disparity exists between ethnic groups with 
regard to the progression of cancer, which can encompass advanced stage disease, 
metastasis, recurrence, and mortality. Data from the National Center for Health Statistics 
has been compiled regarding cancer mortality rates, as well as projections for the number 
of cancer deaths for the year 2014 (Siegel et al., 2014). This epidemiological data 
indicates five-year survival rates are lower among African Americans than for Whites for 
female breast, colorectum, esophageal, kidney and renal pelvis, liver and intrahepatic bile 
duct, lung and bronchus, melanoma of the skin, non-Hodgkin lymphoma, oral cavity and 
pharynx, ovary, prostate, urinary bladder, uterine cervix, and uterine corpus cancer 
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(Siegel et al., 2014). The only cancer site with equal five-year survival between ethnic 
groups is pancreas (Siegel et al., 2014).  
By observing death rates in this epidemiological study, ethnic disparities are 
evident. The death rates for cancer are 207.7 in 10,000 among African Americans and 
172.4 in 10,000 among Whites (DeSantis et al., 2007). It is suggested that barriers to 
care, including socioeconomic disparities, may help to explain the ethnic differences 
observed in cancer outcomes; however, research has suggested that these differences 
remain after controlling for such factors (DeSantis et al., 2007).  
The question of ethnicity-related differences in cancer outcomes is one that is 
complex in nature, specifically in that associations with minority status are not all in the 
same direction. Additionally, differences in cancer outcomes may exist within our 
general conceptualization of ethnic groups. For example, differences in Chinese 
Americans, Japanese Americans, and Korean Americans may be observed; however, we 
would conceptualize all of the three ethnic subgroups as Asian Americans. Research has 
explored the differences in cancer characteristics and mortality among ethnic groups for 
various cancer tumor sites. 
It has been shown that African American women have a significantly greater risk 
of more advanced breast cancer, as measured by larger tumors (Haas et al., 2008), more 
advanced cancer stage at diagnosis (Bradley, Given, & Roberts, 2001; Haas et al., 2008; 
Komenaka et al., 2010; Li, Malone, & Daling, 2003; Ooi, Martinez, & Li, 2011), higher 
grade tumors (Chlebowski et al., 2005; Li et al., 2003), a higher likelihood of negative 
hormone receptor status (Chlebowski et al., 2005; Komenaka et al., 2010), and greater 
distant recurrences (Komenaka et al., 2010), compared to NH White women. However, 
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one study found no differences in tumor size or stage among these ethnic groups 
(Chlebowski et al., 2005). Furthermore, African Americans with breast cancer have been 
shown to have greater disease-specific mortality (Bradley et al., 2001; Chlebowski et al., 
2005; Du, Lin, Johnson, & Altekruse, 2011; Haas et al., 2008; Komenaka et al., 2010; Li 
et al., 2003; Ooi et al., 2011; Perkins, Cooksley, & Cox, 1996) and overall mortality (Du 
et al., 2011; Komenaka et al., 2010), compared to NH White women.  
The differences in disease-specific mortality remained after controlling for either 
stage or Medicaid/Medicare status (Bradley et al., 2001), body mass index, age, tumor 
stage, and whether the patient was in the observational or clinical arm of the study 
(Chlebowski et al., 2005), receipt of adequate care (Haas et al., 2008), age and 
employment (Komenaka et al., 2010), and stage, SES, and treatment (Perkins et al., 
1996). The differences in overall survival remained after controlling for patient 
characteristics, tumor characteristics, income, poverty, education, treatment, and health 
insurance (Du et al., 2011), as well as after controlling for clinical stage and age at 
diagnosis (Komenaka et al., 2010). However, after controlling for age at diagnosis, 
clinical stage, and hormone status, disease-specific survival was no longer significantly 
different between ethnic groups and when controlling for estrogen-receptor status, overall 
survival was not significantly different (Komenaka et al., 2010).  
The majority of research regarding ethnic differences in cancer outcomes has 
focused on differences in African American and NH White women with breast cancer. 
Little research has explored ethnic differences between other cancer types or in other 
ethnicities. This is an area that much improvement is needed. Epidemiological studies are 
the primary method of exploring ethnic differences in cancer outcomes. Obtaining data 
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from cancer registries and surveillance programs may not be very informative, as it is 
possible that considerable data is missing and the data that are available often are 
dichotomous, leaving little room to conduct complex analyses. For example, 
Surveillance, Epidemiology, and End Results Program (SEER) public use data often does 
not contain detailed information on tumor characteristics, cancer treatment, and prognosis 
(Yu et al., 2009). Data from large databases are excellent for helping to recognize areas 
and trends in cancer outcomes. However, the results from such datasets should inform 
cross-sectional, experimental, and longitudinal research to understand and explain ethnic 
cancer disparities.  
Access to care does not seam to explain much of the variance in cancer outcomes. 
It appears that presenting at a later stage to physicians, which is a strong prognostic 
indicator of mortality, does not explain why African Americans have poorer outcomes. 
Therefore, it is not an issue of incidence, but rather other factors are playing a role in the 
differences in cancer outcomes that are observed.  
A theoretical model has been introduced to help elucidate racial disparities in 
cancer morbidity and mortality. Several factors have been proposed to explain differences 
in cancer mortality between ethnic groups. Patient factors, provider factors, and the 
health system are embedded in social, economic, and the public health landscape in a 
proposed model of mortality rate ratio among individuals with cancer (Blackman & Masi, 
2006). Patient factors include many important features of the disparities seen in mortality, 
including, among others, cultural attitudes and beliefs, being Non-English speaking, and 
a delay in seeking medical care (Blackman & Masi, 2006). Additionally, more advanced 
stage at diagnosis and having tumors that are more aggressive are also included 
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(Blackman & Masi, 2006); however, there is little examination as to why these 
differences in tumor characteristics are observed in those who are ethnic minorities. 
Blackman and Masi (2006) believe that the factors above all play a role in the ethnic 
differences observed in cancer outcomes. It is suggested that by implementing 
interventions from the various perspectives (i.e., patient, provider, and health system) 
disparities may decline.  
Associations with neighborhood stress. Research has shown that there is an 
interaction between individual and neighborhood SES with regard to mortality 
(Winkleby, Cubbinm & Ahn, 2006). It is suggested that individuals with low individual 
SES living in a neighborhood with high SES have the highest all-cause mortality rates, 
presumably due to not having full access to resources in their neighborhood because of 
their personal SES (Winkleby et al., 2006). However, specifics regarding mortality due to 
cancer were not explored in the aforementioned study. It has been shown that individuals 
living in poverty areas and who are younger, age 25 through 54, are statistically more 
likely to die from cancer than those living in non-poverty areas; however, this 
relationship was not observed for individuals aged 55 to 74 (Waitzman & Smith, 1998). 
In a sample of women with ovarian cancer, neighborhood disadvantage was shown to be 
related to higher tumor grade and neighborhood affluence was shown to be related to 
more advanced tumor stage at diagnosis (Peterson et al., 2014). In a study of colorectal 
and head and neck cancer patients in Taiwan, those with low individual SES living in 
disadvantaged neighborhoods has the highest mortality, as did those with breast and lung 
cancer with low individual SES living in advantaged neighborhoods (Chang et al., 2012). 
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Interestingly, the importance of researching the neighborhood effect on mortality 
has been emphasized as larger effects are observed with mortality rather than morbidity 
(Ellen et al., 2001). This is due to the notion that there are only modest differences across 
communities concerning specific diseases; however, the disease trajectory is significantly 
informed by one’s neighborhood environment (Ellen et al., 2001). Mixed results have 
been shown regarding mortality and neighborhood stress, and it appears that individual 
income, and possibly the interaction with access to care and resources may help to 
explain these differences. Given the significant role that neighborhood stress plays on the 
health and disease processes of an individual, and knowing the link between stress and 
cancer progression and mortality, examining these associations is crucial. 
Associations with cancer-related stress. Limited research has been completed 
concerning cancer-related stress and cancer progression and survival. Among a sample of 
individuals with various types of cancer, avoidance but not intrusive thoughts were 
shown to be predictive of disease progression one year after diagnosis (Epping-Jordan, 
Compas, & Howell, 1994). These findings seem intuitive in that those who are avoidant 
may not follow through with treatments or may not present to their physicians promptly 
when symptoms of recurrence are evident. Therefore, there appear to be strong 
implications for cancer-related stress regarding tumor progression and survival, which 
warrant additional exploration in the hopes of better understanding the consequences of 
cancer-related stress. 
Physiological Disruption and Medical Outcomes of Cancer (Figure 1 Arrow C) 
Associations with circadian disruption. 
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Rest/activity rhythms. Research has shown that disruption of circadian rhythms 
can be linked to progression of tumors as well as early mortality in cancer patients. A 
literature review indicated that clock genes influence cell cycles in mammary epithelium, 
which can lead to an improper division of the cells, leading to more aggressive breast 
tumors (Blakeman, Williams, Meng, & Streuli, 2016). In a murine model, ablation of the 
SCN resulted in the loss of circadian rhythmicity, which was associated with faster tumor 
growth than in the control mice, which in turn lead to earlier mortality (Filipski et al., 
2009). Additionally, mice with tumors had increased tumor growth and shorter survival 
when light/dark cycles disrupted circadian rhythms (Li & Xu, 1997). Among patients 
with metastatic colorectal cancer, rest/activity rhythms have been shown to be 
significantly related to survival (Innominato et al., 2009; Lévi et al., 2014; Mormont et 
al., 2000). Additionally, sleep disruption was significantly predictive of survival in 
women with advanced breast cancer (Palesh et al., 2014). Given the demonstrated 
rest/activity rhythm relationships with survival in colorectal cancer patients, it would be 
interesting to see if this relationship generalizes to other cancer populations. Additionally, 
determining whether rest/activity rhythms, when measured at various time points 
throughout the cancer treatment trajectory (e.g., presurgically, during adjuvant treatment, 
and during survivorship), influence survival is worthy of exploration. 
Hypothalamic pituitary adrenal (HPA) axis. Women with more advanced stage 
ovarian cancer had higher levels of salivary cortisol in the morning and afternoon 
compared to women with early stage ovarian cancer (Weinrib et al., 2010). Additionally, 
when comparing cortisol levels of women with ovarian cancer to healthy controls, it has 
been observed that afternoon and evening salivary cortisol is significantly higher in 
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women with ovarian cancer (Weinrib et al., 2010). The afternoon cortisol levels were not 
significantly higher in women with ovarian cancer compared to those with benign 
disease; however, the evening cortisol levels were significantly different (Weinrib et al., 
2010). With regard to morning cortisol levels, no significant differences were observed 
between any of the three groups (i.e., ovarian cancer, benign disease, healthy controls; 
Weinrib et al., 2010). Among women with metastatic breast cancer, those with more 
severe metastatic spread had higher mean salivary cortisol levels; however, no significant 
differences were observed in mean cortisol levels of any samples collected throughout 
each day between women with breast cancer and healthy controls (Abercrombie et al., 
2004). 
Diurnal cortisol slopes and cancer has also been explored. Flatter diurnal salivary 
cortisol slopes were observed in women with cancer compared to healthy controls; 
however, no significant diurnal salivary cortisol slope differences were found in women 
with more severe metastatic spread (Abercrombie et al., 2004). Among women with 
ovarian cancer, no significant differences were observed between those with early or 
advanced stage cancer (Weinrib et al., 2010).  
Diurnal salivary cortisol slope was associated with mortality, such that those with 
earlier mortality had flattened slopes, which is indicative of a lack of diurnal variation in 
cortisol (Sephton et al., 2013). Additionally, flattened cortisol slopes were associated 
with advanced stage lung cancer, as well as poorer performance status (Sephton et al., 
2013).  This study also explored CAR and diurnal area under the curve (AUC); however, 
no association was observed with these cortisol variables and survival (Sephton et al., 
2013).  
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Among those with metastatic renal cell carcinoma, salivary cortisol slope was 
significantly associated with survival (Cohen et al., 2012). In women with metastatic 
breast cancer, similar results were observed, such that those with flattened diurnal 
salivary cortisol slopes had shorter length of survival (Sephton, Sapolsky, Kraemer, & 
Spiegel, 2000). Furthermore, steeper salivary cortisol slopes were associated with 
metastases in the chest wall and adjacent lymph nodes rather than bone or distant organ 
metastases (Sephton et al., 2000). Additionally, it has been shown that increased 
nighttime cortisol levels and flattened cortisol slope were associated with early mortality 
in women with ovarian cancer (Schrepf et al., 2015). However, in a sample of individuals 
with metastatic colorectal cancer, neither serum total cortisol nor salivary free cortisol 
were predictive of survival over a period of four-year follow-up (Mormont, Bogdan, 
Cormont, Touitou, & Levi, 2002).  
Clinical human research has shown that those with cancer have greater mean 
cortisol levels compared to controls and those with benign disease and advanced cancer 
have higher cortisol levels that those with early stage cancer. Those with cancer also have 
flatter slopes compared to healthy controls. Furthermore, in differing cancer types 
flattened cortisol slopes have been shown to be associated with early mortality. Literature 
reviews have demonstrated that circadian disruption of endocrine rhythms exists in 
patients with cancer, and this dysregulation plays a vital role in tumor burden and cancer 
progression (Antoni et al., 2006; Eismann et al., 2010). Specifically, glucocorticoids may 
promote cancer progression through angiogenesis, invasion, migration, and apoptosis 
(Antoni et al., 2006). 
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Associations with immune function. Immune parameters may act to suppress or 
promote the growth of tumors. Inflammation tends to play a vital role in the growth and 
spread of cancer and the interplay between tumor promoting, and tumor suppressing 
immune factors help in the determination of the outcome of the tumor (Zamarron & 
Chen, 2011). High peripheral levels of VEGF have been shown to be indicative of early 
mortality in hepatocellular carcinoma (Jin-no et al., 1998) and gastric cancer 
(Karayiannakis et al., 2002). MMP-9 plays a role in the metastasis of cancer, particularly 
elevated levels are associated with rapid progression, secondary metastasis, and poorer 
survival (Deryugina & Quigley, 2006). Either disruption or loss of TGF-β signaling leads 
to either migration, invasion, and metastasis or rapid growth and metastasis, respectively 
(Derynck, Akhurst, & Balmain, 2001).  
A specific genetic polymorphism of IL-1β leads to significantly higher production 
of IL-1β and shorter survival in a group of individuals with pancreatic cancer (Barber, 
Powell, Lynch, Fearon, & Ross, 2000). TNF-α is involved in all processes of the 
progression of tumors (Balkwill, 2006). IL-6 serves to enhance growth and progression of 
tumors, as well as influences survival (Grivennikov et al., 2010). Higher IL-6 levels have 
been shown to be associated with a greater number of metastatic sites in women with 
breast cancer (Salgado et al., 2003) and are associated with poorer prognosis in both lung 
and breast cancer patients (Hodge, Hurt, & Farrar, 2005). Increases in IL-6 may be due in 
part to increased production of IL-6R (Scambia et al., 1995).  
Expression of MCP-1 plays a role in the histologic grade of cancers, such that 
MCP-1 negative tumors tend to be well-differentiated (Valković, Lučin, Krstulja, Dobi-
Babić, & Jonjić, 1998). Additionally, IL-12 and IFN-γ may play a role in the progression 
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of tumors (Mantovani et al., 2008). Research has shown relationships between immune 
function and tumor characteristics, progression, and mortality. Therefore, continued 
research may be beneficial in further understanding the relationship between immune 
function and the progression of cancer, as well as survival. Exploring relationships in 
individuals with active tumors prior to treatment allows for better understanding of the 
role that cancer plays in associations with immune disruption, compared to treatment 
effects. 
Summary and Hypotheses 
Health disparities, and more specifically, differences in cancer outcomes, are 
increasingly reported both for ethnicity and neighborhood stress-related variables. 
Additionally, research has shown a strong relationship between psychosocial stress, 
physiological disruption, and disease progression, particularly within a cancer population. 
However, life context (e.g., ethnicity and neighborhood-related stressors) has rarely been 
explored within this framework and little research has explored relationships between 
psychosocial stress and physiological disruption among individuals with cancer.  
Two specific aims were explored in this dissertation: The first explored the 
relationships between ethnicity, neighborhood stress, and cancer-related stress in a group 
of women with breast cancer. The second aim explored the relationships between 
psychosocial stress, physiological disruption, and medical outcomes of cancer 
(progression-free survival time).  
Aim 1. Associations between psychosocial stress measures. 
Hypothesis 1A. Ethnicity and neighborhood will be significantly and positively 
correlated with one another (Figure 2, Arrow A).  
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Hypothesis 1B. Ethnicity and cancer-related stress will be significantly and 
positively correlated with one another (Figure 2, Arrow B). 
Hypothesis 1C. Neighborhood socioeconomic stress and cancer-related stress will 
be significantly and positively correlated with one another (Figure 2, Arrow C). 
 Aim 2. Associations between psychosocial stress, physiological disruption, and 
medical outcomes of cancer (progression-free survival).  
Figure 2. Aim 1, associations between psychosocial stress measures. 
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Hypotheses 2A. Tests of hypotheses 2 will explore associations of psychosocial 
stress (i.e., ethnicity, neighborhood stress, and cancer-related stress) with physiological 
disruption (i.e., circadian, endocrine, and immune; Figure 1, Arrow A).  
Hypothesis 2A.1. African American ethnicity will be independently associated 
with greater circadian disruption, endocrine disruption, and immune disruption (Figure 
3). 
 
 
 
Figure 3. Hypothesis 2A.1, associations of ethnicity with physiological 
disruption. 
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Hypothesis 2A.2. Neighborhood stress will be independently associated with 
greater circadian disruption, endocrine disruption, and immune disruption (Figure 4). 
 
 
Figure 4. Hypothesis 2A.2, associations of neighborhood stress with physiological 
disruption. 
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Hypothesis 2A.3. Cancer-related stress will be independently associated with 
greater circadian disruption, endocrine disruption, and immune disruption (Figure 5). 
 
 
 
 
 
 
Figure 5. Hypothesis 2A.3, associations of cancer-related stress with physiological 
disruption. 
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Hypotheses 2B. Tests of hypotheses 2B will explore associations of psychosocial 
stress with medical outcomes of cancer (progression-free survival time; Figure 1, Arrow 
B). 
Hypothesis 2B.1. African American ethnicity will be independently associated 
with shorter breast cancer progression-free survival time (Figure 6, Arrow 1). 
Hypothesis 2B.2. Neighborhood stress will be independently associated with 
shorter breast cancer progression-free survival time (Figure 6, Arrow 2). 
Hypothesis 2B.3. Cancer-related stress will be independently associated with 
shorter breast cancer progression-free survival time (Figure 6, Arrow 3). 
 
 
Figure 6. Hypotheses 2B, associations of psychosocial stress with medical outcomes 
of cancer (progression-free survival time). 
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Hypotheses 2C. Tests of hypotheses 2C will explore associations of physiological 
disruption and medical outcomes of cancer (progression-free survival time; Figure 1, 
Arrow C). 
Hypothesis 2C.1. Circadian disruption will be independently associated with 
shorter breast cancer progression-free survival time (Figure 7, Arrow 1). 
Hypothesis 2C.2. Endocrine disruption will be independently associated with 
shorter breast cancer progression-free survival time (Figure 7, Arrow 2). 
Hypothesis 2C.3. Immune disruption will be independently associated with 
shorter breast cancer progression-free survival time (Figure 7, Arrow 3). 
Figure 7. Hypotheses 2C, associations of physiological disruption with medical 
outcomes of cancer (progression-free survival time). 
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METHODS 
 
Participants 
Participants in this study were recruited as part of a previous study titled “Stress, 
Coping and Sleep in Newly Diagnosed Women with Breast Cancer.” The study was 
designed to understand how a breast cancer diagnosis impacts stress and the ability to 
cope; therefore, participants were recruited as close as possible to their diagnosis of 
breast cancer. The prior studies that utilized the data tested hypotheses that are separate 
from those examined in this study. The prior studies explored relationships between daily 
ratings of cancer-related stress and coping with actigraphy and cortisol measures (Dedert 
et al., 2012) and the associations between social integration, support, and immune 
function (serum and stimulated; Cash et al., 2015).  
Women diagnosed with primary, recurrent, or metastatic breast cancer who had 
not begun treatment (i.e., surgery, chemotherapy, or radiation) were eligible for 
enrollment according to a protocol approved by the University of Louisville Institutional 
Review Board. Inclusion criteria required that all participants be English speakers 
without active psychoses. 
Recruitment 
Recruitment personnel (i.e., graduate research assistants from Dr. Sandra 
Sephton’s laboratory) were present in the clinic of Dr. Anees Chagpar, the referring 
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surgical oncologist, to recruit eligible participants. Dr. Kelly McMasters also referred 
patients when Dr. Chagpar did not hold clinic. Recruitment occurred when the referring
physician was in clinic, which occurred two days per week. Therefore, recruitment took 
place in two clinics, one day at the University Surgical Associates clinic and the other 
day at the James Graham Brown Cancer Center. Medical records were examined to 
determine which patients were possibly eligible for recruitment. Additionally, clinic 
personnel would help alert research assistants to potentially eligible patients. Eligible 
patients were introduced to the study by surgical oncologist, Dr. Anees Chagpar after a 
biopsy to confirm diagnosis of breast cancer was completed. Patients who were not 
referred during their visit to the clinic were invited to enroll by phone.  
Initial recruitment occurred from May 2005 through June 2007. During this wave 
of recruitment, 49 participants were enrolled and provided at least partial data on self-
report questionnaire, actigraphy, saliva, and immune measures. Complete serum immune 
data was obtained from 30 participants. Incomplete immune data occurred due to 
inability to complete a blood draw. A second wave of recruitment from December 2008 
to February 2009 occurred to increase the sample size. An additional 11 participants were 
enrolled, for a total of 60 participants. 
 During both waves of recruitment, 91 potentially eligible patients were referred to 
the study. Five were introduced to the study; however, due to their time constraints were 
not enrolled in the clinic and were unable to be reached by phone. Response burden 
and/or time constraints were the reasons that 22 potential patients declined to participate. 
One participant was not enrolled because of difficulties understanding data collection 
procedures and low English proficiency. Additionally, one patient felt she lived too far 
	  	   51 
away to participate, one patient was scheduled for treatment too soon to complete data 
collection, and one patient declined because she was uncomfortable consenting to review 
of medical records.  Of the 60 participants enrolled, one participant provided no data due 
to an illness, one provided no data due to time demands of having family visit, and one 
was unable to complete collection due to increased time constraints following enrollment. 
Seven participants provided partial self-report data, two participants experienced 
problems with actiwatch recording, which prevented actigraphy data collection, one 
participant did not provide saliva samples, and seven participants did not provide blood 
samples. Overall, there was enough data provided by 57 participants to be included in 
analyses.  
Data Collection Procedures 
A graduate research assistant obtained informed consent and research 
authorizations per requirements of HIPAA. Study rationale and procedures were 
explained and data collection materials were provided to participants. Participants were 
provided with two questionnaire packets, one that contained demographic and self-report 
measures and one that contained daily items to assess variables related to actigraphy (e.g., 
time going to bed and waking up) and cortisol (e.g., alcoholic and caffeinated beverage 
consumption). A wrist-worn actiwatch was placed on the participant’s wrist at this time 
and information was provided regarding actiwatch care (e.g., the watch was not water-
resistant) and an opportunity to ask questions. The participants were asked to wear the 
actiwatch for the coming three days. Participants were also provided with a saliva 
collection kit, as well as a demonstration of saliva collection and an opportunity to 
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practice and ask questions. Participants were asked to collect four saliva samples per day 
over the next three days. Participants had blood drawn by a trained phlebotomist.   
Neighborhood stress and progression-free survival data were collected at a later 
date by a research assistant. The neighborhood stress data were gathered via the United 
States Census. Progression-free survival data were obtained from the Kentucky Cancer 
Registry (KCR). 
Measures 
Demographics. Participants completed a background questionnaire, which 
assessed various demographic variables, including age, ethnicity, religious affiliation, 
education, employment, household income, and living situation. Additionally, the 
background questionnaire also assessed medical history and current medications that the 
participant was taking.  
Psychosocial Stress Measures 
Ethnicity. Self-reported ethnicity was a categorical variable for which participants 
indicated which of the following ethnicities they identified with most: non-Hispanic (NH) 
White, African American, Hispanic, Asian American, Native American, and other. Out of 
respect for potential ethnic/cultural differences, analyses only included those reporting 
their ethnicity as NH White or African American. 
Neighborhood stress. Participant addresses were provided as a part of the 
demographic data collection. Data regarding each participant’s neighborhood status was 
obtained from the United States Census Bureau’s 2010 census data using the participant 
addresses. For each participant, the following four variables were the only neighborhood 
data extracted from www.census.gov’s American FactFinder application: percentage of 
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households below the poverty line, median household income, percentage of single-
parent homes, and percentage of renter-occupied housing in the neighborhood. The data 
was obtained at the census tract level, which is a small subdivision of a county. Sarah 
Ehresman, research manager for the Kentucky State Data Center, served as a consultant 
for obtaining data from the American FactFinder application by providing information 
regarding geocoding and demonstrating how to use the software.  
An index of neighborhood stress was created with principal components analysis 
(PCA), as we believe that one factor score would be more representative of the 
cumulative neighborhood stress, rather than variables used individually. Additionally, a 
PCA was chosen in order to minimize the number of statistical tests that were run. To 
conduct a PCA, first neighborhood stress variables were log-transformed due to 
skewness, then standardized into z-scores since the four variables of neighborhood stress 
are not the same scale of measurement (i.e., percentages and median values). Then factor 
scores were created for each individual case with the regression method, as we expected 
the variables to be correlated with one another, in SPSS using loadings from the PCA 
with varimax rotation. Factor scores are the sum of the product of the factor loading and 
the value of the individual variable of neighborhood stress. Factor scores were used as the 
independent variable, neighborhood stress, in analyses. 
Cancer-related stress. The Impact of Events Scale (IES) is a measure of a 
participant’s current amount of distress related to their cancer (Horowitz et al., 1979). 
The IES measures both intrusive thoughts and avoidance associated with the diagnosis 
and treatment of cancer. The 15-item measure asked that participants rate the frequency 
of the occurrence of each item over the past seven days on a four-point Likert scale 
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ranging from “not at all” to “often.” The test-retest reliability of the total score is 0.87, 
and for the intrusions and avoidance subscales 0.89 and 0.79, respectively (Horowitz et 
al., 1979).  
Scores greater than 19 on the IES total score are of high clinical concern 
(Horowitz, 1982); however, this is an arbitrary cutoff and does not indicate a specific 
clinical diagnosis (Joseph, 2000). Scores of 35 or above may be clinically significant for 
the presence of symptoms of PTSD (Haagsma et al., 2012; Wohlfarth, van den Brink, 
Winkel, & ter Smitten, 2003).  
While there are no specific African American norms for the IES, it has been used 
in studies that recruited both NH White women and African American women with 
breast cancer (Cordova et al., 1995), as well as studies of only African American women 
with breast cancer (Taylor et al., 2003). Therefore, it appears that this measure is 
appropriate to use in exploring cancer-related stress in both NH White and African 
American populations. 
Circadian rhythms. 
Rest/activity rhythms. Circadian rest/activity rhythms were measured via wrist-
worn movement recording devices (Ancoli-Israel et al., 2003; MicroMini-Motionlogger; 
Ambulatory Monitoring Systems, Inc, Ardsley NY). Over a consecutive period of four 
nights and three days, the participants’ body movements were recorded. Participants were 
asked to remove the actigraph watch when doing activities that would cause the device to 
get wet. Sleep intervals for each participant were set by integrating self-reported times for 
sleep onset and awakening with actigraphy data, with preference given to actigraphy data 
when discrepant.  
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Commercially available software was utilized to score all one-minute epochs and 
the following measures were obtained: rest/activity rhythm measured by the 
autocorrelation coefficient of activity measured across 24 hours, and two dichotomy 
indices comparing daytime activity level to the activity level while the participant was in 
bed (i.e., daytime sedentary behavior, nighttime restfulness). Rest/activity rhythm, a 
measure of circadian consistency or the similarity of patterns of activity across days, was 
calculated by correlating the epochs of activity during the first day of collection with the 
epoch of activity at the same time on the other days. Similar activity levels evidence a 
strong circadian rhythm at similar times of day, which yields a high rest/activity rhythm. 
The dichotomy indices compare activity when in bed with activity when out of bed. The 
dichotomy index for inactivity out of bed, which is daytime sedentary behavior, is the 
percentage of activity counts out of bed that fall below the median level of activity counts 
when the participant is in bed. The dichotomy index for inactivity in bed, indicative of 
nighttime restfulness, is the percentage of activity counts in bed that is below the median 
level of activity counts when the participant is out of bed. A higher dichotomy index 
indicates more frequent inactivity. Therefore, greater daytime sedentariness is consistent 
with circadian disruption, whereas greater nighttime restfulness is consistent with strong 
circadian rhythmicity. 
Salivary cortisol profiles. Participants provided a total of 12 saliva samples, 
specifically three consecutive days at waking, 30 minutes after waking (+30), at four in 
the afternoon, and immediately prior to bed. Medication Event Monitoring System 
(MEMS) bottles and caps (Aardex, 2001) were used to store cotton saliva collection 
swabs and recorded the exact date and time the bottle was opened. Participants were 
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asked not to eat, drink, brush their teeth, use mouthwash, chew gum, or smoke for 30 
minutes prior to saliva collection. Upon completion of data collection, the saliva samples 
were centrifuged, aliquoted, and stored at -80° C. 
Assays were conducted using an enzyme immunoassay (EIA) developed for use 
in saliva (Salimetrics, Inc., State College, PA). The sensitivity of the assay was 0.003 
µg/dL. To ensure accuracy between assay plates, assay reliability is measured as the 
coefficient of variation (CV; mean divided by standard deviation). CVs for low and high 
controls should be less than 15% and 5%, respectively. For these data, the inter-assay CV 
was 10.45% for low controls and 4.03% for high controls.  
The MEMS and self-reported saliva collection times were highly correlated 
(Spearman’s r = .962), which suggests that the participant reports of collection times 
were reliable (Kraemer et al., 2006). MEMS collection times were used when there were 
discrepant reports. Additionally, actigraphy data were reviewed to examine for 
discrepancies between waking and bedtime self-reports, with preference given to 
actigraphy data. Collection time and cortisol values greater than four standard deviations 
from the mean were considered outliers and deleted (n = 9 samples, 1.3%). Also, non-
adherence to the collection time protocol resulted in deletion of the cortisol values (n = 
83, 12.3%). See Dedert et al., 2012 for further details. 
Cortisol values were log-transformed. The cortisol awakening response (CAR) 
was calculated as the unstandardized beta of natural log-transformed cortisol regressed on 
collection time and included the waking and +30 min samples. Diurnal cortisol slope was 
calculated with the waking, 4:00 o’clock, and bedtime samples, excluding the +30 min 
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sample, as the unstandardized beta of log-transformed cortisol regressed on collection 
time. Diurnal mean cortisol was calculated using all 12 log-transformed values.  
Immune function. A trained phlebotomist drew blood using an empty 
Vacutainer tube. Blood was collected as close to study entry as possible, always before 
surgical treatment. Circadian patterns of immune molecule release in system circulation 
occur (Kronfol, Nair, Zhang, Hill, & Brown, 1997); therefore, a restriction in the timing 
of the blood draw was attempted as much as possible within the limits of the schedule at 
the clinic where recruitment occurred. The majority of blood draws took place in the 
early afternoon (M = 1:15 PM, median = 1:32 PM) with 40 of the samples being 
collected in the afternoon and 11 in the morning (Cash et al., 2015). 
When the blood draw was completed, whole blood samples from the non-
anticoagulant tube were centrifuged to separate serum from red blood cells. Serum, which 
gives the measure of the general level of immune parameters present, was pipetted, and 
aliquots were immediately frozen at -80° C until assayed.  
Cytokines were analyzed using electrochemiluminescent quantitative arrays from 
MesoScale Discovery (Gaithersburg, MD). Each sample was analyzed in duplicate 
according to the manufacturer protocol. Assay plates were imaged on a SECTOR Imager 
2400A and data were analyzed using Discovery Workbench software (MesoScale). In 
addition to running all manufacturer specified controls, a pooled internal control was 
used, and validation and maintenance of assay quality were assured by running additional 
samples of the pooled control “spiked” with known amounts of analytes to fall within 
specific regions of the standard curve. 
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Factor analyses were previously completed to determine groupings of the 10 
immune parameters with a data-driven approach (Cash et al., 2015). The factor score 
from each of the three clusters that emerged from the exploratory factor analysis (EFA) 
was utilized in analyses. Factor 1 included VEGF, MMP-9, and TGF-β and is indicative 
of tumor invasion and immunosuppression. Factor 2 included proinflammatory and 
chemotactic markers, including IL-1β, IL-6R, TNF-α, and MCP-1. Factor 3 included IL-
6, IL-12, and IFN-γ, measures of proinflammation and TH-1 type processes. 
Medical outcomes of cancer (progression-free survival time) Consent was 
obtained in order to access patient data from the KCR for determination of recurrent 
status or survival in future analyses. Progression-free survival data were obtained from 
KCR approximately five years after the last participant was recruited.  
Medical records review. Functional status, measured with the Karnofsky 
Performance Status scale (Schag, Heinrich, & Ganz, 1984), and information regarding 
medications were collected during the initial interview. Medical charts were reviewed 
after surgery in order to obtain accurate data on treatment choice and surgical pathology 
information, including cancer stage and histology. 
Control variables. The control variables utilized were age at time of cancer 
diagnosis and cancer stage for all analyses, as both are associated with variance in the 
speed of the progression of the tumor, as well as the level of associated psychosocial 
stress (Andersen, Kiecolt-Glaser, & Glaser, 1994; Antoni et al., 2006). Additionally, 
yearly income was controlled in all analyses as recruitment took place in two different 
clinics, under the same surgical oncologist, where income varied significantly (Cash et 
al., 2015; Dedert et al., 2012). 
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Statistical Analyses 
Data reduction and approach to analyses. All questionnaire data were manually 
entered, cleaned, and examined for abnormal responses. Data were analyzed using an 
exploratory/hypothesis generating approach, rather than hypothesis testing, in order to 
maximize breadth of investigation to better understand the data provided by this sample 
of presurgical breast cancer patients. Exploratory analyses are useful in elucidating 
relationships that are not yet fully understood. However, there are drawbacks to 
exploratory research, including that a significant number of analyses are likely to yield 
some significant relationships that are spurious. Therefore, it is necessary to be cautious 
in the interpretation of exploratory research. By hypothesis generating, a large number of 
analyses were run in order to better understand and characterize associations within the 
sample and to inform future directions, while taking care not to generalize outside this 
sample. 
Tests of hypotheses. 
Preliminary Analytical Procedures. The assumption of normal distribution of 
variables was evaluated by examining boxplots, histograms, and the skewness statistic. 
Variables that were non-normally distributed were log-transformed. Additionally, for 
variables in Hypothesis 1 that did not exhibit a normal distribution, Spearman 
correlations will be used, as opposed to Pearson correlations.  
Hypothesis 1A. Bivariate correlations were utilized to test the correlations 
between ethnicity and neighborhood stress. A total of one correlation was used to test 
hypothesis 1A. 
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Hypothesis 1B. Bivariate correlations were utilized to test the correlations 
between ethnicity and cancer-related stress. A total of one correlation was used to test 
hypothesis 1B. 
Hypothesis 1C. Bivariate correlations were utilized to test the correlation between 
neighborhood stress and cancer-related stress. A total of one correlation was used to test 
hypothesis 1C. 
Hypothesis 2A.1. Hierarchical linear regressions were performed to determine the 
relationship between ethnicity and physiological disruption. The theoretically-derived 
control variables, age at diagnosis, stage, and income, were entered in the first block, 
ethnicity was entered in the second block, and each physiological disruption variable was 
entered separately as the outcome. A total of nine regressions were used to test 
hypothesis 2A.1. 
Hypothesis 2A.2. Hierarchical linear regressions were run to determine the 
relationship between neighborhood stress and physiological disruption. Analyses were 
completed in the same manner as hypothesis 2A.1; however, neighborhood stress was 
entered into the second block as the independent variable. A total of nine regressions 
were used to test hypothesis 2A.2. 
Hypothesis 2A.3. Hierarchical linear regressions were conducted to determine the 
relationship between cancer-related stress and physiological disruption. Cancer-related 
stress was entered as the independent variable in block two, with all other variables 
treated in the same manner as hypothesis 2A.1. A total of nine regressions were used to 
test hypothesis 2A.3. 
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Hypothesis 2B.1. Survival analyses estimate the likelihood of an event occurring 
at a certain time. Participants were tracked over a period of time, with the focus on the 
time at which the event (i.e., recurrence/death or last contact for those who have not 
experienced recurrence or death) occurred. Therefore, time refers to the amount of time 
from either date of initial diagnosis or date of study entry until the event. In Cox 
proportional hazards analyses, the dependent variable is composed of two parts, the event 
status (i.e., recurrence/death or no recurrence/death) and the time to the event. 
A two-tailed Cox proportional hazards model was used to test the effects of 
ethnicity on progression-free survival time, measured from the date of initial diagnosis 
and the date of study entry. The two time variables were entered, independently, into the 
time box, the event (i.e., progression-free survival status) was entered into the status box, 
and the independent variable, ethnicity, was entered into block one. For significant 
associations, additional tests will be completed as a check for potential confounding 
variables and their effects on the findings (Kraemer et al., 2001; Kraemer et al., 2008). A 
total of two regressions were used to test hypothesis 2B.1 
Hypothesis 2B.2. The Cox proportional hazards model was used in survival 
analyses testing the prognostic value of neighborhood stress on progression-free survival 
time. The analyses were completed similarly to hypothesis 2B.1; however, for this 
hypothesis the independent variable was neighborhood stress. A total of two regressions 
were used to test hypothesis 2B.2. 
Hypothesis 2B.3. The Cox proportional hazards model was used in survival 
analyses testing the prognostic value of cancer-related stress on progression-free survival 
time. For these analyses, the independent variable was cancer-related stress, and the 
	  	   62 
analyses were conducted in the same way as hypothesis 2B.1. A total of two regressions 
were used to test hypothesis 2B.3. 
Hypothesis 2C.1. The Cox proportional hazards model was used in separate 
survival analyses testing the prognostic value of autocorrelation coefficient, daytime 
sedentary behavior, and nighttime restlessness on progression-free survival time. 
Analyses were completed in the same manner as hypothesis 2B.1; however, in these 
analyses, the independent variables were variables of circadian disruption (i.e., 
autocorrelation coefficient, daytime sedentary behavior, and nighttime restlessness). A 
total of six regressions were used to test hypothesis 2C.1. 
Hypothesis 2C.2. The Cox proportional hazards model was used in separate 
survival analyses testing the prognostic value of CAR, diurnal cortisol slope, and mean 
cortisol on progression-free survival time. Hypothesis 2C.2 looks at CAR, diurnal cortisol 
slope, and mean cortisol as individual predictors and, as in hypothesis 2B.1, all other 
variables were treated in a similar fashion. A total of six regressions were used to test 
hypothesis 2C.2. 
Hypothesis 2C.3. The Cox proportional hazards model was used in separate 
survival analyses testing the prognostic value of three immune factors on progression-
free survival time. The analyses for hypothesis 2C.3 were conducted similarly to 
hypothesis 2B.1; however, in these analyses the independent variables were the three 
immune factors. A total of six regressions were used to test hypothesis 2C.3. 
Power Analyses. Given that this study utilized previously collected data, post hoc 
power analyses were conducted to determine that we have adequate power with the 
sample size that was recruited to complete analyses. Power to detect effects is based on 
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calculations using G*Power statistical software (Faul, Erdfelder, Lang, & Buchner, 2007) 
for correlations and hierarchical linear regressions and XLSTAT-Power (Addinsoft, 
2014) for Cox proportional hazards models. For hypothesis 1 little research was available 
for the specific stressors that are included in analyses; therefore, since the profile of mood 
states total mood disturbance (POM-TMD) was not be used in any analyses, the 
correlation between the IES and POM-TMD was used to complete power analysis for this 
hypothesis. Estimates were set at 0.354 for effect size with a sample size of 57 and α = 
.05, hypothesis 1 has 80% power to detect effects (Faul et al., 2007). 
Very limited research has studied the associations that are explored in hypotheses 
2A.1, 2A.2, and 2A.3 and no effect size could be found in the literature that was obtained. 
Therefore, estimates were set at a medium effects size of f2 = .15. With a sample size of 
57 and α = .05, hypotheses 2A.1, 2A.2, and 2A.3 has 82% power to detect effects (Faul 
et al., 2007).  
For hypothesis 2C.2 power analysis for the Cox regression was completed in the 
XLSTAT-Power program. With the event rate (i.e., recurrence/death) set at 50% and the 
hazards ratio of 34867.43, the standard deviation of cortisol slope 0.062, and the 
correlation between days of survival since diagnosis and cortisol slope of -0.194 (Sephton 
et al., 2013), with a sample size of 57 and α = .05, the power to detect effects was 100% 
(Addinsoft, 2014). Unfortunately, power analyses could not be calculated for hypotheses 
2B.1, 2B.2, 2B.3, 2C.1, and 2C.3. While previous literature reports hazards ratios for 
analyses between ethnicity and survival (Chlebowski et al., 2005), neighborhood stress 
and survival (Waitzman & Smith, 1998), psychological distress and survival (Hamer, 
Chida, & Molloy, 2009), circadian disruption and survival (Lévi et al., 2014), and 
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immune function and survival (Karayiannakis et al., 2002), the additional data needed to 
calculate power analyses for cox regression (i.e., standard deviation of the independent 
variable and the correlation between the independent and dependent variable) was not 
reported. 
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RESULTS 
 
Sample Characteristics 
Sociodemographic characteristics. Study participants ranged in age from 21 to 
79 years, with an average (SD) age of 52.32 (13.30) years. Participants were mostly 
married (n = 17; 30.9%), divorced and still single (n = 17; 29.1%), or widowed (n = 10; 
18.2%). Additionally, many participants were living with their spouse (n = 15; 27.3%), 
with only their children (n = 11; 20.0%), or alone (n = 10; 18.2%) and about one third of 
participants were currently renting their home (n = 19; 35.8%). 
The majority of participants had received a high school diploma (n = 36; 65.5%). 
Approximately 61% (n = 31) of participants were below the poverty line, with the 
majority of participants indicating that their annual household income was less than 
$20,000 (n = 20; 39.2%) or ranging from $20,000 - $39,999 (n = 13; 25.5%). Nearly half 
of our participants were unemployed (n = 27; 47.4%) and nearly 10% (n = 5) of 
participants did not have insurance. Additional and more detailed sociodemographic 
characteristics are provided in Table 1. 
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Table 1 
Sociodemographic Characteristics 	   Frequency	   Percent	  
Marital	  Status	   	   	  	  	  	  	  	  Single	   7	   12.7%	  	  	  	  	  	  Single,	  divorced	   16	   29.1%	  	  	  	  	  	  Single,	  cohabitating	   1	   1.8%	  	  	  	  	  	  Married	   17	   30.9%	  	  	  	  	  	  Divorced,	  remarried	   3	   5.5%	  	  	  	  	  	  Widowed	   10	   18.2%	  	  	  	  	  	  Widowed,	  remarried	   1	   1.8%	  
Education	   	   	  	  	  	  	  	  Middle	  School	   3	   5.5%	  	  	  	  	  	  High	  School	   36	   65.5%	  	  	  	  	  	  Associates/Technical	   5	   9.1%	  	  	  	  	  	  Bachelors	   5	   9.1%	  	  	  	  	  	  Masters	   4	   7.3%	  	  	  	  	  	  Doctorate	   2	   3.6%	  
Income	   	   	  	  	  	  	  	  Less	  than	  $20,000	   20	   39.2%	  	  	  	  	  	  $20,000	  -­‐	  $39,999	   13	   25.5%	  	  	  	  	  	  $40,000	  -­‐	  $59,999	   5	   9.8%	  	  	  	  	  	  $60,000	  -­‐	  $79,999	   4	   7.8%	  	  	  	  	  	  $80,000	  -­‐	  $99,999	   4	   7.8%	  	  	  	  	  	  $100,000	  and	  above	   5	   9.8%	  
Employment	   	   	  	  	  	  	  	  Currently	  Employed	   30	   52.6%	  	  	  	  	  	  Not	  Currently	  Employed	   27	   47.4%	  
Living	  Situation	   	   	  	  	  	  	  	  Living	  alone	   10	   18.2%	  	  	  	  	  	  Living	  with	  spouse/partner	  only	   15	   27.3%	  	  	  	  	  	  Living	  with	  spouse/partner	  and	  child(ren)	  only	   7	   12.7%	  	  	  	  	  	  Living	  with	  child(ren)	  only	   11	   20.0%	  	  	  	  	  	  Living	  with	  other	  relatives	   8	   14.5%	  	  	  	  	  	  Living	  with	  non-­‐relatives	   2	   3.6%	  	  	  	  	  	  Other	   2	   3.6%	  
Own	  or	  Rent	  Home	   	   	  	  	  	  	  	  Own	   34	   64.2%	  	  	  	  	  	  Rent	   19	   35.8%	  
Poverty	  Line	   	   	  	  	  	  	  	  Above	   20	   39.2%	  	  	  	  	  	  Below	   31	   60.8%	  
Insurance	  Status	   	   	  	  	  	  	  	  Private	   24	   47.1%	  	  	  	  	  	  Public	   9	   17.6%	  	  	  	  	  	  Other	   13	   25.5%	  	  	  	  	  	  None	   5	   9.8%	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Clinical characteristics. The majority of participants had stage I (n = 25; 42.4%), 
primary (n = 52; 88.1%) breast cancer. Additionally, 77.4% (n = 41) of participants had 
positive ER status, 75.0% (n = 39) had positive PR status, and almost 90% (n = 42) had 
Her2Neu negative status, which is reflective of the most common hormone status 
combination (Onitilo et al., 2009). Furthermore, eight participants (17.0%) had triple 
negative status, for which there are fewer treatment options (Bauer et al., 2007) and is 
linked to shorter survival time (Onitilo et al., 2009). The primary treatment of choice was 
mastectomy (n = 49; 94.2%), while the remainder chose lumpectomy. The Karnofsky 
Performance Status scale provides a rating of patient’s functional status (Schag et al., 
1984) with scores ranging from 100 (no evidence of disease or impairment from disease) 
to 0 (deceased). The majority of patients’ functional status was rated as no evidence of 
disease or impairment from disease (i.e., Karnofsky = 100; n = 23; 44.2%) or minor signs 
or symptoms of disease (i.e., Karnofsky = 90; n = 20; 38.5%), suggesting there was 
minimal to no impairment due to disease symptomatology. Additional clinical 
characteristics are presented in Table 2.  
Table 2 
Clinical Characteristics 
Age	  at	  Diagnosis	   Mean	  (SD)	   52.18	  (13.39)	  
	   Frequency	   Percent	  
Stage	   	   	  	  	  	  	  	  0	  (DCIS)	   5	   8.5%	  	  	  	  	  	  I	   25	   42.4%	  	  	  	  	  	  IIA	   7	   11.9%	  	  	  	  	  	  IIB	   4	   6.8%	  	  	  	  	  	  IIIA	   10	   16.9%	  	  	  	  	  	  IIIB	   1	   1.7%	  	  	  	  	  	  IIIC	   3	   5.1%	  	  	  	  	  	  IV	   4	   6.8%	  
Grade	   	   	  	  	  	  	  	  Well-­‐differentiated	   8	   13.6%	  
	  	  	  	  	  Moderately-­‐differentiated	   23	   39.0%	  	  	  	  	  	  Poorly-­‐differentiated	   20	   33.9%	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ER	  Status	   	   	  	  	  	  	  	  Positive	   41	   77.4%	  	  	  	  	  	  Negative	   12	   22.6%	  
PR	  Status	   	   	  	  	  	  	  	  Positive	   39	   75.0%	  	  	  	  	  	  Negative	   13	   25.0%	  
Her2Neu	  Status	  	   	   	  	  	  	  	  	  Positive	   5	   8.5%	  	  	  	  	  	  Negative	   42	   89.4%	  
Triple	  Negative	   	   	  	  	  	  	  	  Yes	   8	   17.0%	  	  	  	  	  	  No	   39	   83.0%	  
Lymphovascular	  Invasion	   	   	  	  	  	  	  	  Yes	   12	   25.5%	  	  	  	  	  	  No	   35	   74.55	  
Primary,	  Recurrence,	  or	  Metastatic	   	   	  	  	  	  	  	  Primary	   52	   88.1%	  	  	  	  	  	  Recurrence	  or	  Metastatic	   	  	  7	   11.9%	  
Menopausal	  Status	   	   	  	  	  	  	  	  Pre-­‐menopausal	   23	   40.4%	  	  	  	  	  	  Peri-­‐menopausal	   4	   7.0%	  	  	  	  	  	  Post-­‐menopausal	   30	   52.6%	  
Karnofsky	  Rating	   	   	  	  	  	  	  	  100%	   23	   44.2%	  	  	  	  	  	  90%	   20	   38.5%	  	  	  	  	  	  80%	   6	   11.5%	  	  	  	  	  	  70%	   1	   1.9%	  	  	  	  	  	  60%	   2	   3.8%	  
 
Co-morbid medical disorders. Three participants (5.1%) reported having 
recurrent breast cancer and had previously received chemotherapy and/or radiation. 
Additionally, one participant (1.7%) reported a history of previous cervical cancer. While 
the majority of participants reported no co-morbid medical conditions (n = 29; 49.1%), 
the most common co-morbid medical conditions for this sample were high blood pressure 
(n = 15; 25.4%) and diabetes (n = 10; 17.0%). Other co-morbid medical conditions 
included arthritis/osteoarthritis (n = 3; 5.1%), hypothyroidism (n = 2; 3.4%), and 
myocardial infarction (n = 2; 3.4%). One participant (1.7%) reported having scoliosis and 
one (1.7%) reported having chronic obstructive pulmonary disease. Additionally, one 
participant (1.7%) reported having chronic fatigue syndrome, simple partial seizures, skin 
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lesions, and chronic hives; one reported having scleroderma and local positive antinuclear 
antibody, which is a diagnostic test for lupus; one reported having supraventricular and 
ventricular tachycardia and a heart murmur, in addition to hypertension; and one reported 
sarcoidosis and asthma, in addition to hypertension and osteoarthritis. 
Medications. Table 3 presents medications used by greater than 10% of 
participants. Additionally, less than 10% of participants used medications such as 
antihistaminics and sleep medications (n = 5); analgesics, bronchodilators, thyroid 
medication, and vitamin supplements (n = 4); anticonvulsants, antitussives, 
benzodiazepines, potassium, and urinary antispasmodics (n = 3); adrenergics, antibiotics, 
estrogens, and vasodilating agents (n = 2), and anticoagulants, nasal anti-inflammatory 
agents, antidiarrheal medications, antirheumatoids, antiviral medications, asthma 
medications, cathartics and laxatives, contraceptives, corticosteroids, iron replacements, 
insulin, muscle relaxants, prophylaxis, proton pump inhibitor, parathyroid hormones, 
respiratory relaxer, sedatives, sulfonylureas, and unclassified therapeutics (n = 1).  
Table 3 
Medications 	   Frequency	   Percent	  Antihypertensive	   16	   27.1%	  NSAIDS	  (e.g.,	  aspirin,	  ibuprofen)	   16	   27.1%	  Diuretics	   11	   18.6%	  Antilipidemic	   11	   18.6%	  Antidiabetics	   10	   16.9%	  Antidepressants	   9	   15.3%	  Cardiac	  Medications	   7	   11.9%	  Anxiolytics	   6	   10.2%	  Gastrointestinal	  Medications	   6	   10.2%	  Opiate	  Agonists	   6	   10.2%	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Ethnicity. Fifty-seven participants provided information regarding ethnicity. The 
majority of participants were non-Hispanic (NH) White (n = 33; 57.9%) and African 
American (n = 21; 36.8%). Two participants reported their ethnicity as Native American 
(3.5%), and one participant reported her ethnicity as Asian American (1.8%). As 
previously reported, analyses excluded participants who reported an ethnicity other than 
NH White or African American out of respect for potential cultural/ethnic differences on 
outcome variables. Additionally, the small sample size would not allow statistical 
analyses to explore ethnic differences for those who reported their ethnicity as Native 
American or Asian American. 
Neighborhood stress. Census tract data was available for 47 participants. 
Neighborhood stress was measured with four variables, the percentage of households 
below the poverty level within the census tract, the median household income in the 
census tract, the percentage of single-parent homes within the census tract, and the 
percentage of renter-occupied homes within the census tract. The 47 participants lived in 
a total of 41 different census tracts. Within the census tracts, the average (SD) percentage 
of households below the poverty level was 16.66 (12.71), the average (SD) median 
household income was $50,868.72 ($23,617.78), the average (SD) percentage of single-
parent homes was 39.84 (24.82), and the average (SD) percentage of renter-occupied 
homes was 31.16 (19.25). 
Cancer-related stress. The Impact of Events Scale (IES) total distress score was 
used to measure participants’ current amount of distress related to their cancer. Fifty-six 
participants provided IES data. During data cleaning, an error with the IES wording was 
identified. For the second half of our participants, the wording on the IES had been 
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changed, such that the Likert scale read “not at all, rarely, sometimes, and never” rather 
than the appropriate “not at all, rarely, sometimes, and often.” It was determined that one 
participant who answered endorsed a “3” truly meant “never” and did not mean “often.” 
By viewing a scatterplot of IES baseline and IES daily comparison scores that one 
participant was an outlier. We then reviewed her IES baseline raw data with her IES 
intrusions daily raw data. It was determined that her baseline raw data did not match the 
daily raw data based on the IES daily scores of mostly zero. Based on this, we changed 
her “threes” to “zeros” on the IES baseline raw data to better match her apparent intended 
responses. Therefore, that participant’s data was edited accordingly, and the total score 
was then calculated with this edited data.  
The average (SD) total distress score was 28.38 (15.37), which suggests the 
presence of symptoms of both intrusive thoughts and avoidance of thoughts related to a 
cancer diagnosis. Scores of 19 or greater are worthy of additional investigation and scores 
35 or greater likely represents a diagnosis of PTSD (Horowitz et al., 1979). In this 
sample, 43 (76.8%) participants scored 19 or greater and 26 (46.4%) participants scored 
35 or greater on the IES.  
Physiological Disruption Characteristics 
Circadian disruption. Descriptive statistics for wrist-worn actigraphy variables 
are presented in Table 4. Of the 57 participants, one participant was provided with a 
watch that was initialized in the wrong recording mode, which meant that the data that 
was returned was unusable for the calculations. One participant’s actiwatch battery failed 
and there was not time to collect replacement data before surgical treatment. Therefore, 
the resulting sample size for actigraphy data was 55. The average (SD) rest/activity 
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rhythm coefficient of .28 (.17) is indicative of a relatively rhythmic circadian activity 
pattern in this sample. Additionally, percentages for nighttime restfulness (97.38%) and 
daytime sedentariness (6.03%) show that many of the sample experienced restful 
evenings and a good amount of activity during the day, which are indicative of high 
circadian rhythmicity. 
Table 4 
Actigraphy Descriptive Statistics 
 N Mean (SD) 
Rest/activity rhythm 55 .28 (.17) 
Nighttime restfulness, %age 55 97.38 (3.26) 
Daytime sedentariness, %age 55 6.03 (5.41) 
 
Endocrine disruption. Descriptive statistics for diurnal cortisol variables are 
presented in Table 5. Note that the CAR slope is more vulnerable to missing data than the 
other variables; therefore, the sample size for CAR slope is lower than the sample size for 
diurnal cortisol slope and diurnal cortisol mean. Average (SD) raw cortisol for the three-
day collection was 0.25 (.11). Average and 95% confidence intervals for raw cortisol 
values for each point of data collection point are presented in Figure 8, which appears to 
resemble a healthy diurnal cortisol slope, with a peak approximately 30 minutes after 
awakening and a nadir at bedtime.  
Table 5 
Diurnal Cortisol Descriptive Statistics 
 N Mean (SD) 
CAR Slope, log(µg/dL)/hr 45 .10 (.47) 
Diurnal Cortisol slope, log(µg/dL)/hr 57 -.07 (.09) 
Diurnal Mean Cortisol, log(µg/dL) 57 -1.89 (.48) 
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Figure 8. Mean with 95% confidence interval diurnal salivary cortisol values over the 
three-day data collection period. 
Immune function. Descriptive statistics for serum cytokine levels are provided in 
Table 6. Serum cytokines were grouped into three factors using EFA (previously 
described, Cash et al., 2015). Factor 1 includes VEGF, MMP-9, and TGF-β, factor 2 
includes IL-1β, IL-6R, TNF-α, and MCP-1, and factor 3 includes IL-6, IL-12, and IFN-γ.  
Table 6 
Immune Function Descriptive Statistics  
 N Mean (SD) 
Factor 1   
     VEGF, pg/mL 50 383.99 (228.86) 
     MMP-9, pg/mL 50 28.84 (18.23) 
     TGF-β, pg/mL 50 2.67 (1.04) 
Factor 2   
     IL-1β, pg/mL 50 0.52 (2.05) 
     IL-6R, pg/mL 50 6242.39 (1687.03) 
     TNF-α, pg/mL 
     MCP-1, pg/mL 
50 
50 
24.30 (115.03) 
148.19 (60.00) 
Factor 3   
     IL-6, pg/mL 50 19.19 (120.41) 
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     IL-12, pg/mL 50 17.95 (31.28) 
     IFN-γ, pg/mL 50 1.16 (1.07) 
 
Progression-Free Survival 
Data on progression-free survival was obtained from KCR at a median of seven 
years post-enrollment and was available for 53 participants. Of the 53 participants, 30.2% 
(n = 16) had experienced a recurrence or had passed away. Six women had recurrent 
disease, but had not passed away. Ten participants had passed away, of which eight had 
recurrent disease. Descriptive statistics for progression-free survival from date of 
diagnosis or date of data collection are provided in Table 7.  
Table 7 
Progression-Free Survival Descriptive Statistics 
  Days Years 
 N Mean (SD) 
From Date of Diagnosis 49 2103.63 (823.84) 5.76 (2.26) 
From Date of Background Completion 49 2000.33 (799.90) 5.48 (2.19) 
From Date of Actigraphy Collection 49 2081.59 (810.58) 5.70 (2.22) 
From Date of Cortisol Collection 52 2030.46 (795.48) 5.56 (2.18) 
From Date of Blood Draw 45 1984.13 (789.22) 5.43 (2.16) 
 
Principal Components Analysis of Neighborhood Stress 
A principal components analysis (PCA) was performed with orthogonal rotation 
(varimax) to determine the degree to which the four variables of neighborhood stress that 
were collected (i.e., percentage of households below the poverty line, median household 
income, percentage of single-parent homes, and percentage of renter-occupied housing in 
the neighborhood) varied together. Given that the data were skewed and on different 
scales (i.e., percentages and median values), the data were transformed and standardized 
to address each concern, respectively.  
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The Kaiser-Meyer-Olkin (KMO) statistic, a measure of sampling adequacy, was 
.852, which is in the “great” range and is indicative that the sample size is adequate and 
the PCA will yield distinct and reliable factors (Field, 2009). Additionally, all KMO 
values for individual items were greater than .82, which is well above the acceptable limit 
of .5 (Field, 2009). Bartlett’s test of sphericity indicated that correlations between items 
were sufficiently large enough to run PCA, χ2 (6) = 166.56, p < .001 (Field, 2009). One 
variable had an eigenvalue greater than one, and through examination of the scree plot, 
there was one point of inflection, which justify that the four variables in the PCA cluster 
to form one factor (Field, 2009), which represents neighborhood stress. Factor scores for 
each participant were obtained using the regression method in SPSS, and these scores 
were used as the independent variable in analyses. Table 8 provides the anti-image 
correlation matrix for the PCA. Table 9 provides the eigenvalues and total variance 
explained by the PCA. Table 10 provides the factor loadings.  
Table 8 
Anti-Image Correlation Matrix 
 % Households 
Below Poverty 
Level 
Median 
Household 
Income 
% Single-
Parent Homes 
% Renter-
Occupied 
Homes 
% Households 
Below Poverty 
Level 
.828* .503 -.136 -.384 
Median 
Household 
Income 
-- .832* .372 .121 
% Single-Parent 
Homes 
-- -- .878* -.330 
% Renter- 
Occupied 
Homes 
-- -- -- .875* 
* Measures of Sampling Adequacy 
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Table 9 
Total Variance Explained 
 Initial Eigenvalues Extraction Sums of Squared 
Loadings 
Component Total % of 
Variance 
Cumulative 
% 
Total % of 
Variance 
Cumulative 
% 
% Households 
Below Poverty 
Level 
3.423 85.576 85.576 3.423 85.576 85.576 
Median Household 
Income 
0.225 5.614 91.190    
% Single-Parent 
Homes 
0.220 5.504 96.694    
% Renter- 
Occupied Homes 
0.132 3.306 100.000    
 
Table 10 
Factor Loadings 
Factor Variables Included Factor Loading 
1 % Households Below Poverty Level .936 
 Median Household Income -.934 
 % Single-Parent Homes .915 
 % Renter-Occupied Homes .915 	  
Primary Analyses 
For tests of hypotheses, significant results are presented in tables. When multiple 
independent variables were entered to test the same outcome (e.g., survival analyses with 
three actigraphy measures all relating to survival), data are presented from step 1 of only 
one model. Effect sizes for each step of the model are denoted by R2 and ΔR2 values 
presented in each table. Full result tables are presented in Appendix C.  
Hypothesis 1A, 1B, and 1C. Ethnicity, neighborhood stress, and cancer-
related stress will be significantly and positively correlated with one another (Figure 
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2). Ethnicity and neighborhood stress were highly correlated, r(43) = .615, p < .001. NH 
White ethnicity was statistically significantly correlated with lower neighborhood stress, 
whereas African American ethnicity was statistically significantly correlated with greater 
neighborhood stress. Neither ethnicity nor neighborhood stress was significantly 
correlated with cancer-related stress. The correlation matrix is presented in Table 11. 
Table 11 
Spearman’s rho correlation matrix for hypothesis 1. 
 
 1 2 3 
1. Ethnicity -- .615* -.066 
2. Neighborhood 
stress 
-- -- .172 
3. Cancer-related 
stress 
-- -- -- 
* p < .001 	  
Hypothesis 2. Tests of hypotheses 2 will explore associations of psychosocial 
stress (i.e., ethnicity, neighborhood stress, and cancer-related distress) with 
physiological disruption (i.e., circadian, endocrine, and immune; Figure 1, Arrow 
A), associations of psychosocial stress and medical outcomes of cancer (i.e., 
progression-free survival; Figure 1, Arrow B), and associations of physiological 
stress and medical outcomes of cancer (Figure 1, Arrow C). 
Ethnicity as a predictor. Hypothesis 2A.1. African American ethnicity will be 
independently associated with greater circadian disruption, endocrine disruption, and 
immune disruption. 
Circadian outcomes (Figure 3). In the model of ethnicity predicting rest/activity 
rhythms, control variables as a group (ΔR2 = .223; F(3, 39) = 3.728, p = .019) were 
significant predictors in the model and income added significant predictive power to the 
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model (partial r = .442; Figure 9). The overall model was not significant. Patients with 
lower income had less rhythmic circadian patterns of activity. 
In the model of ethnicity predicting nighttime restfulness, control variables were 
not significant predictors of nighttime restfulness as a group, nor were they significant 
individually. The overall model was not significant.  
Control variables as a group (ΔR2 = .185; F(3, 39) = 2.942, p = .045) were 
significant predictors in the model of ethnicity predicting daytime sedentariness, and 
income added significant predictive power to the model (partial r = -.378; Figure 9). The 
overall model was not significant. Patients with lower income had greater circadian 
disruption. 
Endocrine outcomes (Figure 3). In the models of ethnicity predicting endocrine 
disruption, control variables were not significant as a group, nor were they significant 
individually. Additionally, ethnicity did not emerge as significantly associated with 
variables of endocrine disruption.  
Immune outcomes (Figure 3). In both the model of ethnicity predicting immune 
factor 1 and the model predicting immune factor 2, control variables were not significant 
as a group, nor were they significant individually. The overall models for factor 1 and 
factor 2 were not significant.  
In the model of ethnicity predicting immune factor 3 (IL-6; IL-12; IFN-γ), control 
variables as a group (ΔR2 = .342; F(3, 32) = 5.546, p = .004) were significant predictors. 
Additionally, age added significant predictive power to the model (partial r = -.566; 
Figure 9). The overall model was not significant. Younger patients had greater secretion 
of inflammatory/TH1-type cytokines (Factor 3: IL-6; IL-12; IFN-γ). 
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Neighborhood stress as a predictor. Hypothesis 2A.2. Neighborhood stress will 
be independently associated with greater circadian disruption, endocrine disruption, and 
immune disruption. 
Circadian outcomes (Figure 4). Control variables as a group (ΔR2 = .281; F(3, 36) 
= 4.680, p = .007) were significant predictors in the model neighborhood stress predicting 
rest/activity rhythms and income added significant predictive power (partial r - .503; 
Figure 11). However, the overall model was not significant. Patients with lower income 
had less rhythmic circadian pattern of activity. 
Figure 9. Significant associations with control variables for associations of 
ethnicity with physiological disruption. 
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In the model of neighborhood stress predicting nighttime restfulness, control 
variables were not significant as a group, nor were they significant individually. The 
overall model was not significant  
In the model of neighborhood stress predicting daytime sedentariness, control 
variables as a group were not significant. Income added significant predictive power to 
the model in predicting daytime sedentariness (partial r = -.361; Figure 11). The overall 
model was not significant. Patients with lower income had greater circadian disruption. 
Endocrine outcomes (Figure 4). Control variables were not significant as a group, 
nor were they significant individually in the model of neighborhood stress predicting 
CAR slope. The overall model was not significant. 
In the model testing relationships of control variables and neighborhood stress 
with diurnal cortisol slope, control variables were not significant as a group. However, 
income added significant predictive power to the model (partial r = -.365; Figure 11). The 
overall model was not significant. Patients with lower income had flatter slopes, which 
are indicative of a less healthy pattern.  
The overall model of the association of neighborhood stress with diurnal cortisol 
mean was significant (ΔR2 = .246; F(4, 36) = 4.557, p = .001; Figure 10); however, 
control variables as a group were not significant, nor were they significant individually. 
Neighborhood stress was noted to be a significant predictor in the model testing diurnal 
cortisol mean (partial r = .520), demonstrating that patients with greater neighborhood 
stress had greater overall cortisol secretion, which is indicative of a less healthy pattern of 
cortisol secretion. Significant results are presented in Table 12. 
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Figure 10. Significant association between neighborhood stress and endocrine 
disruption (i.e., diurnal mean). 
 
Table 12 
Significant results for hypothesis 2A.2: Hierarchical regression analyses entered  
neighborhood stress as a predictor of endocrine disruption. 
Variable N B SE B β R2 ΔR2 p of ΔR2 
Diurnal cortisol mean 41       
Step 1     .090 .090 .314 
Age  .011 .006 .277    
Stage  .027 .038 .113    
Income  -.022 .046 -.076    
Step 2     .336 .246 .001* 
Neighborhood stress  .290 .079 .537    
* p < .05 
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Figure 11. Significant associations with control variables for associations of 
neighborhood stress with physiological disruption. 
Immune outcomes (Figure 4). In both the model of neighborhood stress predicting 
immune factor 1 and the model predicting immune factor 2, control variables were not 
significant as a group, nor were any of them significant individually. The overall models 
for factor 1 and factor 2 were not significant.  
In the model of neighborhood stress predicting immune factor 3 (IL-6; IL-12; 
IFN-γ), control variables as a group (ΔR2 = .438; F(3, 30) = 7.799, p = .001) were 
significant predictors in the model. Additionally, age (partial r = -.622; Figure 10) and 
stage (partial r = -.396; Figure 11) added significant predictive power to the model 
predicting immune factor 3 (IL-6; IL-12; IFN-γ). However, the overall model was not 
significant. Younger patients and patients who had lower stage disease had greater 
section of inflammatory/TH1-type cytokines (Factor 3: IL-6; IL-12; IFN-γ).  
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Cancer-related stress as a predictor. Hypothesis 2A.3. Cancer-related stress will 
be independently associated with greater circadian disruption, endocrine disruption, and 
immune disruption. 
Circadian outcomes (Figure 5). Control variables as a group (ΔR2 = .236; F(3, 41) 
= 4.225, p = .011) were significant predictors in the model of cancer-related stress 
predicting rest/activity rhythms. Income added significant predictive power to the model 
in in predicting rest/activity rhythms (partial r = .465; Figure 14). The overall model was 
not significant. Patients with lower income had less rhythmic circadian pattern of activity. 
In the model predicting nighttime restfulness, control variables were not 
significant as a group, nor were they significant individually. The overall model was also 
not significant.  
In the model predicting daytime sedentariness, control variables as a group were 
not significant; however, income added significant predictive power to the model (partial 
r = -.370; Figure 14). The overall model was not significant. Patients with lower income 
had greater circadian. 
Endocrine outcomes (Figure 5). In the model of cancer-related stress predicting 
CAR slope, control variables were not significant as a group, nor were they significant 
individually. Additionally, the overall model was not significant.  
The association of cancer-related stress with diurnal cortisol slope was significant 
in the overall model (ΔR2 = .084; F(1, 42) = 4.182, p = .047; Figure 12). Control variables 
were not significant as a group, nor were they significant individually. Cancer-related 
stress was noted to be a significant predictor in the model testing diurnal cortisol slope 
(partial r = -.301; Figure 12), demonstrating that patients with greater cancer-related 
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Figure 12. Significant association between cancer-related stress and 
endocrine disruption (i.e., diurnal slope). 
stress had steeper slopes, which is indicative of a healthier pattern. For descriptive 
purposes, mean and 95% confidence interval raw cortisol values are shown across three 
days of sample collection. IES summary scores were split at median IES (Figure 13). 
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In the model of cancer-related stress predicting diurnal cortisol mean, control 
variables were not significant as a group, nor were they significant individually. The 
overall model was not significant. Significant results are presented in Table 13. 
Table 13 
Summary of results for hypothesis 2A.3: Hierarchical regression analyses entered cancer-
related stress as a predictor of endocrine disruption. 
Variable N B SE B β R2 ΔR2 p of ΔR2 
Diurnal cortisol slope 47       
Step 1     .071 .071 .358 
Age  -.001 .001 -.099    
Stage  -.002 .006 -.053    
Income  -.013 .008 -.258    
Step 2     .156 .084 .047* 
Cancer-related stress  -.002 .001 -.292    
* p < .05 
Figure 13. Mean and 95% confidence interval raw diurnal cortisol 
values with median split IES summary scores. 
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Figure 14. Significant associations with control variables for associations of 
cancer-related stress with physiological disruption. 
	  
Immune outcomes (Figure 5). In both the model of cancer-related stress predicting 
immune factor 1 and the model predicting immune factor 2, control variables were not 
significant as a group, nor were they significant individually. The overall models for 
factor 1 and factor 2 were not significant.  
Control variables as a group (ΔR2 = .288; F(3, 35) = 4.170, p = .007) were 
significant predictors in the model of cancer-related stress predicting immune factor 3 
(IL-6; IL-12; IFN-γ). Additionally, age (partial r = -.509; Figure 14) added significant 
predictive power to the model. However, the overall model was not significant. Younger 
patients had greater secretion of inflammatory/TH1-type cytokines (Factor 3: IL-6; IL-12; 
IFN-γ). 
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Ethnicity as a predictor of progression-free survival (Figure 6, Arrow 1). 
Hypothesis 2B1. African American ethnicity will be independently associated with 
shorter breast cancer progression-free survival. 
Ethnicity did not emerge as a significant predictor of progression-free survival 
measured from either date of diagnosis or date of study entry.  
Neighborhood socioeconomic stress as a predictor of progression-free survival 
(Figure 6, Arrow 2). Hypothesis 2B.2. Neighborhood stress will be independently 
associated with shorter breast cancer progression-free survival. 
Neighborhood stress did not emerge as a significant predictor of progression-free 
survival measured from either date of diagnosis or date of study entry.  
Cancer-related stress as a predictor of progression-free survival (Figure 6, 
Arrow 3). Hypothesis 2B.3. Cancer-related stress will be independently associated with 
shorter breast cancer progression-free survival. 
Cancer-related stress did not emerge as a significant predictor of progression-free 
survival from either date of diagnosis or date of stress assessment.  
Circadian disruption variables as predictors of progression-free survival 
(Figure 7, Arrow 1). Hypothesis 2C.1. Circadian disruption will be independently 
associated with shorter breast cancer progression-free survival. 
No circadian disruption variables (i.e., rest/activity rhythms, nighttime restfulness, 
and daytime sedentariness) emerged as significant predictors of progression-free survival 
from either date of diagnosis or date of first actigraphy assessment.  
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Endocrine disruption variables as predictors of progression-free survival 
(Figure 7, Arrow 2). Hypothesis 2C.2. Endocrine disruption will be independently 
associated with shorter breast cancer progression-free survival. 
No endocrine disruption variables (i.e., CAR slope, diurnal cortisol slope, and 
diurnal cortisol mean) emerged as significant predictors of progression-free survival from 
either date of diagnosis or date of first cortisol collection. 
Immune disruption variables as predictors of progression-free survival (Figure 
7, Arrow 3). Hypothesis 2C.3. Immune disruption will be independently associated with 
shorter breast cancer progression-free survival. 
No immune factors (i.e., Factor 1, Factor 2, and Factor 3) emerged as significant 
predictors of progression-free survival from either date of diagnosis or date of blood 
draw.  
Post hoc analyses. 
In tests of hypothesis 2A.3, cancer-related stress was related to diurnal cortisol 
slope, such that participants who endorsed greater cancer-related stress had steeper 
cortisol slopes, which are indicative of a healthy cortisol pattern. Given that these 
findings are in the opposite direction than hypothesized, post hoc analyses were 
conducted to gain a better understanding of this relationship. Upon examining subscales 
of the IES, the measure of cancer-related stress, avoidance (partial r = -.410), but not 
intrusions were significantly related to diurnal cortisol slope. For descriptive purposes, 
mean and 95% confidence interval raw cortisol values are shown across 3 days of sample 
collection. IES avoidance scores were split at the median (Figure 15). Therefore, patients  
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who endorsed greater levels of cancer-related avoidance had steeper, healthier diurnal 
cortisol slopes. Post hoc analyses results are presented in Table 14. 
 
 
 
 
 
 
 
 
 
 
 
 
Table 14 
Summary of results for post hoc analyses: Hierarchical regression analyses entered 
cancer-related stress subscales as a predictor of diurnal cortisol slope. 
Variable N B SE B β R2 ΔR2 p of ΔR2 
Diurnal Cortisol Slope 48       
Step 1     .091 .091 .234 
Age  -.001 .001 -.124    
Stage  -.003 .006 -.077    
Income  -.015 .008 -.283    
Step 2     .244 .153 .005* 
Cancer-related stress: 
Avoidance 
 -.004 .001 -.399    
* p < .05 	  
 
Figure 15. Mean and 95% confidence interval raw diurnal cortisol 
values with median split IES avoidance scores. 
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Summary of Results 
Primary analyses showed that ethnicity and neighborhood stress were statistically 
significantly associated, such that NH White patients had lower neighborhood stress and 
African American patients had greater neighborhood stress, which includes the 
percentage of households below the poverty line, median household income, percentage 
of single-parent homes, and percentage of renter-occupied housing in the neighborhood. 
This supports the hypothesis that ethnicity and neighborhood stress would be correlated, 
as both can be viewed measures of psychosocial stress. However, cancer-related stress 
was not significantly correlated with either ethnicity or neighborhood stress.  
For associations of ethnicity with circadian variables, the control variables (i.e., 
age, stage, and income) as a group were significant predictors of rest/activity rhythms (p 
= .019) and daytime sedentariness (p = .045), with effect sizes of .223 and .185, 
respectively. Control variables as a group were not significant predictors for associations 
of ethnicity with endocrine variables. For associations of ethnicity with immune 
variables, the control variables (i.e., age, stage, and income) as a group were significant 
predictors of Factor 3 (p = .004) with an effect size of .342.  
 For associations of neighborhood stress with circadian variables, the control 
variables (i.e., age, stage, and income) as a group were significant predictors of 
rest/activity rhythms (p = .007) with an effect size of .281. In analyses of relationships 
between neighborhood stress and endocrine disruption, control variables as a group were 
not significant predictors. Control variables as a group were significant predictors of 
Factor 3 (p = .001) with an effect size of .438 in analyses of associations between 
neighborhood stress and immune disruption. Additionally, neighborhood stress was 
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statistically significantly related to diurnal cortisol mean, such that patients with greater 
neighborhood stress had greater overall cortisol secretion, which is indicative of a less 
healthy pattern of cortisol secretion.  
For associations of cancer-related stress with circadian variables, the control 
variables (i.e., age, stage, and income) as a group were significant predictors of 
rest/activity rhythms (p = .011) with an effect size of .236; however, the control variables 
as a group were not significant predictors for associations of cancer-related stress with 
endocrine variables. In analyses testing associations of cancer-related stress with immune 
variables, control variables as a group were significant predictors of Factor 3 (p = .007) 
with an effect size of .288. Cancer-related stress was statistically significantly related to 
diurnal cortisol slope, such that those reporting greater cancer-related stress had steeper 
diurnal cortisol slopes, which is indicative of a healthier cortisol profile. Post hoc 
analyses revealed that symptoms of avoidance, but not intrusions, were driving the 
relationships between cancer-related stress and diurnal cortisol slope, such that patients 
who endorsed greater avoidance had steeper slopes.  
Analyses failed to support hypotheses that psychosocial stress factors are 
associated with variables of circadian disruption and immune disruption. However, two 
results were not statistically significant, but are worthy of discussion. The relationship 
between ethnicity and immune factor 2 (IL-1β, IL-6R, TNF-α, MCP-1) was not 
significant (p = .085), but the direction of the relationship indicates African American 
participants had lower levels of factor 1 immune parameters than NH White participants. 
The relationship between neighborhood stress and immune factor 1 (VEGF, MMP-9, 
TFG- β) was not significant (p = .066); however, the relationship between the variables 
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indicates that participants with greater neighborhood stress had lower levels of immune 
factor 1 parameters.   
Interestingly, income was a significant control variable for the circadian 
disruption variables rest/activity rhythms and daytime sedentariness. Participants with 
lower income had less rhythmic circadian patterns of activity and greater daytime 
sedentary behavior, both of which are indicative of circadian disruption. Additionally, 
age was a significant control variable for immune factor 3 (IL-6, IL-12, IFN-γ). Younger 
participants had greater secretion of these immune parameters. In analyses exploring the 
relationship between neighborhood stress and diurnal cortisol slope, income arose as a 
significant control variable, such that participants with lower income had flatter cortisol 
slopes, indicative of a less healthy cortisol pattern. 
Analyses failed to support the hypotheses that psychosocial stress factors and 
physiological disruption would be predictive of progression-free survival.   
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DISCUSSION 
 
This exploratory study examined the effects of psychosocial stress on 
physiological disruption in presurgical breast cancer patients. Additionally, the predictive 
value of psychosocial stress and physiological disruption on progression-free survival 
was also explored. As expected, ethnicity and neighborhood stress were correlated, such 
that African American participants had greater neighborhood stress. Therefore, it appears 
that the African American women in our sample are more likely to live in a neighborhood 
that can be viewed as socioeconomically stressful (i.e., a higher percentage of households 
below the poverty line, lower median household income, higher percentage of single-
parent homes, and higher percentage of renter-occupied housing). Associations of 
ethnicity and neighborhood stress with cancer-related stress did not emerge. 
Ethnicity was not related to any measure of physiological disruption (i.e., 
circadian disruption, endocrine disruption, and immune disruption). Although no 
significant associations were observed in these analyses, these associations should 
continue to be explored within a cancer context, as it is possible that physiological 
disruption may help to explain ethnic cancer disparities. 
Participants experiencing greater neighborhood stress had greater overall diurnal 
cortisol mean secretion. This suggests that stress associated with the socioeconomic
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status of one’s neighborhood may have an adverse impact on physiology. It is possible 
that the likely chronic nature of neighborhood stress alters physiology, specifically 
cortisol secretion. Additional analyses are warranted to explore how neighborhood stress 
impacts physiological disruption, particularly measures of chronic stress. Neighborhood 
stress was not associated with any other measure of physiological disruption. 
Women experiencing greater cancer-related stress in our sample had steeper 
diurnal cortisol slopes, which can be indicative of a healthier cortisol profile. This finding 
is interesting in that it is in the opposite direction than anticipated. Post hoc analyses 
showed that avoidance, but not intrusions, were significantly associated with diurnal 
cortisol slope. Patients who endorsed greater avoidance had steeper slopes, which may 
indicate that during the presurgical period, avoidance may be a healthy way of coping 
through this acutely stressful period. Therefore, it is possible that in this sample of breast 
cancer patients who are presurgical, avoidance is serving as a buffer to stress, rather than 
a detriment, which may lead to a healthier diurnal cortisol pattern. Continued analysis is 
needed to determine the role of cancer-related stress, particularly avoidance, on 
physiological disruption during the presurgical phase of breast cancer treatment.  
Cancer-related stress was not associated with measures of circadian disruption, 
other measures of endocrine disruption (i.e., CAR slope or mean diurnal cortisol), or 
measures of immune disruption. 
In analyses exploring associations between measures of psychosocial stress and 
physiological disruption, patients with lower income had less rhythmic circadian patterns 
of activity (i.e., greater circadian disruption). Patients with lower income had less healthy 
cortisol slope profiles (i.e., flatter slopes). Therefore, it is likely that individual 
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socioeconomic status may serve as a source of stress in our sample, and in turn, may 
influence circadian and endocrine physiology.  
Additionally, greater secretion of inflammatory/TH1-type cytokines (i.e., IL-6, IL-
12, IFN-γ) was observed in younger patients for analyses testing relationships between 
psychosocial stress and physiological disruption. It is possible that age may affect 
immune function in women with breast cancer. Research would benefit from exploration 
of potential differences in immune function between younger and older breast cancer 
patients, which may aid in the understanding of the difference in the epidemiology and 
prognosis of breast cancer in younger women. 
Our analyses of psychosocial and physiological variables as prognostic indicators 
of progression-free survival produced no significant findings.  
A fair amount of cancer research has focused on the relationships between 
psychosocial stress, physiological disruption, and disease progression; however, life 
context (e.g., ethnicity and neighborhood-related stressors) has rarely been explored 
within this framework. These novel data provide an opportunity to explore multiple types 
of psychosocial stress (i.e., ethnicity, neighborhood stress, and cancer-related stress) and 
their relationship with physiological disruption measures (i.e., circadian, endocrine, and 
immune disruption). By exploring these varying facets of stress, one can begin to 
understand which domains may be most salient in presurgical breast cancer patients and 
can provide suggestions for medical and psychological clinical interventions. 
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Associations Between Measures of Psychosocial Stress: Ethnicity was correlated 
with neighborhood stress, but not cancer-related stress. Neighborhood stress was 
not correlated with cancer-related stress (Figure 2). 
We conceptualized neighborhood stress as a composite of four variables related to 
socioeconomic status (i.e., percentage of households below the poverty line, median 
household income, percentage of single-parent homes, and percentage of renter-occupied 
housing in the neighborhood). Thus, we expected associations of our neighborhood stress 
measure with indicators of poverty. As expected, this study revealed that, in this sample 
of presurgical breast cancer patients, ethnicity was related to neighborhood stress. These 
findings are consistent with previous literature that indicates that, in the United States, 
ethnic minorities live in areas with concentrated poverty (Jargowsky & Yang, 2006; 
Lichter, Parisi, & Taquino, 2012). Additionally, African Americans have higher rates of 
individuals of living in areas of concentrated poverty compared to NH Whites (Lichter et 
al., 2012).  
Neither ethnicity nor neighborhood stress was associated with cancer-related 
stress. These findings are inconsistent with previous literature regarding cancer-related 
stress symptoms across ethnicities. In a study of women who had been diagnosed with 
breast cancer in the prior two to three months, African American women were more 
likely than White women to endorse traumatic symptoms related to the cancer diagnosis 
and met criteria for PTSD (Vin-Raviv et al., 2013).  A large proportion of participants in 
the study had completed surgery (i.e., lumpectomy or mastectomy) at baseline (Vin-
Raviv et al., 2013). Therefore, it is possible that the discrepancy in the timing of the 
administration of the cancer-related stress assessment in our study compared to the study 
	  	   97 
by Vin-Raviv and colleagues (2013) may explain the differences in findings. This may be 
due to African Americans experiencing differences in treatment and expectations for 
recovery. African Americans are often diagnosed with more adverse cancer pathology 
(Middleton et al., 2003), which is likely to need more intensive intervention and could 
make recovery more difficult. African American breast cancer patients have reported 
having a lack of information regarding treatment protocols and expectations regarding 
side effects (Lackey, Fates, & Brown, 2001), which could increase stress following 
surgery. Furthermore, African Americans often rely on support from extended family and 
friends to cope; however, a sample of African American women with breast cancer 
reported that it was difficult to receive the support they needed due to their families own 
difficulties with coping (Ashing-Giwa et al., 2004). Furthermore, patients with colorectal 
cancer reported feeling as though their cancer was a burden on family, which was related 
to lower perception of physical health improvement (Kim, Shaffer, Rocha-Lima, Milton, 
& Carver, 2016). Therefore, a lack of adequate support, or feeling as though one is a 
burden on family may contribute to increases in stress following the receipt of cancer 
treatment. 
We expected to see associations of cancer-related stress with ethnicity and 
neighborhood stress. This hypothesis was based on the assumption that African 
Americans and those living in neighborhoods with lower socioeconomic resources would 
be more disadvantaged, possibly with less access to healthcare, which would translate to 
greater stress regarding their diagnosis. Lazarus and Folkman’s (1984) theoretical model 
of stress and coping may help in understanding discrepancies between our presurgical 
breast cancer sample from other post-surgical samples. Women face new cancer-related 
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challenges throughout the cancer trajectory (e.g., surgery, treatment, recovery, 
negotiating the medical system, fear of recurrence, and mortality). It is possible that they 
may experience an imbalance between stress and their resources to cope with demands, 
and that this imbalance may be greater after beginning treatment. Therefore, our lack of 
associations may be due to the assessment period being prior to initiation of any 
treatment interventions (e.g., surgery). It may be that over time, as the participants in the 
study adjust to the treatment and associated physical, social, and emotional changes, 
cancer-related stress may change. It is possible that ethnicity and neighborhood stress 
may play a role in those changes, particularly when taking into consideration 
disadvantages seen in ethnic minorities and those living in neighborhoods with high 
stress (e.g., fewer resources). However, in this study, women’s ethnicity and current 
neighborhood status appeared unrelated to their perception of stress related to cancer.  
Associations Between Psychosocial Stress and Physiological Disruption 
African American ethnicity was not related to circadian disruption, 
endocrine disruption, or immune disruption (Figure 3). Ethnicity was not 
significantly related to measures of physiological disruption in this study. No research 
has explored ethnic differences in rest/activity rhythms. Given that we have exhausted the 
options in the literature that applies to this study, we compare our sample to those 
exploring ethnic differences in sleep, which is likely correlated with rest/activity rhythms. 
Sleep research has shown ethnic differences in sleep architecture (Rao et  al., 1999), total 
sleep time (Hale & Do, 2007; Lemola et al., 2013; Profant et al., 2002), sleep efficiency 
(Lemola et al., 2013); daytime sleepiness (Ancoli-Israel et al., 1995; Chen et al., 2015); 
and difficulties falling (Ancoli-Israel et al., 1995; Jean-Louis et al., 2000) and staying 
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asleep (Jean-Louis et al., 2000). Given these studies explored sleep, which is 
fundamentally different than rest/activity rhythms, this may explain why we did not 
observe a relationship with ethnicity, while other studies assessing sleep did. 
Furthermore, it does not appear that there are published studies that have explored 
ethnicity and either sleep or rest/activity relationships in cancer samples. It is possible 
that within this sample of breast cancer patients, circadian rhythms may not be influenced 
by ethnicity. This could be due to additional factors seen in patients with cancer, 
particularly those with active tumors, which explain greater variance in circadian 
disruption than ethnicity. 
The lack of a significant relationship between ethnicity and endocrine disruption 
is inconsistent with previous literature that has shown salivary cortisol secretion and 
diurnal cortisol slope dysregulation in African Americans, but not NH Whites. 
Specifically, among healthy young to middle-aged women, African Americans had flatter 
diurnal cortisol slopes (Cohen et al., 2006); this relationship was also observed in middle-
aged to older adult women (McCallum et al., 2006). Hispanic middle to older-aged 
women had significantly flatter slopes compared to NH Whites in a sample consisting of 
caregivers and non-caregivers (Gallagher-Thompson et al., 2006). In a sample of 
pregnant women, African Americans had flatter cortisol slopes than their Hispanic 
counterparts (Suglia et al., 2010). Among healthy adults, African Americans had flatter 
slopes and lower waking cortisol levels (Hajat et al., 2010). Similar findings have been 
observed in African American and Hispanic adolescents (DeSantis et al., 2007). 
However, research did not find ethnic differences in endocrine disruption in a population-
based study of middle-aged men and women utilizing urinary cortisol (Masi et al., 2004). 
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Inconsistences with prior research may be related to differences in measurement or 
analysis of data (e.g., cortisol slope calculation).  
Within our sample, the lack of an association between ethnicity and endocrine 
disruption could be due to other factors that may account for endocrine disruption. For 
example, previous research showing ethnic differences in overall cortisol secretion 
indicated that perceived stress may explain ethnic differences (Bennett et al., 2004). 
Additionally, in a community-based sample of adult men and women, African American 
and Hispanic/Latino participants had flatter slopes associated with increased psychosocial 
stress (DeSantis, Adam, Hawkley, Kudielka, & Cacioppo, 2015). It is possible that the 
perception of stress related to ethnicity (e.g., racial/ethnic discrimination) may be related 
to endocrine disruption, and only measuring ethnicity may not fully capture this effect.   
Limited research has explored ethnic differences in immune disruption and has 
shown that, in healthy adults, lower levels of IL-8 and G-CSF (Mayr et al., 2007) and 
higher levels of IL-6 and CRP have been observed in African Americans compared to 
NH Whites (Stowe et al., 2010). We did not observe ethnic differences in immune 
variables. The inconsistences with prior research may be due to a number of different 
factors, such as methodological differences, differences in blood collection (i.e., serum 
vs. plasma), and differences in collection time (Mayr et al., 2007; Stowe et al., 2010). 
Additionally, one study’s sample was only men (Mayr et al., 2007), which may also 
explain the differences between their findings and this study. Indeed, there are sex 
differences in immune function (Nakamura et al., 2000; Oertelt-Prigione, 2012). Other 
factors may better explain differences in immune functioning than ethnicity. For 
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example, it is possible that the ethnic differences observed in plasma CRP may be driven 
by body mass index and obesity (Stowe et al., 2010). 
In this study, ethnicity is conceptualized as a potential psychosocial stressor. The 
lack of associations observed between ethnicity and physiological disruption may 
indicate that factors related to ethnicity (e.g., racial/ethnic discrimination) may better 
capture ethnicity as a stressor. Ethnicity-related factors, such as racial/ethnic 
discrimination can likely be conceptualized as a chronic stressor. Among adolescents, 
increased perceived discrimination was associated with elevated cortisol levels 
throughout the day (Huynh, Guan, Almeida, McCreath, & Fuligni, 2016) and ethnicity 
moderated the relationship between perceptions of discrimination and diurnal cortisol 
slope (Zeiders, Hoyt, & Adam). Additionally, African American young women reporting 
one or two discriminatory experiences had higher levels of CRP than those who had not 
had these experiences (Cunningham, et al., 2012). Therefore, factors closely related to 
ethnicity, such as perceived discrimination, may contribute to changes in physiological 
disruption.  
Neighborhood stress was associated with elevated diurnal mean cortisol, but 
not with circadian or immune disruption (Figure 4). Neighborhood stress was 
significantly associated with diurnal cortisol mean, a measure of endocrine disruption. 
Previous research has shown that individuals living in neighborhoods with increased 
levels of perceived stressors had an increase of cortisol throughout the day and evening, 
starting three hours after waking, and lower overall cortisol mean (Karb et al., 2012). 
However, these stressors were not socioeconomic in nature, as Karb and colleagues 
(2012) explored perceived neighborhood violence, safety, physical hazards, and quality 
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of neighborhood service and observed homicides, robberies and burglaries, physical 
disorder and deterioration, vacant lots and houses, and stress conditions (Karb et al., 
2012). Neighborhood violence has been shown to be associated with low waking cortisol, 
and a “weaker, less consistent” association with neighborhood poverty and cortisol slope 
(Do et al., 2011, p. 630). Furthermore, research has shown associations between total 
serum cortisol and a neighborhood stress index comprised of unemployment rates, 
poverty, female head of households with dependent children, and vacant housing (Dulin-
Keita et al., 2012).  
The differences in findings in this study and the literature may be due to differing 
methods of measurement of cortisol, as well as differences in what neighborhood 
stressors were explored. As demonstrated among adolescents living in neighborhoods 
perceived as discriminatory (Huynh et al., 2016), it is possible that living in a 
neighborhood that can be considered dangerous or socioeconomically stressful has an 
impact on physiological disruption by increasing secretion of cortisol. Within this sample 
of women, those living in areas with high neighborhood stress may have been 
experiencing these stressors for an extended period, which could manifest in stress that is 
chronic in nature. It may be that chronic neighborhood stress functions similarly to other 
chronic stressors, contributing to increasing overall cortisol production in response to the 
stress, which, in turn, may have harmful effects on health. 
Neighborhood stress was not significantly related to circadian disruption. No data 
on neighborhood stress and rest/activity rhythms is available. For comparison purposes, 
neighborhood stress has been shown to be related to sleep (Hale et al., 2010; Hill et al., 
2009; Steptoe et al., 2008). It is important to note that while there is a probable 
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correlation between rest/activity rhythms and sleep, these are different parameters. 
Rest/activity rhythms are measured over multiple days and are based on circadian 
patterns of activity. Research has focused exclusively on relations with sleep and 
neighborhood disorder and crime. The differences in measures of neighborhood stress, as 
well as assessing sleep, rather than rest/activity rhythms, may explain the discrepancies in 
findings seen in previous research and this study. One study exploring the relationship 
between sleep and neighborhood stress found that this association was no longer 
significant after adjusting for self-reported health (Steptoe et al., 2008).   
Neighborhood stress was not significantly related to immune disruption. While no 
significant findings were seen in this study, this is an exciting area for further research as 
the literature on stress and immune function is vast, and one article exploring the 
relationship between neighborhood stress and health suggested that immune function may 
mediate this relationship (Steptoe & Feldman, 2001). In a study of NH Whites and 
African Americans, middle to older age adults living in more deprived neighborhoods 
had greater odds of inflammation than those who live in less deprived areas (Dulin Keita, 
Judd, Howard, Carson, Ard, & Fernandez, 2014). Additionally, greater neighborhood 
deprivation was related to greater levels of IL-6, CRP, and fibrinogen (i.e., a protein for 
clotting; Nazmi, Roux, Ranjit, Seeman, & Jenny, 2010). Exploring the possible role of 
neighborhood stress on immune function within a cancer population could yield 
significant findings that may help us understand how neighborhood stress may affect 
physiology relevant to cancer. Additionally, in this study we explored relationships in the 
context of an active tumor (i.e., presurgically). It is possible that tumor influences on 
immune disruption could introduce variance that could mask stress-immune effects. 
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To understand relationships between neighborhood stress and physiological 
disruption, the length of time the individual lived in a particular neighborhood should be 
considered. This is relevant in determining whether neighborhood stress could be 
considered an acute or chronic source of stress for the individual. If neighborhood stress 
for the individual is acute in nature, we may not see effects on physiological disruption. If 
the individual recently moved from a neighborhood of high stress to an area of low stress, 
we may see significant findings given the variation in amount of time spent in the current 
neighborhood and the potential for sustained effects from living in the prior 
neighborhood. However, it is possible in this scenario to not see associations between 
neighborhood stress and physiological disruption due to possible improved access or 
resources if one moves from a neighborhood with high stress to a neighborhood with low 
stress. Access to resources (e.g., transportation, medical facilities) may explain 
relationships observed when exploring the effects of neighborhood stress. 
A theoretical framework has been developed to understand cancer disparities in 
relation to neighborhood chronic toxic stress exposure (DeGuzman & Schminkey, 2016). 
This model proposes that the social and built environment; which is a product of 
historical events (e.g., racial segregation) and neighborhood associated chronic toxic 
stressors (e.g., violence), influence health behaviors, mental health, and genomics (i.e., 
genomic epigenetic modifications and DNA damage); which in turn, affect cancer 
outcomes (DeGuzman & Schminkey, 2016). Considering this model of the complex 
effects of neighborhood stress on cancer increases the interest regarding the influence of 
neighborhood stress of physiological disruption, as well as the potential associated effects 
on outcomes (e.g., quality and quantity of life) in cancer patients.  
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Cancer-related stress was associated with greater diurnal cortisol 
rhythmicity. This association may be explained by adaptive avoidance of cancer-
related thought. Interestingly, within our sample of presurgical breast cancer patients, 
cancer-related stress was related to steeper, more rhythmic cortisol slopes. Post hoc 
analyses revealed a significant relationship between avoidance, but not intrusions, and 
these “healthier” diurnal cortisol slopes. The avoidance subscale includes staying away 
from reminders; avoidance of emotions; thought suppression; not trying to “deal with” 
the negative emotions and difficulties; trying to remove an event from memory; and not 
talking about the event. It is possible that within this sample of women, these strategies of 
avoidance provided a buffering effect for the acute stressor that is a breast cancer 
diagnosis. Research from our lab exploring daily intrusions and daily avoidant coping 
relationships with diurnal cortisol slope did not emerge as significant in this same sample 
of women (Dedert et al., 2012). Differing strategies in data collection included daily 
intrusions and daily avoidant coping measured each day over three days, during the 
cortisol collection in the study by Dedert and colleagues (2012). Additionally, avoidant 
coping was measured using subscales of the Brief COPE measure (Dedert et al., 2012), 
whereas this study utilized the IES. The difference in data collection may account for the 
differences in findings.  
The presurgical phase includes medical evaluations and preparation for surgery 
and is often associated with significant mood disturbance and elevated distress in 
relation to sleep difficulties, fatigue, and concentration difficulties in women with breast 
cancer (Cimprich, 1999). Further, the pre-treatment period was the most stressful for 
women with breast cancer (Culver, Arena, Antoni, & Carver, 2002; Northouse, 1998) 
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with the distress decreasing over time following initial diagnosis (Compas & Luecken, 
2002; Culver et al., 2002; Burgess et al., 2005). Among men with prostate cancer who 
had completed treatment, avoidant coping was found to be related to flatter diurnal 
cortisol slopes at baseline and four-month follow-up (Hoyt et al., 2014). Given the 
differences between our findings and those who have completed treatments, it may be 
that avoidance provides a safeguard to changes in circadian regulation during the acutely 
stressful presurgical period, but may have detrimental effects on physiology during the 
post-treatment period or in response to chronic stress. 
Cancer-related stress was not significantly related to circadian disruption. Limited 
research has explored the relationship between cancer-specific distress, a measure of 
intrusions and avoidance, and circadian rhythms. Research conducted on this same 
sample of women by our lab showed associations between daily intrusions and daily 
avoidant coping with consistency of rest/activity rhythms, daytime sedentariness, and 
nighttime restlessness (Dedert et al., 2012). However, the collection strategy for cancer-
related stress (i.e., intrusions and avoidance) differed, in that this study explored cancer-
related stress at one-time point, baseline, whereas the study by Dedert and colleagues 
(2012) explored these variables daily over the same three days that actigraphy was 
collected. The average (SD) days between our collection at baseline and the actigraphy 
collection were 0.167 days (3.975), with a median of one day. The discrepancy in 
findings may be explained by day-to-day variability. Therefore, it may be that nuanced 
variations in daily levels of intrusions and avoidant coping are better predictors of 
circadian disruption than obtaining data on a patient’s average levels over the past week. 
It may be that in the days following a cancer diagnosis, cancer-related stress may increase 
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as the individual has had more opportunity to reflect on their diagnosis and the 
implications that the diagnosis and treatment will have on their quality and quantity of 
life. Additionally, it is possible that individually, either intrusions or avoidance may be 
better associated with circadian disruption than the combination of the two.  
Cancer-related stress was not associated with other measures of endocrine 
disruption (i.e., CAR slope and diurnal cortisol mean). Research completed by our lab, 
using the same sample of women, did not observe associations between daily intrusions 
or daily avoidant coping with CAR slope or diurnal mean cortisol (Dedert et al., 2012). 
Other previous research has shown that intrusions and avoidance might be related to 
cortisol alterations. One meta-analysis indicated that following a traumatic event, there 
might be increases in cortisol production, but generally, cortisol levels are lower in 
individuals with PTSD (Yehuda, 2002). This contrasts with our sample as PTSD 
develops after at least one month of symptoms following a traumatic event; whereas, 
data was collected in our sample an average (SD) of 19.21 (20.82) days after diagnosis, 
with a median of 14 days. Within a sample of healthy women with no personal or family 
histories of breast cancer, breast cancer specific intrusions were related to increased 
cortisol responses to acute stressors at work (Dettenborn et al., 2006).  
Cancer-related stress was not significantly related to immune disruption. Prior 
research has shown increased cancer-related stress to be related to inhibition of cellular 
immune response (Andersen et al., 1998), decline in natural killer cell activity and 
stimulated IFN-γ (Von Ah et al., 2007), and elevations of plasma IL-1Rα (Mundy-Bosse 
et al., 2011) among post-surgical breast cancer patients. In metastatic breast cancer 
patients, depression was related to suppressed immunity (Sephton et al., 2009). 
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Additionally, in ovarian cancer patients, increased vegetative depression was associated 
with elevated plasma IL-6 (Lutgendorf et al., 2008) and increased helplessness was 
related to increased serum VEGF (Lutgendorf et al., 2002). It is possible that the lack of 
findings in this study may be due to differences in measurements of distress (e.g., 
cancer-related stress vs. depression) and immune function (e.g., serum vs. stimulated 
cytokines), as well as timing of data collection (e.g., presurgical vs. post-surgical). 
 In this study, the timing of the measurement of variables, including cancer-related 
stress and physiological disruption, was prior to any surgical procedure. Receiving a 
cancer diagnosis can be regarded as an acutely stressful period, and it may be that this 
period of stress has not been experienced for a long enough amount of time to be related 
to or cause changes in physiological disruption, which could explain the lack of findings. 
It is also possible that in the short term, avoidance, one aspect of cancer-related stress, 
may provide effects that protect against changes to physiology. Avoidance has been 
conceptualized to include denial (Taylor & Stanton, 2007), which is “trying to push the 
reality of the situation away” (Carver, 1997, p.98). In addition to denial, avoidance also 
includes repression, distraction, and disengagement (Carver, Scheier, & Weintraub, 
1989). In a study of women with breast cancer, within one week following mastectomy, 
denial was associated with lower levels of stress, which indicates that denial may be a 
short term adaptive coping response to a diagnosis of cancer (Watson, Greer, Blake, & 
Shrapnell, 1984). Denial was also seen in a sample of lung cancer patients, which the 
authors suggest is normal and highlights a need to protect one’s self from the stress 
associated with a cancer diagnosis, and that over time use of denial and distraction 
decrease (Vos, Putter, van Houwelingen, & de Haes, 2008). It is possible that maintaining 
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as much normalcy as possible during the early phases of the cancer trajectory may prove 
beneficial in managing the short-term stress of a diagnosis. However, longitudinal 
research within a cancer population may elucidate the risks and benefits of various types 
of coping throughout cancer diagnosis, treatment, and survivorship. Indeed, in a sample 
of women with early stage breast cancer, denial and a fighting spirit were significantly 
more likely to be predictive of five-year survival than stoic acceptance of 
hopelessness/helplessness (Greer, Morris, & Pettingale, 1979).  
No predictors of progression-free survival emerged. 
 Measures of psychosocial stress (i.e., ethnicity, neighborhood stress, and cancer-
related stress) were not significantly related to medical outcomes of cancer (progression-
free survival) in this study. These findings are inconsistent with previous literature that 
shows significant ethnic disparity in cancer survival; however, the previous research has 
largely been epidemiological in nature.  
Disparities in survival rates among NH White and African American breast 
cancer patients may be attributed to racial differences in patterns of care (Diehr et al., 
1989), treatment options and choices (Bradley, Given, & Roberts, 2002; Hershman et al., 
2005), barriers to access to care (DeSantis, Siegel, Bandi, & Jemal, 2011), 
noncompliance with therapy, and incomplete treatment adherence, which may be related 
to socioeconomic status (Baquet, Mishra, Commiskey, Ellison, & DeShields, 2008).  
However, it has been suggested that the ethnic disparity in mortality may be due to 
factors other than those related to access to care (Chlebowski et al., 2005). For example, 
ethnic differences in genetics, which may also be attributed to neighborhood stress, could 
explain differences in cancer outcomes (DeGuzman & Schminkey, 2016). Therefore, 
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cross-sectional, experimental, and longitudinal research would be beneficial to help 
elucidate these disparities.  
There are possible explanations for the lack of significant findings in this study. It 
is possible that the sample size for those who have had recurrent disease or have passed 
was too small to detect significant effects. With survival analyses, it is suggested that at 
least 50% of participants should have experienced a recorded event (i.e., recurrence or 
death in this study). This study only had 30% of participants that had recurrent disease or 
passed; therefore, this may have been too small a proportion to detect significant effects.  
Another, related, possibility is that of missing data. Considering the low number of 
participants for whom survival data were available (n = 16), analyses may have been 
underpowered. 
Measures of physiological disruption (i.e., circadian, endocrine, and immune) 
were not significantly related to progression-free survival. These findings are inconsistent 
with previous literature that have shown rest/activity rhythms (Innominato et al., 2009; 
Lévi et al., 2014;  Mormont et al., 2000), diurnal cortisol slope (Cohen et al., 2012; 
Schrepf et al., 2015; Sephton et al., 2013; Sephton et al., 2000), VEGF (Jin-no et al., 
1998; Karayiannakis et al., 2002), and IL-1β (Barber et al., 2000) to be associated with 
shorter survival in various cancer populations. As described above, it is possible that the 
small sample size provided too little statistical power to reveal significant findings. In 
addition, it is possible that no significant findings were observed because this sample of 
women was presurgical. It is plausible that presurgical cancer patients have not had 
significant changes to physiological disruption markers that affect survival (Cash et al., 
2015). If this is the case, these results could be promising in that interventions targeted 
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during the presurgical period, or prior to neoadjuvant treatment may delay physiological 
disruption, or weaken the effects of physiological disruption on survival.   
Extensive research has shown that various psychosocial interventions decrease 
stress related to the experiences of cancer diagnosis and treatment, which may improve 
physiology throughout and following treatment (Antoni, 2013). However, prehabilitation 
research is a nascent area within the cancer rehabilitation continuum, which focuses on 
the time between diagnosis and the beginning of treatment (Silver, 2015). Preoperative 
interventions can focus on physical functioning, nutrition, psychological health, and 
stress management, which may influence physiological and psychological outcomes in 
patients with cancer (Silver, 2015). Indeed, a review of the cancer prehabilitation 
literature revealed that preoperative psychological interventions had significant effects on 
immune function, psychological outcomes, somatic symptoms, and quality of life 
(Tsimopoulou et al., 2015). 
Associations have been observed between psychosocial stress and physiological 
disruption with another cancer outcome, quality of life (QOL). In a study exploring the 
relationships between distress and QOL with this same sample of women, an association 
between cancer-related stress and QOL, as well as ethnic differences were observed 
(Rebholz et al., 2016). For example, NH White women reported poorer emotional QOL 
in relation to cancer-related distress, which may indicate that African American women 
utilize more effective means of coping or rely on or experience more positive social 
support (Rebholz et al., 2016). Research has shown that African Americans are more 
likely to use spirituality in coping with cancer-related stressors (Culver, Arena, Antoni, & 
Carver, 2002). Additionally, research has shown relationships between circadian 
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disruption (Innominato et al., 2009) and endocrine disruption (Carlson, Speca, Patel, & 
Goodey, 2004; Miller, Ancoli-Israel, Bower, Capuron, & Irwin, 2008) and QOL. IL-6 has 
also been shown to be associated with fatigue, which strongly affects QOL in cancer 
patients (Cleeland et al., 2003; Seruga, Zhang, Bernstein, & Tannock, 2008).   
Low-income patients had poor circadian coordination. 
In analyses exploring associations between psychosocial stress and circadian 
disruption, patients reporting lower income had greater circadian disruption, indicated by 
less rhythmic rest/activity patterns and greater daytime sedentary behavior. Within this 
same sample of women, lower income was associated with greater rest/activity disruption 
in tests of associations with daily intrusions and daily avoidant coping (Dedert et al., 
2012). Income likely serves as a significant source of stress, which may negatively 
impact rest/activity rhythms. Therefore, income disadvantage appears to play a role in 
circadian disruption and should be further explored to understand the mechanisms driving 
this association. 
Additionally, income emerged as a significant predictor in the analysis assessing 
the relationship between neighborhood stress and endocrine disruption, such that patients 
reporting lower income levels had flatter diurnal cortisol slopes, which are indicative of a 
less healthy profile. In a large study of older adults, financial insecurity explained a 
portion of the variance in the relationship between social position and cortisol slope 
(Kumari et al., 2010). Lower socioeconomic status was related to lower waking cortisol 
levels and flatter cortisol slopes in the early portion of the day (Hajat et al., 2010). In 
contrast, higher income has been shown to be related to steeper cortisol decline over the 
day (Wang et al., 2014). The findings of this study support previous literature that 
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income, one measure of an individual’s socioeconomic status, may serve as a source of 
stress that influences endocrine physiology. Disadvantage related to low income is a 
significant stressor to many individuals and is potentially more salient to those affected 
by cancer as they face treatment decisions that are likely to influence various areas of life 
related to income, such as the ability to work or care for family and the home. Continued 
research is needed to better understand the role income plays in chronic endocrine 
changes, as socioeconomic disadvantage may influence cancer progression. 
Younger patients had greater immune disruption.  
In the analyses assessing the associations of psychosocial stress and immune 
disruption, younger patients had greater secretion of inflammatory/TH1-type cytokines 
(i.e., IL-6, IL-12, IFN-γ). Research has shown that younger women with breast cancer are 
often diagnosed at a later stage and have adverse pathology as evidenced by higher grade 
tumors, negative hormone receptor status, and overexpression of HER2 (Assi et al., 
2013). Research has shown IL-6 levels increase as one ages in samples of older adults 
(Kiecolt-Glaser, Preacher, MacCallum, Atkinson, Malarkey, & Glaser, 2003), healthy 
subjects (Wei, Xu, Davies, & Hemmings, 1992), and women (Haden, Glowacki, Hurwitz, 
Rosen, & LeBoff, 2000). While these findings are in the opposite direction as those we 
observed, our results are not surprising given the more difficult prognosis of younger 
breast cancer patients and the likely associated stress. Further research should explore 
relationships between age and these cytokines in breast cancer patients to understand how 
age may influence inflammation/TH1-type immunity. Better understanding this potential 
relationship may lead to avenues for treatment that could improve outcomes for younger 
breast cancer patients. 
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Strengths and Limitations 
This study represents the first examination of multiple types of psychosocial 
stress and physiological disruption in presurgical breast cancer patients. By examining 
ethnicity, the impact of the environment (i.e., neighborhood), one’s perception of stress 
related to a cancer diagnosis, and changes in physiology through the use of subjective 
self-report measures, census data, and objective measures allowing for a more 
comprehensive evaluation of stress. Therefore, by collecting data on multiple sources of 
stress measured with different methods, it is possible to explore the importance of both 
psychosocial stress and physiological disruption during the cancer process.  
Utilizing census data to study the effects of neighborhood stress is an approach 
that allows for a more accurate reflection of the status of the neighborhood, reflected as a 
census tract, compared to obtaining self-report of one’s perceptions of their neighborhood 
stress. Both methods of measurement hold merit to use in research; however, by utilizing 
census data, it is possible to obtain an objective understanding of neighborhood stress. By 
conducting a principal components analysis (PCA), it was possible to explore four 
variables that loaded onto one factor, neighborhood stress. This helped to limit the 
number of analyses run when exploring the effects of neighborhood stress on 
physiological disruption and medical outcomes of cancer.  
Measuring circadian disruption with two indicators (i.e., rest/activity rhythms and 
diurnal cortisol rhythms) allows for these two types of circadian rhythms to be measured 
via separate and objective methodology (i.e., activity levels and salivary cortisol levels, 
respectively). Actigraphy data may be more likely to be influenced by exogenous factors, 
which, for example, may include cues from the social environment (e.g., light exposure, 
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meal timing). Diurnal cortisol measurement depicts endogenous rhythms regulated by the 
SCN. 
For multiple reasons, a novel aspect of this study is the timing of recruitment and 
data collection, which occurred relatively soon after the cancer diagnosis and prior to 
surgical treatment. There is a dearth of research during this time point, with the majority 
of studies focusing on patients during adjuvant treatment or those with survivor status 
(i.e., greater than or equal to five years disease-free). By assessing mental and emotional 
state and physiology prior to surgery and other treatments, it is possible to gain an 
understanding of these variables with an active tumor present in the body. Our data were 
not clouded by variability resulting from physically and emotionally demanding cancer 
treatments. Additionally, by conducting assessments at this time point it is possible to 
assess psychosocial and biological constructs before the long-term cancer treatment 
process alters them. By assessing physiology presurgically and prior to other types of 
treatment (e.g., neoadjuvant chemotherapy and radiation therapy), systems have not yet 
been dysregulated by these medical interventions. 
It is noteworthy that this sample was ethnically diverse. The ethnic breakdown of 
the sample was approximately 58% NH White and about 37% African American. There 
were an additional three participants, two reporting their ethnicity as Native American 
and one reporting her ethnicity as Asian American. These three individuals were 
excluded from the analyses utilizing ethnicity as a predictor, due to potential cultural 
differences in psychosocial stress and physiological disruption. Rather than grouping the 
individuals into a general minority category, it is preferable to consider the different 
cultural factors of each specific ethnic group. Additionally, given the small sample size of 
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Native Americans and Asian Americans, it was necessary to exclude them from the 
analyses.    
The overall relatively small sample size of the study is itself another limitation. A 
larger study would provide greater power and allow for the detection of small magnitude 
effects (i.e., phenomena with smaller effect sizes). Additionally, there were missing data, 
which coupled with the small sample size created problems with the survival analyses. 
No survival analyses emerged as significant. This is likely, in part, due to the low number 
of participants with a recorded event (i.e., 30% of participants with recurrence or death) 
once predictor-missing data were accounted for. The number of events was already low 
for survival analyses and once the removal of those with missing data, the number was 
even lower. 
This study was exploratory in nature. This was an approach that was taken to 
provide direction for the generation of hypotheses in future research studies, rather than 
to confirm hypotheses. Therefore, the results presented here should be considered with 
caution as they are not generalizable outside this sample. Given the large number of 
analyses that were run, results must be interpreted with great caution. Our many non-
significant findings could be attributable to the small sample size, or may be due to 
differences in data collection and statistical tests compared to previous studies. However, 
given the exploratory nature of the study, the results should serve as a guide for the 
development of future research and relationships that were not significant should be 
explored further. 
Future Directions 
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The results of this study point to a number of directions for additional research to 
explore. It is reasonable to think that some aspects of psychosocial stress may influence 
physiological disruption early in the cancer trajectory, even before any surgical or 
medical intervention. Further studying the impact of psychosocial stress on physiological 
disruption within cancer populations may provide an even greater understanding of how 
stress affects physiology when an individual experiences chronic disease.  
It may be beneficial to consider the manner in which the psychosocial factors are 
measured in research. This study used a dichotomous self-report of ethnicity; however, an 
improved manner for measuring ethnicity would be to utilize a validated measure, such as 
the Multigroup Ethnic Identity Measure (MEIM; Phinney, 1992; Phinney & Ong, 2007). 
The MEIM would be more beneficial than a dichotomous or categorical self-report of 
ethnicity, as it would allow for a better understanding of one’s ethnic identity, sense of 
belonging with their ethnic origin, and the possible impact that this has on physiological 
disruption.  
With regard to neighborhood stress, it would be useful for future research to 
include an index, as this study did, to assess various factors that may impact 
physiological disruption. By utilizing an index of neighborhood stress, researchers would 
be able to explore various areas, such as neighborhood poverty levels, median 
neighborhood income, and other factors, that may contribute to the difficulty of living in 
a particular neighborhood. This could allow for a better understanding of what individual 
factors may contribute to changes in physiological disruption. Additionally, knowledge 
would be gained as to the impact of the cumulative nature of environmental stressors 
within the neighborhood context.  
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 Mediator and moderator variables were not explored in this study for multiple 
reasons, including the small sample size and that the study sought to utilize exploratory 
analyses to gain a better understanding of direct relationships between psychosocial stress 
and physiological disruption. However, the role of mediators and moderators are essential 
in better understanding the relationships between psychosocial stress and physiological 
disruption. Potential mediators and moderators that would be advantageous to study 
include access to and utilization of healthcare, social support, coping resources, which 
may include active coping strategies, religiosity or spirituality, and meaning making or 
benefit finding. While this list is not exhaustive, it highlights potential variables of 
significance. 
While this study employed a cross-sectional design, longitudinal research could 
illuminate how psychosocial stress and physiological disruption change over time. It is 
likely that there is a time during the cancer trajectory that psychosocial stress and 
physiological disruption are stronger predictors of one another, as well as stronger 
predictors of survival. A longitudinal design can allow for hierarchical linear modeling, 
which can illuminate the period during which psychosocial factors most strongly predict 
cancer outcomes. From gaining this type of knowledge, substantial implications for 
medical and psychological intervention would result. By knowing what psychosocial 
stress or physiological disruption factor is a stronger predictor at a particular time during 
one’s cancer journey, more assessments could be completed during that period, which 
might lead to either psychological or medical interventions to improve the quality or 
extend the quantity of life for individuals with cancer. 
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Future research that investigates psychosocial stress would benefit from including 
ethnicity and neighborhood stress, in addition to an individual’s perceived stress related 
to their diagnosis. With these additions, research will more adequately explore various 
stressors that may play a role in physiological disruption. By continuing to explore these 
associations, research can begin to understand more about the driving factors of 
physiological disruption. This may help to identify the most predictive aspects of stress, 
identify future medical and clinical treatments, and delay or prevent adverse changes to 
physiology/health outcomes. 
Research should continue to explore the mechanisms of stress effects on cancer 
survival. Research in which assessments are completed prior to surgery or other medical 
intervention is crucial. Research of this nature may shed light on the effects of an active 
tumor on physiological disruption and the possible implications throughout the cancer 
trajectory, as well as the individual’s lifespan. If associations are seen between early 
onset psychosocial stress, physiological disruption, and survival; we may discover new 
markers to target early in the cancer process.  
The current study explored novel relationships between psychosocial stress and 
physiological disruption within a sample of women that were awaiting surgery for breast 
cancer. The association between neighborhood stress and endocrine physiology 
emphasizes the importance of improved resources and access within disadvantaged 
neighborhoods, which would likely reduce stress and improve resident’s health. An 
unexpected relationship between avoidance and healthier diurnal cortisol slopes 
indicates that avoidance may serve to help maintain normalcy during the acutely 
stressful, chaotic, presurgical period. These intriguing findings highlight the importance 
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of psychosocial intervention while awaiting treatment for cancer. Prehabilitation 
interventions, when psychosocial stress is probably most salient to a woman with cancer, 
are worthy of investigation. Research of this nature could aid in identifying methods for 
improvement of quality, and possibly quantity, of life for women with breast cancer.
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APPENDIX A 
 Abbreviations: DCIS, ductal carcinoma in situ; TNM, tumor-node-metastasis; ER, 
estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor 
receptor 2; QOL, quality of life; SES, socioeconomic status; NH, non-Hispanic; ASD, 
acute stress disorder; PTSD, post-traumatic stress disorder; DSM, Diagnostic and 
Statistical Manual of Mental Disorders; SCN, suprachiasmatic nucleus; HPA, 
hypothalamic-pituitary-adrenal; CAR, cortisol awakening response; VEGF, vascular 
endothelial growth factor; MMP, matrix metalloproteinase; TGF, transforming growth 
factor; IL-6R, interleukin-6 receptor; MCP, monocyte chemoattractant protein; IL, 
interleukin; TNF, tumor necrosis factor; IFN, interferon; REM, rapid eye movement; G-
CSF, granulocyte-colony stimulating factor; CRP, C-reactive protein; SEER, 
Surveillance, Epidemiology, and End Results Program; AUC, area under the curve; KCR, 
Kentucky Cancer Registry; IES, Impact of Events Scale; MEMS, medication event 
monitoring system; EIA, enzyme immunoassay; CV, coefficient of variation; EFA, 
exploratory factor analysis; POM-TMD, Profile of Mood States- Total Mood 
Disturbance; PCA, principal component analysis; KMO, Kaiser-Meyer-Olkin; MEIM, 
Multigroup Ethnic Identity Measure 
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APPENDIX B 
 
Ethnicity (as measured in this study) 
What is your racial-ethnic background?  O Asian 
       O Black 
       O Hispanic 
       O Native American 
       O White/Caucasian 
       O Other
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Measure of Cancer-Related Stress 
Impact of Events Scale (IES; Horowitz et al., 1979) 
Below is a list of comments made by people after stressful life events. Please fill in each 
item, indicating how frequently the comments were true for you DURING THE 
CURRENT DAY regarding your diagnosis and treatment of BREAST CANCER. If they 
did not occur, please mark the "Not at All" column. 
 
N
ot
 a
t a
ll 
R
ar
el
y 
So
m
et
im
es
 
O
fte
n 
 0 1 2 3 
1. I thought about it when I didn't mean to. O O O O 
2. I avoided letting myself get upset when I thought about it or was 
reminded of it. O O O O 
3. I tried to remove it from memory. O O O O 
4. I had trouble falling asleep or staying asleep, because of pictures of 
thoughts about it that came into my mind. O O O O 
5. I had waves of strong feelings about it. O O O O 
6. I had dreams about it. O O O O 
7. I stayed away from reminders of it. O O O O 
8. I felt as if it hadn't happened or it wasn't real. O O O O 
9. I tried not to talk about it. O O O O 
10. Pictures about it popped into my mind. O O O O 
11. Other things kept making me think about it. O O O O 
12. I was aware that I still had a lot of feelings about it, but I didn't 
deal with them. O O O O 
13. I tried not to think about it. O O O O 
14. Any reminder brought back feelings about it. O O O O 
15. My feelings about it were kind of numb. O O O O 
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APPENDIX C 
 
All results are presented here in full as a reference. 
 
Spearman’s rho correlation matrix for hypothesis 1. 
 Mean (SD) 1 2 3 
1. Ethnicity -- -- .615* -.066 
2. Neighborhood 
socioeconomic 
stress 
0 (1)+ -- -- .172 
3. Cancer-related 
stress 
28.38 (15.37) -- -- -- 
* p < .001 
+ variable is standardized 
 
 
Summary of results for hypothesis 2A.1: Hierarchical regression analyses entering 
ethnicity as a predictor of circadian rhythm variables. 
Variable N B SE B β R2 ΔR2 p of ΔR2 
Rest/activity rhythm 43       
Step 1     .223 .223 .019* 
Age  .003 .002 .209    
Stage  .008 .011 .104    
Income  .041 .013 .436*    
Step 2     .257 .034 .195 
Ethnicity  -.058 .052 -.170    
Nighttime restfulness 43       
Step 1     .093 .093 .277 
Age  -.001 .042 -.005    
Stage  .102 .269 .059    
Income  .618 .314 .301    
Step 2     .094 .000 .890 
Ethnicity  -.180 1.298 -.024    
Daytime sedentariness 43       
Step 1     .185 .185 .045* 
Age  -.087 .064 -.200    
Stage  .244 .409 .088    
Income  -1.221 .478 -.370*    
Step 2     .189 .004 .655 
Ethnicity  -.890 1.974 -.074    
* p < .05
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Summary of results for hypothesis 2A.1: Hierarchical regression analyses entering 
ethnicity as a predictor of endocrine disruption variables. 
Variable N B SE B β R2 ΔR2 p of ΔR2 
CAR slope 36       
Step 1     .041 .041 .714 
Age  -.006 .007 -.166    
Stage  .013 .044 .051    
Income  .019 .053 .061    
Step 2     .119 .078 .107 
Ethnicity  .335 .202 .314    
Diurnal cortisol slope 45       
Step 1     .056 .056 .495 
Age  -.001 .001 -.072    
Stage  -.006 .007 -.133    
Income  -.011 .008 -.201    
Step 2     .056 .000 .908 
Ethnicity  .004 .033 .020    
Diurnal cortisol mean 45       
Step 1     .070 .070 .391 
Age  .009 .006 .245    
Stage  .035 .038 .143    
Income  -.002 .045 -.005    
Step 2     .081 .011 .491 
Ethnicity  .121 .174 .115    
* p < .05 
 
 
Summary of results for hypothesis 2A.1: Hierarchical regression analyses entering 
ethnicity as a predictor of immune factor variables. 
Variable N B SE B β R2 ΔR2 p of ΔR2 
Factor 1 36       
Step 1     .054 .054 .616 
Age  -.005 .010 -.078    
Stage  -.088 .071 -.214    
Income  -.056 .078 -.057    
Step 2     .055 .001 .852 
Ethnicity  -.066 .351 -.039    
Factor 2 36       
Step 1     .07 .076 .465 
Age  .018 .013 .219    
Stage  -.071 .091 -.132    
Income  .071 .101 .120    
Step 2     .161 .085 .085 
Ethnicity  -.767 .432 -.344    
Factor 3 36       
Step 1     .342 .342 .004* 
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Age  -.045 .011 -.560*    
Stage  -.105 .077 -.194    
Income  -.040 .086 -.067    
Step 2     .388 .046 .137 
Ethnicity  .568 .372 .252    
* p < .05 
 
 
Summary of results for hypothesis 2A.2: Hierarchical regression analyses entering 
neighborhood socioeconomic stress as a predictor of circadian rhythm variables. 
Variable N B SE B β R2 ΔR2 p of ΔR2 
Rest/activity rhythm 40       
Step 1     .281 .281 .007* 
Age  .003 .002 .214    
Stage  .013 .011 .171    
Income  .045 .013 .497*    
Step 2     .282 .002 .763 
Neighborhood 
socioeconomic stress 
 -.008 .027 -.048    
Nighttime restfulness 40       
Step 1     .097 .097 .295 
Age  -.006 .045 -.023    
Stage  .292 .268 .176    
Income  .532 .324 .262    
Step 2     .099 .003 .747 
Neighborhood 
socioeconomic stress 
 -.218 .671 -.058    
Daytime sedentariness 40       
Step 1     .148 .148 .119 
Age  -.075 .065 -.180    
Stage  -.202 .389 -.081    
Income  -1.092 .471 -.359*    
Step 2     .163 .014 .444 
Neighborhood 
socioeconomic stress 
 .750 .968 .133    
* p < .05 
 
 
Summary of results for hypothesis 2A.2: Hierarchical regression analyses entering 
neighborhood socioeconomic stress as a predictor of endocrine disruption variables. 
Variable N B SE B β R2 ΔR2 p of ΔR2 
CAR slope 34       
Step 1     .046 .046 .696 
Age  -.007 .007 -.183    
Stage  .005 .043 .023    
Income  .026 .053 .089    
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Step 2     .080 .034 .308 
Neighborhood 
socioeconomic stress 
 -.141 .136 -.211    
Diurnal cortisol slope 41       
Step 1     .138 .138 .135 
Age  -.001 .001 -.111    
Stage  -.001 .006 -.021    
Income  -.018 .007 -.366*    
Step 2     .139 .001 .829 
Neighborhood 
socioeconomic stress 
 -.003 -.015 -.037    
Diurnal cortisol mean 41       
Step 1     .090 .090 .314 
Age  .011 .006 .277    
Stage  .027 .038 .113    
Income  -.022 .046 -.076    
Step 2     .336 .246 .001* 
Neighborhood 
socioeconomic stress 
 .290 .079 .537    
* p < .05 
 
 
Summary of results for hypothesis 2A.2: Hierarchical regression analyses entering 
neighborhood socioeconomic stress as a predictor of immune factor variables. 
Variable N B SE B β R2 ΔR2 p of ΔR2 
Factor 1 34       
Step 1     .076 .076 .490 
Age  -.008 .011 -.126    
Stage  -.036 .069 -.091    
Income  -.114 .080 -.253    
Step 2     .180 .103 .066 
Neighborhood 
socioeconomic stress 
 -.309 .162 -.356    
Factor 2 34       
Step 1     .032 .032 .803 
Age  .013 .015 .163    
Stage  -.017 .088 -.034    
Income  .048 .102 .086    
Step 2     .049 .017 .477 
Neighborhood 
socioeconomic stress 
 -.156 .217 -.145    
Factor 3 34       
Step 1     .438 .438 .001* 
Age  -.046 .011 -.602*    
Stage  -.150 .064 -.324*    
Income  -.070 .074 -.950    
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Step 2     .473 .035 .177 
Neighborhood 
socioeconomic stress 
 .213 .154 .207    
* p < .05 
 
 
Summary of results for hypothesis 2A.3: Hierarchical regression analyses entering 
cancer-related stress as a predictor of circadian rhythm variables. 
Variable N B SE B β R2 ΔR2 p of ΔR2 
Rest/activity rhythm 45       
Step 1     .236 .236 .011* 
Age  .002 .002 .191    
Stage  .010 .011 .127    
Income  .041 .012 .461*    
Step 2     .176 .015 .374 
Cancer-related stress  -.001 .001 -.123    
Nighttime restfulness 45       
Step 1     .092 .092 .262 
Age  .000 .039 .000    
Stage  .246 .250 .149    
Income  .523 .291 .269    
Step 2     .092 .000 .972 
Cancer-related stress  .001 .034 .005    
Daytime sedentariness 45       
Step 1     .156 .156 .071 
Age  -.074 .058 -.188    
Stage  -.140 .366 -.056    
Income  -1.087 .426 -.368*    
Step 2     .160 .004 .664 
Cancer-related stress  .022 .050 .064    
* p < .05 
 
 
Summary of results for hypothesis 2A.3: Hierarchical regression analyses entering 
cancer-related stress as a predictor of endocrine disruption variables. 
Variable N B SE B β R2 ΔR2 p of ΔR2 
CAR slope 39       
Step 1     .042 .042 .674 
Age  -.006 .006 -.181    
Stage  .003 .040 .014    
Income  .019 .049 .067    
Step 2     .058 .016 .455 
Cancer-related stress  -.004 .005 -.129    
Diurnal cortisol slope 47       
Step 1     .071 .071 .358 
Age  -.001 .001 -.099    
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Stage  -.002 .006 -.053    
Income  -.013 .008 -.258    
Step 2     .156 .084 .047* 
Cancer-related stress  -.002 .001 -.292    
Diurnal cortisol mean 47       
Step 1     .067 .067 .391 
Age  .008 .006 .227    
Stage  .041 .036 .169    
Income  .003 .043 .011    
Step 2     .118 .051 .127 
Cancer-related stress  .007 .005 .227    
* p < .05 
 
 
Summary of results for hypothesis 2A.3: Hierarchical regression analyses entering 
cancer-related stress as a predictor of immune factor variables. 
Variable N B SE B β R2 ΔR2 p of ΔR2 
Factor 1 39       
Step 1     .050 .050 .608 
Age  -.002 .011 -.037    
Stage  -.060 .069 -.144    
Income  -.085 .079 -.180    
Step 2     .051 .001 .853 
Cancer-related stress  -.002 .009 -.031    
Factor 2 39       
Step 1     .064 .064 .502 
Age  .018 .013 .227    
Stage  -.046 .082 -.092    
Income  .040 .094 .070    
Step 2     .074 .010 .551 
Cancer-related stress  .007 .011 .100    
Factor 3 39       
Step 1     .288 .288 .007* 
Age  -.040 .011 -.505*    
Stage  -.116 .073 -.229    
Income  -.069 .083 -.120    
Step 2     .315 .028 .248 
Cancer-related stress  .011 .009 .168    
* p < .05 
 
 
Summary of results for hypothesis 2B.1: Cox proportional hazards model entering 
ethnicity as a predictor of progression-free survival. 
 B SE B Wald Hazards Ratio 95% Confidence Interval 
Time Since DD      
Ethnicity .157 .579 .073 1.170 .376-3.637 
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Time Since SE+      
Ethnicity -.078 .542 .021 .925 .320-2.678 
* p < .05 
+ Study entry (SE) calculated from date of first cortisol collection 
 
 
Summary of results for hypothesis 2B.2: Cox proportional hazards model entering 
neighborhood socioeconomic stress as a predictor of progression-free survival. 
 B SE B Wald Hazards Ratio 95% Confidence Interval 
Time Since DD      
Neighborhood 
socioeconomic 
stress 
.302 .263 1.319 1.352 .808-2.263 
Time Since SE+      
Neighborhood 
socioeconomic 
stress 
.271 .257 1.112 1.311 .793-2.168 
* p < .05 
+ Study entry (SE) calculated from date of first cortisol collection 
 
 
Summary of results for hypothesis 2B.3: Cox proportional hazards model entering 
cancer-related stress as a predictor of progression-free survival. 
 B SE B Wald Hazards Ratio 95% Confidence Interval 
Time Since DD      
Cancer-related 
stress 
-.001 .020 .003 .999 .961-1.038 
Time Since SE+      
Cancer-related 
stress 
-.014 .019 .569 .986 .950-1.023 
* p < .05 
+ Study entry (SE) calculated from date of stress assessment 
 
 
Summary of results for hypothesis 2C.1: Cox proportional hazards model entering 
circadian disruption variables as predictors of progression-free survival. 
 B SE B Wald Hazards Ratio 95% Confidence Interval 
Time Since DD      
Rest/activity 
rhythm 
.712 1.539 .214 2.038 .100-41.633 
      
Nighttime 
restfulness 
-.012 .082 .880 1.012 .862-1.188 
      
Daytime 
sedentariness 
.000 .050 .000 1.000 .907-1.103 
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Time Since SE+      
Rest/activity 
rhythm 
.910 1.524 .356 2.484 .125-49.285 
      
Nighttime 
restfulness 
-.016 .082 .040 1.016 .865-1.194 
      
Daytime 
sedentariness 
-.002 .050 .001 .998 .904-1.102 
* p < .05 
+ Study entry (SE) calculated from date of first actigraphy assessment 
 
 
Summary of results for hypothesis 2C.2: Cox proportional hazards model entering 
endocrine disruption variables as predictors of progression-free survival. 
 B SE B Wald Hazards Ratio 95% Confidence Interval 
Time Since DD      
CAR slope .470 .739 .404 1.599 .376-6.806 
 
Diurnal cortisol 
slope 
 
.093 
 
3.166 
 
.001 
 
1.098 
 
.002-543.143 
      
Diurnal cortisol 
mean 
.463 .531 .762 1.589 .562-4.496 
Time Since SE+      
CAR slope .404 .731 .306 1.498 .357-6.281 
      
Diurnal cortisol 
slope 
1.207 2.926 .170 3.343 .011-1035.063 
      
Diurnal cortisol 
mean 
.421 .498 .716 1.524 .574-4.045 
* p < .05 
+ Study entry (SE) calculated from date of first cortisol collection 
 
 
Summary of results for hypothesis 2C.3: Cox proportional hazards model entering 
immune factors as predictors of progression-free survival. 
 B SE B Wald Hazards Ratio 95% Confidence Interval 
Time Since DD      
Factor 1 -.168 .258 .422 .846 .510-1.402 
      
Factor 2 -.108 .359 .091 .897 .444-1.812 
      
Factor 3 -.123 .304 .163 .884 .487-1.606 
Time Since SE+      
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Factor 1 -.168 .251 .448 .846 .518-1.382 
      
Factor 2 -.226 .338 .447 .798 .412-1.546 
      
Factor 3 -.214 .291 .542 .807 .456-1.428 
* p < .05 
+ Study entry (SE) calculated from date of blood draw 
 
 
Summary of results for post hoc analyses: Hierarchical regression analyses entered 
cancer-related stress subscales as a predictor of diurnal cortisol slope. 
Variable N B SE B β R2 ΔR2 p of ΔR2 
Diurnal Cortisol Slope 48       
Step 1     .091 .091 .234 
Age  -.001 .001 -.124    
Stage  -.003 .006 -.077    
Income  -.015 .008 -.283    
Step 2 
Cancer-related stress: 
Intrusions 
 
 
 
-.001 
 
.002 
 
-.124 
.107 .015 .395 
Step 2     .244 .153 .005* 
Cancer-related stress: 
Avoidance 
 -.004 .001 -.399    
* p < .05 
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cortisol data. 
Directed by Sandra Sephton, Ph.D. 
Supervised by Emily Eismann, B.A. (Ph.D. Candidate) 
 
Undergraduate Research Assistant 
September 2009-December 2009 
Entered data into SPSS and cleaned the undergraduate stress study data. 
Directed by Sandra Sephton, Ph.D. 
Supervised by Scott Hanneman, B.A. (Ph.D. Candidate) 
 
Laboratory and Data Analytic Experience 
Endocrinology 
Experience preparing and running enzyme-linked immunosorbent assays (ELISA) for 
salivary cortisol. Experience in collecting, preparing, processing, and preserving human 
saliva samples. Experience in cortisol data cleaning and reduction. 
 
Immunology 
Experience processing and preserving serum and plasma human blood samples. 
Experience preparing under sterile technique and preserving human whole blood samples 
for stimulated immunomodulator analysis. Experience preparing immunomodulator 
stimulation media. 
 
Circadian Rhythms 
Experience in initializing and downloading MicroMini Motionlogger Actiwatches. 
Experience in cleaning and scoring actigraphy data. 
 
Data Analysis 
Experience in conducting univariate and multivariate analyses, structural equation 
modeling, hierarchical linear modeling, survival analyses, and geocoding. Experience 
using the following statistical software: SPSS, AMOS, HLM, and American Fact Finder 
(Census data). 
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Research Funding  
Title: Understanding the prognostic significance of circadian disruption in lung cancer, 
and piloting an intervention 
Role: Research Assistant 
PI: Sandra Sephton, Ph.D. 
Status: Funded 
Dates: June 1, 2014-May 31, 2016 
Budget: $150,000 
Sponsor: Kentucky Lung Cancer Research Board 
Description: This study will explore circadian disruption as a mediator of psychosocial 
effects on tumor progression. Innovations of the study include a focus on circadian 
disruption as a potential mediator of psychosocial effects on tumor progression; studying 
distress in a population of high need; and piloting a portable, highly feasible psychosocial 
intervention in lung cancer patients. 
 
Title: Gene-Environment Interactions in the Biobehavioral Sequelae of Breast Cancer 
Diagnosis and Treatment 
Role: Research Assistant 
PI: Sandra Sephton, Ph.D. 
Status: Funded 
Dates: January 1, 2011-June 30, 2011 
Budget: $3,000 
Sponsor: University of Louisville Intramural Incentives Grant-Undergraduate Research 
Grant 
Description: This genotyping study will explore how the serotonin transporter gene (5-
HTT) and the circadian genes Period3 (PER3) and Neuronal PAS domain protein 2 
(NPAS2) interact with the stress of breast cancer diagnosis and treatment to produce 
psychopathology and circadian disruption. 
 
Published Manuscripts 
Rebholz, W.N.; Cash, E.; Zimmaro, L.A.; Bayley-Veloso, R.; Phillips, K.; Chagpar, A.; 
Dhabhar, F.; Spiegel, D.; Saltsman Bell, B.N.; Sephton, S.E. (2016) Distress and 
QOL in an Ethnically Diverse Sample Awaiting Breast Cancer Surgery. Journal 
of Health Psychology. In Press. doi: 10.1177/1359105316659916. 
 
Zimmaro, L.A., Salmon, P., Naidu, H., Rowe, J., Phillips, K., Rebholz, W.N., Giese-
Davis, J., Cash, E., Dreeben, S., Bayley-Veloso, R.C., Jablonski, M., Hicks, A., 
Siwik, C., and Sephton, S.E. (2016) The Role of Dispositional Mindfulness in 
Stress and Health Outcomes in University Undergraduate Students. Mindfulness, 
7, 874-885. doi: 10.1007/s12671-016-0526-8. 
 
Cash, E.; Sephton, S.E.; Chagpar, A.B.; Spiegel, D.; Rebholz, W.N.; Zimmaro, L.A.; 
Tillie, J.M.; Dhabhar, F.S. (2015) Circadian disruption and tumor 
promotion/progression signals in breast cancer patients awaiting surgery. Brain 
Behavior, Immunity, 102-114. doi: 10.1016/j.bbi.2015.02.017. 
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Cash, E.; Salmon, P.; Weissbecker, I.; Rebholz, W.N; Bayley-Veloso, R.; Zimmaro, L.; 
Floyd, A.; Dedert, E.; Sephton, S.E. (2014). Mindfulness Meditation Alleviates 
Fibromyalgia Symptoms in Women: Results of a Randomized Trial.  Annals of 
behavioral medicine, 1-12. doi: 10.1007/s12160-014-9665-0 
 
Sephton, S. E., Lush, E., Dedert, E. A., Floyd, A. R., Rebholz, W. N., Dhabhar, F. S., 
Spiegel, D., & Salmon, P. (2013). Diurnal cortisol rhythm as a predictor of lung 
cancer survival. Brain, behavior, and immunity, 30 Suppl, S163-170. doi: 
10.1016/j.bbi.2012.07.019 
 
Published Abstracts and Presentations  
Seibert, A.; Pace, A.; Rebholz, W.; Wilson, L.; Bumpous, J.M.; Cash, E. (2016). 
Preoperative Biomarkers as Predictors of Surgical Complications and Survival in 
Head and Neck Cancer. Poster presentation at the AHNS 9th Annual International 
Conference, Seattle, WA.  
 
Pace, A.; Seibert, A.; Rebholz, W.; Wilson, L.; Bumpous, J.M.; Cash, E. (2016). 
Psychological Distress and Malnutrition Biomarkers are associated with Head and 
Neck Cancer Progression and Survival. Oral paper presentation at the American 
Psychosomatic Society 74th Annual Scientific Meeting, Denver, CO.     
 
Rebholz, W.N., Weissbecker, I., Cash, E., Bayley-Veloso, R., Zimmaro, L.A., Phillips, 
K., Sephton, S.E. (2015). Diurnal Cortisol Rhythms and Systemic Norepinephrine 
Predict Gynecologic Cancer Survival. Poster presentation at the American 
Psychosomatic Society 73rd Annual Scientific Conference, Savannah, GA. 
 
Cash, E.; Chilton, P.; Rebholz, W.; Bayley-Veloso, R.; Zimmaro, L.; Chagpar, A.B.; 
Spiegel, D.; Dhabhar, F.S.; Sephton, S.E. (2015). HPA and Rest/Activity 
Rhythms Independently Associated with Different Aspects of Inflammatory 
Response in Patients Awaiting Treatment for Breast Cancer. Oral paper 
presentation at the American Psychosomatic Society 73rd Annual Scientific 
Meeting, Savannah, GA. 
 
Bayley-Veloso, R., Weissbecker, I., Rebholz, W.N., Cash, E., Zimmaro, L.A., Phillips, 
K., Salmon, P., Sephton, S.E. (2015). Do traumatic events build resilience 
and promote survival through social support in gynecologic cancer?. Poster 
presentation at the American Psychosomatic Society 73rd Annual Scientific 
Conference, Savannah, GA. 
 
Zimmaro, L.A.; Rebholz, W.; Cash, E.; Bayley-Veloso, R.; Phillips, K.; Salmon, P.; 
Sephton, S.E. (2105). Optimism as a Moderator of Psychoneuroimmune Pathways 
in Lung Cancer Patients. Poster presentation at the American Psychosomatic 
Society 73rd Annual Scientific Conference, Savannah, GA. 
 
Phillips, K.; Salmon, P.; Patel, H.; Rowe, J.; Rebholz, W.; Zimmaro, L.; Bayley-Veloso, 
R.; Cash, E.; Giese-Davis, J.; Sonnier, H.; Sephton, S.E. (2015). The Role of 
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Mindfulness in Stress and Health Outcomes in University Undergraduate 
Students. Poster presentation at the American Psychosomatic Society 73rd Annual 
Scientific Conference, Savannah, GA. 
 
Gettelfinger, J.; Rebholz, W.; Russ, E.; Wilson, L.; Sephton, S.E.; Bumpous, J.M.; Cash, 
E. (2014). Depressive Symptoms Predict Poor Treatment Adherence and 
Response in Head and Neck Cancer. Paper presentation at the Kentucky Society 
for Otolaryngology Annual Meeting, August 1-2. 
 
Cash, E.; Gettelfinger, J.; Rebholz, W.; Russ, E.; Wilson, L.; Sephton, S.E.; Bumpous, 
J.M. (2014). Depressive Symptoms Predict Poor Treatment Adherence and 
Response in Head and Neck Cancer. Paper presentation at the International 
Federation of Head and Neck Oncologic Societies 5th World Congress and 
American Head and Neck Society Annual Meeting, New York, NY, July 26-30. 
 
Rebholz, W.N., Weissbecker, I., Cash, E., Bayley, R., Zimmaro, L.A., Sephton, S.E. 
(2014). Distress and support: Links with circadian disruption and quality of life 
in gynecologic cancer. Oral paper presentation at the American Psychosomatic 
Society 72nd Annual Scientific Conference, San Francisco, CA. 
 
Sephton, S.E., Cash, E., Chagpar, A., Spiegel, D., Rebholz, W.N., Bayley, R.C., 
Zimmaro, L.A., and Dhabhar, F.S. (2014). Biological correlates of marital status 
in recently diagnosed breast cancer patients. Oral paper presentation at the 
American Psychosomatic Society 72nd Annual Scientific Conference, San 
Francisco, CA. 
 
Cash, L., Rebholz, W., Gettelfinger, J., Russ, E., Wilson, L., Bumpous, J. M., Sephton, S. 
E. (2014). Depressive Symptoms Predict Poor Treatment Adherence and 
Response in Head and Neck Cancer. Poster presentation at the American 
Psychosomatic Society 72nd Annual Scientific Conference, San Francisco, CA. 
 
Bayley, R., Rebholz, W., Cash, E., Weissbecker, I., Salmon, P., Sephton, S. (2014). 
Associations between Trauma Across the Lifespan, Health Behaviors, and 
Allostatic Load in Gynecologic Cancer Patients. Poster presentation at the 
American Psychosomatic Society 72nd Annual Scientific Conference, San 
Francisco, CA. 
 
Zimmaro, L.A., Rebholz, W.N., Bayley, R., Cash, L., Sephton, S.E. (2014). Gender 
Differences among Lung Cancer Patients in Appraisal, Coping, and Distress. 
Poster presentation at the American Psychosomatic Society 72nd Annual 
Scientific Conference, San Francisco, CA. 
 
Rebholz, W.N., Cash, E., Dhabhar, F., Chagpar, A., Chapman, L.K., Sephton, S.E. 
(2013). Psychological distress, but not stress physiology, is associated with 
quality of life in presurgical breast cancer patients. Poster presentation at the 
	  	   180 
American Psychosomatic Society 71st Annual Scientific Conference, Miami, 
Florida. 
 
Rebholz, W.N., Sephton, S. (2013). Social support in lung cancer patients: the association 
with endocrine and immune function. Poster presentation at the American 
Psychosomatic Society 71st Annual Scientific Conference, Miami, Florida. 
 
Cash, E., Sephton, S.E., Chagpar, A.B., Spiegel, D., Rebholz, W.N., Dhabhar, F.S. 
(2013). Circadian disruption and tumor promotion/progression signals in newly 
diagnosed breast cancer patients. Poster presentation at the American 
Psychosomatic Society 71st Annual Scientific Conference, Miami, Florida. 
 
Bayley, R., Rebholz, W.N., Sephton, S.E. (2013). Cancer-specific distress, coping, and 
health behaviors in lung cancer patients. Poster presentation at the American 
Psychosomatic Society 71st Annual Scientific Conference, Miami, Florida. 
 
Gesler, W., Lush, E., Dhabhar, F., Chagpar, A., Chapman, L.K., Dedert, E., Sephton, S. 
(2012). Psychological distress, but not stress physiology, is associated with 
quality of life in presurgical breast cancer patients. Poster presentation at the 
University of Louisville Graduate Student Research Symposium, Louisville, KY. 
 
Gesler, W.N.; Dhabhar, F.S.; Chagpar, A.B.; Lush, E.; Dedert, E.A.; Daup, M.B.; 
Spiegel, D.; Dayyat, E.A.; Tillie, J.M.; McMasters, K.M.; Sephton, S.E. (2011). 
Cancer-Specific Distress: No Association with Serum Cytokines in Presurgical 
Breast Cancer Patients. Poster presentation at the American Psychosomatic 
Society 69th Annual Scientific Conference, San Antonio, TX.  
 
Daup, M., Lush, E., Gesler, W., Dedert, E., McMasters, K., Sephton, S., Chagpar, A. 
(2010).  Is cancer specific distress correlated with time to definitive surgery in 
breast cancer patients? Poster Presentation at the San Antonio Breast Cancer 
Symposium, San Antonio, TX. 
 
Gesler, W., Dhabhar, F., Chagpar, A., Dedert, E., Lush, E., Daup, M., Dayyat, E., 
McMasters, K., Sephton, S.E. (2010). Distress and Inflammation in Women 
Newly Diagnosed with Breast Cancer. Poster Presentation at the James Graham 
Brown Cancer Center Ninth Annual Retreat, Louisville, KY. 
 
Manuscripts in Preparation 
Rebholz, W.N.; Cash, E.; Bayley, R.C.; Zimmaro, L.A.; Phillips, K.; Siwik, C.; Sephton, 
S.E. Diurnal Cortisol Rhythm and Norepinephrine Predict Gynecologic Cancer 
Survival. To be submitted to Journal of the National Cancer Institute. 
 
Jablonski, M. E.; Dreeben, S.; Hanneman, S.; Vines, L.; Rebholz, W.N.; Bayley, R.; 
Eismann, E.; Sephton, S.E.; Litvan, I.; Houghton, D.; Constantino, A.; Salmon, 
P. A Randomized-Controlled Pilot Study of Mindfulness-Based Stress Reduction 
(MBSR) for Early-Stage Parkinson’s Disease Patient and Caregiver Dyads.  
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Rebholz, W.N.; Weissbecker, I.; Cash, E.; Bayley, R.C.; Sephton, S.E. Distress and 
Support: Links with Circadian Disruption and Quality of Life in Gynecologic 
Cancer. To be submitted to Psychoneuroendocrinology. 
 
Bayley, R., Rebholz, W.N., Cash, E., Weissbecker, I., Salmon, P., Sephton, S. 
Associations between Trauma Across the Lifespan, Health Behaviors, and 
Allostatic Load in Gynecologic Cancer Patients. 
 
Sephton, S.E.; Cash, E.; Chagpar, A.B.; Spiegel, D.; Rebholz, W.N.; Bayley, R.C.; 
Zimmaro, L.Z.; Dhabhar, F.S. Breast Cancer, Circadian Disruption, and 
Stimulated Immunity. To be submitted to Brain, Behavior, Immunity. 
 
Rebholz, W.N.; Sephton, S.E. The Effects of Coping and Social Support on Physiology 
in Patients with Lung Cancer. 
 
Zimmaro, L.A.; Cash, E.; Rebholz, W.N.; Bayley, R.C.; Sephton, S.E. Mindfulness, 
Sleep, and Circadian Rhythms.  
 
Clinical Experience 
July 2015-July 2016 
Predoctoral clinical psychology internship at the Central Texas Veterans Health Care 
System. The predoctoral clinical psychology internship includes three major rotations, 
which are four days a week for three months each, two minor rotations, which are one 
half day a week for six months, and a half day of didactics/group supervision a week. 
Major rotations included primary care/behavioral health, health behavior clinic, and 
mental health clinic. Minor rotations included the psychosocial rehabilitation resource 
center and the Post-Traumatic Stress Disorder clinic. Additional activities included case 
conference write-up and presentation (assessment and intervention case), didactics (EBP 
and general topics relevant to clinical psychology and working in the VA), group 
supervision, diversity seminar, interdisciplinary professional training presentations, and 
staff meetings. 
Training Directors: Andrew Cook, Ph.D. and Erin Andrews, Psy.D., ABPP 
 
April 2016-July 2016 
Predoctoral clinical psychology internship 
The mental health clinic major rotation includes consultation intakes, individual therapy, 
group therapy (facilitating acceptance and commitment therapy (ACT) for anxiety and 
depression and co-facilitating cognitive processing therapy (CPT) for sexual trauma), 
treatment planning, consultation, staff meetings, chart review/clinical report writing, 
reading, and one-on-one supervision. 
Supervised by Kentrell Avery, Psy.D. 
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February 2016-July 2016 
Predoctoral clinical psychology internship 
The Post-Traumatic Stress Disorder clinic minor rotation includes individual therapy 
(coping skills for PTSD, CPT, and prolonged exposure), treatment planning, chart 
review/clinical report writing, reading, and one-on-one supervision. 
Supervised by Regina Hiraoka, Ph.D. 
 
November 2015-March 2016 
Predoctoral clinical psychology internship 
The health behavior clinic major rotation included presurgical evaluations (transplant and 
bariatric), consultation intakes and individual therapy (CBT-insomnia, CBT-chronic pain, 
and chronic disease management), co-facilitating group therapy (MOVE weight 
management, CBT-insomnia, tobacco cessation, disease management), treatment 
planning, consultation, national conference calls, case conferences and presentation, staff 
meetings, co-facilitating motivational interviewing and TEACH trainings, audio 
recordings, chart review/clinical report writing, reading, and one-on-one supervision. 
Supervised by Andrew Cook, Ph.D.  
 
July 2015-January 2016 
Predoctoral clinical psychology internship 
The psychosocial resource and recovery center minor rotation included treatment 
planning sessions, recovery coaching, individual therapy, co-facilitating group therapy 
(mindfulness for depression and stress management), treatment planning, staff meetings, 
audio recording, chart review/clinical report writing, reading, and one-on-one 
supervision. This clinic population includes Veterans with long-term severe mental 
illness needs.  
Supervised by Jennifer Rigsby, Ph.D. 
 
July 2015-November 2015 
Predoctoral clinical psychology internship 
The primary care/behavioral health major rotation included consultation intakes, brief 
solution-focused therapy, consultation-liaison, co-facilitating group therapy (CBT-
insomnia, CBT-chronic pain, and mindfulness-based stress reduction), staff meetings, 
audio recording, chart review/clinical report writing, reading, and one-on-one 
supervision. 
Supervised by Claudia Goleburn, Psy.D. 
 
August 2014-June 2015 
Graduate program practicum 
Clinical practicum learning Cognitive-Behavioral therapeutic interventions with a focus 
on treatment of anxiety disorders in adults and children. Weekly team supervision, peer 
consultation, one-on-one supervision, intakes, assessments, individual therapy, group 
therapy, case conceptualization, audio/visual digital recording review, chart 
review/clinical report writing, and reading are activities that are included. 
Supervised by Janet Woodruff-Borden, Ph.D. 
 
	  	   183 
May 2014-June 2015 
Clinic Graduate Teaching Assistant 
Graduate teaching assistant at the Noble H. Kelley Psychological Services Center, a 
graduate student run clinic at the University of Louisville. Responsibilities include 
coordinating the PSC colloquium series, opening and closing the clinic, checking in 
clients for appointments, phone intakes for therapy and assessment clients, clinical 
interviews/intakes with prospective therapy clients; supervision of graduate students; 
one-on-one supervision, chart review, report writing, and audio/visual digital recording 
review are activities that are included. 
Supervised by Bernadette Walter, Ph.D. 
 
April 2014-June 2015 
Graduate program practicum 
Neuropsychology practicum learning how to conduct dementia assessments. Clinical 
interviewing, administration of neuropsychological assessment battery, collateral 
interview, one-on-one supervision, chart review/assessment report writing, and reading 
are all activities that are included. Additional opportunities to complete surgical 
evaluations (i.e., cochlear implant), conduct cognitive assessments in children with 
possible central auditory processing disorder, and work with therapy clients are included. 
Supervised by Elizabeth Cash, Ph.D. and Eric Russ, Ph.D. 
 
August 2013-August 2014 
Graduate program practicum 
Clinical practicum learning Behavioral/Cognitive-Behavioral therapeutic interventions 
with a focus on treatment of ADHD and emotional difficulties in children. Weekly team 
supervision, peer consultation, one-on-one supervision, intakes, assessments, individual 
therapy, group therapy, case conceptualization, audio/visual digital recording review, 
chart review/clinical report writing, and reading are activities that are included.  
Supervised by Paul Rosen, Ph.D. 
 
May 2013-May 2014 
Graduate program practicum 
Head and neck cancer clinic practicum learning how to conduct health and behavior 
assessments and medical/health related interventions for newly diagnosed patients. 
Clinical interviewing, administration of self-report questionnaires, consultation/liaison 
work, evaluations (e.g., cochlear implant), one-on-one supervision, chart 
review/assessment report writing, program development, and reading are activities that 
are included.  
Supervised by Elizabeth Cash, Ph.D. and Eric Russ, Ph.D. 
 
May 2012-June 2015 
Graduate program practicum 
Assessment practicum learning how to conduct ADHD and learning disability testing for 
adults. Clinical interviewing, administration of standardized testing, one-on-one 
supervision, chart review/clinical report writing, and reading are activities that are 
included. 
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Supervised by David Winsch, Ph.D. 
 
May 2012-June 2015 
Graduate program practicum 
Assessment practicum learning how to conduct advanced placement testing for children. 
Clinical interviewing of parents/legal guardians, administration of standardized testing, 
one-on-one supervision, chart review/clinical report writing, and reading are activities 
that are included. 
Supervised by Bernadette Walter, Ph.D. 
 
August 2011-August 2013 
Graduate program practicum 
Clinical practicum learning a Mindfulness approach to therapeutic interventions, 
primarily working with adults with mood disorders. Weekly team supervision, peer 
consultation, one-on-one supervision, individual therapy, case conceptualization, 
audio/visual digital recording review, chart review/clinical report writing, and reading are 
activities that are included.  
Supervised by Paul Salmon, Ph.D. 
 
Teaching Experience 
2011-2015 
Graduate Teaching Assistant, University of Louisville Department of Psychological and 
Brain Sciences 
Courses Assisted: Psychology 385: Abnormal Psychology; Psychology 344: 
Physiological Psychology; Psychology 443: Intro to Neuroscience; Psychology 302: 
Experimental Psychology (including teaching recitations); Psychology 372: Social 
Psychology; Psychology 375: Personality; Psychology 693: Interviewing Skills 
Practicum; Psychology 680: Intellectual and Cognitive Assessment  
 
Community Service & Volunteer Experience 
Peer Reviewer: American Psychosomatic Society          November 2015 
Conference Abstracts 
 
Athena’s Sisters Empowerment Workshop                      Louisville, KY 
“I am woman, hear me roar”             May 11, 2015 
 
Peer Reviewer: American Psychosomatic Society          November 2014 
Conference Abstracts 
 
Psychiatry Resident Lecture             Louisville, KY  
Topic: Geriatric Neuropsychological Assessment              October 2014 
 
Peer Reviewer: Psychosomatic Medicine           October 2014 
 
Peer Reviewer: Psycho-Oncology               June 2014 
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Cohort Liaison to the Faculty             October 2013-September 2014 
 
Dress for Success Talk     Louisville, KY 
Topic: Stress Management and Your Career              June 18, 2013 
 
Dress for Success Health Fair                Louisville, KY 
Psychological Services Center Representative  November 10, 2012 
 
Heart Walk Volunteer                 Louisville, KY 
American Heart Association                September 22, 2012 
 
St. James Catholic Church     Louisville, KY 
Volunteer       Winter 2011 
        
University of Louisville     Louisville, KY 
Disability Resource Center Note Taker   Fall 2010 
 
Children’s Hospital Foundation    Louisville, KY  
Teen Advisory Board President                Summer 2006-Spring 2007 
 
National Youth Leadership Forum               Atlanta, GA 
Medical Outreach Program                July 25-29, 2006 
 
Professional Membership 
APA Division 29- Psychotherapy     Summer 2013-Summer 2014 
APA Division 38- Health Psychology    Summer 2013-Present 
American Psychological Association                         Summer 2011-Present 
 APAGS-Campus Representative    August 2013-August 2014 
Kentucky Psychological Association                Summer 2011-Present 
American Psychosomatic Society                Spring 2011-Present 
Psi Chi International Honor Society in Psychology                Inducted Spring 2010 
Vice President and Historian: UofL Chapter                     Fall 2010-Summer 2011 
Fundraising Coordinator: UofL Chapter                     Fall 2009-Summer 2010 
